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Scope of the thesis. 
This thesis describes the experiments done to understand the role of the transcription factor 
GATA·l in erythropoiesis and Sertoli cells. 
In Chapter 1 hematopoiesis, erythropoiesis and the GA TA transcription factor family 
are introduced. Hematopoiesis is the process of the formation ofblood cells from 
hematopoietic stem cells via differentiated progenitors. Erythopoiesis is the process of the 
formation of the red blood cells, that if disturbed leads to anaemia. The transcription factor 
GATA-1 is essential for erythropoiesis beyond the proerythroblast stage. Transcription factors 
are proteins that bind DNA and are required for regulation of gene transcription. GATA-1 is 
thought to be important for the expression of alllalown erythroid-specific genes. However, 
these target genes are not completely silenced and are sometimes expressed at considerable 
levels in GATA-1 deficient mice. The precise role of the protein is however still elusive. 
In the second part of the introduction the GATA factor family is introduced. Most 
GATA factors are co-expressed with family members for at least some time during a wide 
variety of differentiation processes. Some clues to the function of the GATA-1 protein might 
therefore be obtained from studies of other family members. 
In erythroid progenitors GATA-1 and GATA-2 proteins are expressed. It has been 
suggested that a relative high level of the GATA-1 protein, compared to GATA-2 protein, 
would instruct erythroid progenitors to terminally differentiate. To test this hypothesis we did 
experiments in which we overexpressed GATA-1 in these ety1:]:rroid progenitors in mice. The 
results of these experiments are described in Chapter 2 and reveal that although GATA-1 is 
essential, it should be downregu!ated during terminal differentiation. Cells overexpressing the 
GATA-1 protein are blocked late in differentiation. This defect is overcome when 
overexpressing cells are in a mixed environment with wild type cells in vivo. The wild type 
cells appear to provide a signal to the GA TA-l overexpressing cells instructing them to 
differentiate. The nature of this signal, which we called red cell differentiation signal or 
REDS, is still unlmo\VIl and the search for this signal is ongoing. 
In Chapter 3 the generation of conditional GATA-1 lmockout mice, using the Cre-
lox.P system, is described. These mice were made to reveal more of GAT A-1 's secrets. These 
mice would make it possible to study the GATA-1 knockout after the embryonic stage. 
In Chapter 4 the condirionallmockout was used to make a tissue-specific lmockout of 
GATA-1 in the testis, the only site of expression ofGATA-1 outside the hematopoietic 
system. Deficiency of the GATA-1 protein in the testis did not result in any obvious 
phenotype. Consequently GATA-1 is not essential in the testis. 
8 
In Chapter 5, a new method to culture and differentiate erythroid progenitors in a 
quick and small scale assay is introduced. This assay has several practical advantages over 
other culture methods. thus adding a useful tool to the arsenal of the molecular hematologist. 
Chapter 6 is a general discussion of the work described in this thesis, and suggests 
several future directions that could be taken to follow-up on the present studies ofGATA-l 
function. 
9 
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Chapter 1 
Introduction: hematopoiesis, erythropoiesis and 
the transcription factor GATA-1 
II 
Hematopoiesis 
Hematopoiesis is the process of formation of blood cells. There are at least eight types 
of blood cells that are very different in their appearance and function. In a simplified 
categorization they can be divided into white and red blood cells and platelets. The white 
blood cells are the lymphocytes, granulocytes (leukocytes, eosinophils, neutrophils) 
monocytes/macrophages and mast cells. They are the soldiers of the immune system and 
protect us against bacteria, viruses and other micro organisms. The platelets are small cell 
fragments that are required for hemostasis. The red blood cells or erythrocytes are small 
biconcave cells that transport oxygen and carbon dioxide through the body. They take up 
oxygen and release carbon dioxide in the lungs and do the reverse in the other tissues. All the 
different blood cells originate from a small population of rare cells, the hematopoietic stem 
cells (Lemischka et al. 1986). 
The hematopoietic stem cells 
Stem cells have the potential to self-renew and to give rise to every type of mature 
blood cells (Ploemacher 1997). The larter ability is called pluripotency. The process of stem 
cells undergoing changes to become a different type of cells is called differentiation. The 
accepted model is that when hematopoietic stem cells divide. a proportion of the daughter 
cells remains stem cells thus forming a continuous source of hematopoietic cells, and other 
daughter cells enter the differentiation process. During this process they divide many times so 
that one stem cell can be the source of a large number of mature blood cells. During 
differentiation the cells go through many different stages in which they change morphology 
and functional characteristics, gradually losing the potential to become any type of blood cell. 
The idea of a pluripotent stem cell was first postulated in the beginning of the 
twentieth century when improvements in histological techniques enabled scientists to 
discriminate between various cells (Bondurant and Koury 1998). At that time it was already 
!mown that the site of blood formation in adults is the bone marrow (Neumann 1868). In this 
tissue there appears to be a continuous sequence of cells chang_ing in morphology and number. 
It was proposed that as cells increase in number, they also change in morphology. This model 
has been further refined and has led to the concept of the hematopoietic tree, a schematic 
representation of the different routes cells can follow to become mature blood cells. Formal 
proof of the existence of stem cells has come from retroviral marked bone marrow 
transplantations in lethally irradiated animals (Lemischka et al. 1986) (Ford et al. 1956). 
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Figure 1: The hematopoietic tree. The different pathways starting from the stem cell leading to the 
mature blood cells are shown. Between the different stages. the cells divide so that a small number of 
stem cells can give rise to a large number of mature cells. 
(Adapted from (Bondurant and Koury 1998)) 
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The committed hematopoietic progenitor cells 
The first "offspring' of the stem cells that have started to differentiate, the committed 
hematopoietic progenitor cells, are cells that can still form different blood cell types but are 
not capable of long term reconstitution of hematopoiesis in lethally irradiated recipients. As 
cells progress in the differentiation tree the cells become more restricted to specific lineage 
choices. These progenitors can be monitored by culturing them in semi-solid media with the 
appropriate mix of growth factors (Metcalf 1989). During culture the progenitors form 
colonies and the mature cells from these colonies can be analysed. More immature cells give 
rise to several cell types in their colonies. The progenitors that give only one cell type in their 
colonies are called the single lineage progenitors, these are the most mature progenitors 
(Bondurant and Koury 1998). 
Regulation of the differentiation process. 
The hematopoietic system is very tightly regulated. Because it must respond to the 
physiological demands of the body, most blood cells need to be to replenished constantly due 
to cell death and tum-over of cells. Factors, such as loss of cells through bleeding, low 
oxygen levels or an infection, also create a demand for new hematopoietic cells. 
Hematopoiesis is regulated through signalling molecules, the hematopoietic growth factors 
(HGF)(Metcalf 1989; Lotem and Sachs 2002). These signalling molecules can come from 
blood cells themselves, but also from different tissues. 
Most of these signals like for instance erythropoietin (Epo) or granulocyte colony 
stimulating factor (G-CSF) are bound by receptors on the cell membrane by which a signal is 
transmitted a to the inside of the cell (Mulcahy 2001). This signal is usually passed on via a 
cascade ofphosphorylations I dephosphorylations of other proteins like the Janus kinase 
family of tyrosine kinases (JAK) and the STAT family proteins whose activity depends on 
their phosphorylation status. This results in regulation of gene expression, survival, or 
apoptotic pathways that may stimulate or inhibit a cell to commit to a specific lineage (Kirito 
eta!. 1997; Bittorf eta!. 2000; de Koning eta!. 2000). 
A very basic question is: how does a stem cells commits itself to become a progenitor 
to a specific cell type? For this enigma two models have been proposed, the deterministic and 
the stochastic model. The deterministic model says the commitment is a predetermined fate. 
An example of proof given for this model are the repopulation experiment with daughter 
HCS cells of clonally derived hematopoietic stem cells, showing sinrilar characteristics 
(Muller-Sieburg et al. 2002). In the stochastic model, gene expression and therefore 
commitment occurs in a probabilistic manner. The probability of the gene expression can 
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however be influenced by factors like transcription factor concentration and cis-regulatory 
elements (Ko 1991). Examples of stochastic gene expression are X-inactivation and globin 
gene expression (Panning and Jaenisch 1998; de Krom eta!. 2002). In the case of globin 
expression in fetal liver cells, it is also shown that although the expression is stochastic, the 
expression pattern can be inherited in daughter cells (de Krom et al. 2002). This may be also 
the case with genes effecting the characteristics of the HSC in the example of the 
deterministic model (Muller-Sieburg et al. 2002). 
Stem cell plasticity 
The dogma that bone marrow stem cells can only give rise to hematopoietic cells and not to 
other tissues has recently been challenged (No Ita and Jordan 2001). In transplantation 
experiments bone marrow stem cells have been shown to possess tissue plasticity as they 
contributed to neuronal, muscle and liver tissue (Gussoni eta!. 1999; Petersen eta!. 1999; 
Brazelton eta!. 2000; Mezey et a!. 2000; Theise eta!. 2000). Vice versa neuronal and muscle 
stem cells have given rise to hematopoietic cells (Bjornson et al. 1999; Jackson et al. 2001). 
There are three theories to explain these phenomena (Nolta and Jordan 2001 ). First, 
the 'two stem cell' theory that explains these results by the presence of neuronal, liver or 
muscle stem cells in the bone marrow, that are isolated together with the hematopoietic stem 
cells. Second, the trans-differentiation theory, that says that a stem cell restricted to one fate 
can differentiate to a stem cells of a different tissue. Third, the totipotent stem cell theory, in 
which a uncommitted stem cell can generate different tissues. More research is needed to 
determine which theory is correct. For example with genotypical marking of stem cells by 
retroviral insertion can discriminate between the 'two stem cell' theory and the other theories. 
As a cautionary note, recent experiments suggest that, rather than stem cell plasticity, 
cell fusion could be the basis of the above observations.(Terada et al. 2002; Wurmser and 
Gage 2002) (Ying et al. 2002) Rigorous karyotyping of the grafted cells will be necessary to 
resolve this issue. 
De-differentiation 
Besides stem cells plasticity there are reports of committed progenitor cells that are able to 
'de-differentiate'. The report where pax-5 -/- pre-B-cells can be re-directed to erythroid, 
myeloid, and lymphoid cell lineages suggest that cells can go up in the hematopoietic 
hierarchy (Fig. I) (Schaniel et al. 2002). Another step further is a report on the reprogramming 
of committed mouse myotubes by ectopic expression of the transcriptional repressor msxl, 
reverting them to cells with a de-differentiated phenotype. These cells could be induced to 
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differentiate into cells expressing chondrogenic, adipogenic, myogenic. and osteogenic 
markers(Odelberg et al. 2000). If de-differentiating is also possible for other committed cell 
types, this could have important clinical consequences. Moreover, it changes the currently 
accepted dogma that cell-commitment is an irreversible process (Lemiscbka 2001) (Cantor 
and Orkin 2001) (Domen and Weissman 1999). 
Hematopoiesis during development 
During development the site of hematopoiesis changes several times. The first site are the 
blood islands of the yolk sac during early embryonic development, 7-11 days postcoitum 
(dpc) in the mouse (Dzierzak et al. 1998). This first wave of blood formation is referred to as 
primitive hematopoiesis and mainly consist of production of red blood cells. Around 11 dpc 
the main site of hematopoiesis changes to the fetal liver and to a lesser extent the fetal spleen. 
From now on it is referred to as defmitive erythropoiesis. Definitive fetal liver erythrocytes 
expel their nucleus and express the fetal globin genes in humans. 
The origin of the definitive or adult hematopoiesis is still under debate as there are two 
main models. One model claims that definitive hematopoiesis originates from cells that have 
migrated from the blood islands in the yolk sac to the Aorta-Gonads-Mesonephros region 
(AGM) and the fetal liver (Palis and Yoder 2001). A second model says that at least two 
independent hematopoietic sites generate blood cells de novo during development: the yolk 
sac, which produces the transient embryonic hematopoietic system, and AGM region as this is 
the frrst site from which definitive hematopoietic stem cells can be isolated (Fig. 2) (Dzierzak 
1999). Although the frrst model seems likely since hematopoietic activity appears frrst in the 
yolk sac, experiments in avian and amphibian species have clearly shown that this wave of 
primitive extraembryonic erythropoiesis is transient and that definitive hematopoiesis is 
almost entirely from intraembryonic origin (Dieterlen-Lievre 1975; Beaupain et al. 1979; 
Dieterlen-Lievre and Martin 1981; Turpen et al. 1981). Furthermore the frrst site to find 
multipotential hematopoietic progenitors is the intraembryonic splanchnopleura (7.5 dpc) and 
the first HSCs are detected in the AGM (10 dpc) (Godin et al. 1993) (Muller et al. 1994). 
Therefore, although ultimate proof is still lacking, the second model is the most probable. 
Around birth the site of hematopoiesis changes to the bone marrow and the spleen in 
mouse. 
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Figure 2: The site of erythropoiesis during embryonic development. Yolk sac. AGM and fetal liver. 
In adults the major site of hematopoiesis is the bone marrow. 
(Taken from (Dzierzak and Medvinsky !995)) 
Erythropoiesis: the formation of erythrocytes 
The ervthrocvte 
The definitive erythrocyte is a small cell of about 7-8 !"ill in diameter with the characteristic 
shape of a flat ball indented from two opposing sites also described as biconcave disk 
(Figure 3) (Evans and Fung 1972). Erythrocytes transport oxygen (02) from the lungs 
through the body and exchange it for carbon dioxide (C02) which is transported back to the 
lungs. where it is exchanged for oxygen again. Since this is the major function of erythrocytes 
they are completely specialized for this purpose. At the final stage of maturation the 
erythrocyte sheds its nucleus, mitochondria and ribosomes. 
The shape enables the erythrocyte to efficiently exchange 02 and C02, because it has 
the maximum surface area for the volume of cytoplasm (Lenard 1974). Furthermore, this 
shape is more able to deform than a sphere, a property essential for an erythrocyte as it has to 
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move through the smallest capillaries to reach the remote regions of tissues (Schmid-
Schonbein 1975). The resilience of the erythrocytes to the stress of circulation is due to the 
structural organization of the membrane, the membrane proteins and the cytoskeleton. The 
reader is referred to review articles for further information on the erythroid membrane 
(Disscher&Carl 2001 and Taka1:uwa Y. 2000 ). 
The O:/C02 transporter protein hemoglobin predominates the cytoplasmic proteins of 
a erythrocytes. 
Maximum 
thickness 
2,6+/-0.3 um 
Minimum 
thickness 
0.8 +I- 0.4 um 
7.8 +/- 0.6 um 
diameter 
Figure 3: Cross section of a definitive erythrocyte in isotonic solution 
(Taken from from (Evans and Fung 1972)) 
Hemoglobin 
Surface area 
135 +/-16 um2 
The hemoglobin protein binds a prosthetic haem group that is essential for the binding of 
oxygen. The beam group is a protoporphyrin IX ring with a iron ion (F e2+) bound in the 
middle (Perutz et al. 1960). Hemoglobin protein functions as a tetramer consisting of two ~­
like and two o:-like globin proteins. In mice there are four ~-like chains (cy, ~HI, ~mojoc and 
~miooc) and three o: chains (1;. 0:1 and O:o) expressed. In human there are five~ chains (E. Gy, 
Ay, i5 and~) and three o: chains (1;. o:, and o:,) expressed (Fraser et al. 1998). 
During development different isoforms are expressed and different combinations can 
be formed (figure 4B and 4C). The embryonic and fetal hemoglobins have a higher affinity 
for oxygen and are therefore capable of taking the oxygen from the mother's adult 
hemoglobins. After birth only the adult globins are expressed. 
The a- and f)-globin genes are expressed from two distinct genetic loci on 
chromosome 16 and 11 respectively . Although the genes are very homologous, the loci differ 
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in the way they are regulated. The order of the genes in the genetic loci resembles the order 
in which they are expressed during development (Fig 4A) (Fraser eta!. 1998). The major 
regulatory glement of «·globin expression is the a:tv1RE (in humans hypersensitive site-40, 
HS-40), an element that can give high expression in a trans gene but not in a copy number 
dependent fashion as has been observed with the major regulatory element of the [3-globin 
locus, the B-globin locus control region (Higgs eta!. 1998: Grosveld 1999). 
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Figure 4: {A) schematic representations of the a-and f)-loci, (B) the site of erythropoiesis and the 
expression of the individual globin genes during development and (C) the embryonic. fetal adult 
globins can form different hetero-tetramers (all in human). 
(Taken from (Weatherall and Clegg 1981)) 
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Besides oxygen, hemoglobin also transports nitric oxide (NO). Nitric oxide is produced by 
vascular endothelium and relaxes smooth muscle cells surrounding the vessels, thereby 
controlling blood flow and pressure. Hemoglobin acts as a scavenger of nitric oxide thereby 
inactivating the NO (Gross and Lane 1999). Furthermore, S-nitrosylation ofNO to a very 
conserved cysteine (J3-hemoglobin Cys93 in human) and release of NO as a S-nitrosothiol 
(SNO) in the nuclens tractus solitarins in the brainstem, is important in the regulational 
control of respiration in response to hypoxia (Lipton eta!. 2001; Lipton 200 I) 
Erythropoiesis 
The process of the production of erythrocytes is called erythropoiesis and occurs, in adults. 
almost exclusively in the bone marrow. As all blood cells, the erythrocyte is a terminally 
differentiated descendent of the hematopoietic stem cell. The erythroid progenitors together 
with the erythrocytes are called the erythron. This name contributes to the concept and 
understanding ofblood as a tissue. (Boycott 1929). Erythropoiesis is highly controlled process 
because the supply of oxygen has to be sufficient at all times. Homeostasis of the erythron is 
necessary in response to changes in the physiological situation such as a low oxygen level 
atmosphere or blood loss . These changes lead to reduced tissue oxygen tension in the kidney. 
In reaction to this the kidney secretes the glycoprotein hormone Erythropoietin (Epo) that 
stimulates growth, differentiation and survival of erythroid progenitors thus increasing the 
number of mature erythrocytes (Koury and Bondurant 1988; Krantz 1991) (Lin et al. 1985). 
The number of erythrocytes is also influenced by breakdown. The average lifespan of 
an erythrocyte is 60 days in mice and 120 days in human. Ageing of red blood cells is 
characterized by loss of enzymatic activity, a less flexible cell membrane and higher cell 
density. Damaged and worn-out cells are removed by the spleen and the liver. The iron is 
reutilised and the globin is degraded to amino acids (Dessypris !998). 
The ervthroid progenitors 
Stem cells and early erythroid progenitors can not be morphologically distinguished. The 
existence of stem cells and early erythroid progenitors can demonstrated by several in vitro 
and in vivo assays including repopulating assays in lethally irradiated mice~ cobble stone area 
assay and colony assays in semi solid media (Heirnfeld and Weissman 1992). Four progenitor 
cells are defined, in order from immature to more mature: the CFU-S, the CFU-GEMM, the 
BFU-E and the CFU-E. The CFU-S, ~olony forming ]!nit §pleen, is a cell that can form 
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colonies in the spleens of lethally irradiated mice (Medvinsk-y et al. 1993). The CFU-S is a 
multipotent cell but does not have a long-term repopulating capability (Bondurant and Koury 
1998). The CFU-GEMM is a multi-lineage progenitor that can be demonstrated with an in 
vitro colony assay in semi-solid medium. The CFU-GE:MJvi can give rise to granulocytes, 
~rythrocytes, _megakaryocytes and _macrophages (Johnson and Metcalf 1977). The BFU-E. 
Qurst forming !!llit ~rythroid, represents a more committed cell that forms large colonies under 
the influence of Epo, interleukin-3 and stem cell factor in an in vitro colony assay with semi-
solid medium. These colonies contain mature erythrocytes (Metcalf and Nicola 1984). A more 
differentiated cell is the CFU-E, _c::olony forming gnit ;:_rythroid, that forms small colonies (8-
64 cells) in a short-time in vitro culture in semi-solid medium (3-4 days) (Wong et al. 1986). 
The CFU-E is very sensitive to and dependent on Epo for its survival and is more frequently 
found in cell cycle than the BFU-E (70-90% versus 0-25% inS-phase) (Gregory and Eaves 
1978). The CFU-E is the earliest erythroid progenitor cell that increases proliferation in 
response to Epo (lscove 1977). It is believed that this cell has the highest number ofEpo-
receptors on its cell membrane (Krantz et al. 1987). 
Later erythroid progenitors can be morphologically distinguished because the cells 
shrink during differentiation, partly due to the reduction of the size of the nucleus (Dessypris 
1998). The earliest morphologically identifiable progenitor is the proerythroblast or 
pronormoblast. In some reports the term normoblast is used instead of erythroblast to 
distinguish it from megaloblast, a pathological erythroblast. The proerythroblast (14 to 19 
~).with visible nucleoli in its nucleus, is already taking up iron for hemoglobin synthesis. 
The presence of the iron containing protein ferritin in pinocytotic vesicles and siderosomes is 
the marker to distinguish proerythroblasts from other immature cells such as myeloblasts and 
lymphoblasts (Dessypris 1998). 
The next stage is the basophilic erythroblast. The nucleoli in the nucleus are no longer 
visible, hemoglobin synthesis has started and the cell has shrunk a little (12 to 17 llm). The 
chromatin is starting to become more condensed. The name is derived from its basic 
cytoplasm that contains a large amount of globin and ribosomal RNA. This gives the cell a 
blue appearance in standard histological staining procedures (Beug et aL 1982), 
The cells further differentiate to polychromatic erythroblasts. This cell type already 
contains a high concentration of hemoglobin protein and has shrunk further (12 to 15 vm). 
This cell still has large amounts of RNA in its cytoplasm but the hemoglobin (acidophilic) gives 
it a red/beige appearance after staining (Dessypris 1998). 
A step further in the differentiation is the orthochromatic or acidophilic erythroblast 
This cell is further reduced in size (8 to 12 )llll) and has an eccentric, pyknotic nucleus 
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containing clumped and compressed DNA. After extrusion of the pyknotic nucleus the cell is 
called a reticulocyte. It is thought that in the bone marrow the nucleus is squeezed out as the 
reticulocyte transfers through the endothelial cell layer into the sinusoidal capillary space. This 
is however not a requirement as cells can also enucleate in culture. The expelled nucleus is 
phagocytosed by a macrophage. The reticulocyte is still a sphere and contains some 
mitochondria, ribosomes, RNA and the Golgi complex. These features disappear upon 
maturation, which takes around 24 hours. The size is comparable to the erythrocyte (7-8 !-lffi). 
Reticulocytes mature in the bone marrow and in the peripheral blood where their number is 
about l% of the number of erythrocytes (Dessypris 1998). 
~-~-~-~-~ CFU.S CFU-GEMM BFU-E CFU-E Pro-erythroblast 
• <ll 
Basophilic erythroblast 
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• 
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• 
• 
-Erythrocyte 
Figure 5: a schematic representation of the subsequent stages of erythroid differentiation 
(Adapted from (Dessypris 1998)) 
The enrthroblasric island 
The environment of maturing erythroid progenitors is the eryt.lrroblastic island This is a sponge-
like structure composed of one or two central macrophages in close contact with erythroid 
progenitors in different stages of differentiation lying in the invaginations of the macrophages, 
with immature cells close to the macrophages and mature cells to the edge of the structure 
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(Bessis et al. 1983). The macrophage is believed to interact with the progenitors in several 
ways, supplying undefined nutrients directly and via rhopheocytosis (intemalisation of vacuoles 
ofilie macrophage). Besides this, 1he macrophage phagocytises 1he expelled nuclei (Allen and 
Dexter 1982). Although erythroid progenitor cells can mature in vitro without the formation 
of an erythroblastic island~ this structure appears to be an important feature in vivo. as such a 
close association between the erythroid progenitors and the macrophages influences local 
concentrations and gradients of growth factors, intercellular transport and the impact of 
mechanical forces (Bessis et al. 1978; Mel!99!). 
proerythroblast 
basophilic erythroblast 
polychromatic erythroblast 
• orthochromatic erythroblast 
e reticulocyte I erythrocyte 
• pyknotic nucleus 
II macrophage 
Figure 6: a simplified model of the ezythroblastic island. The position of the central macrophage and 
the arrangement of the erythroid progenitors within the macrophage's extensions are shown. The 
process of pyknosis. enucleation and phagocytosis of the expelled nuclei arc represented. 
Disorders of red blood cells 
Abnormalities associated with red blood cells can basically be caused by two problems, too 
many red blood cells (polycy1haemia) or too few cells (anemia). The latter is a major cause of 
mortality worldwide (Erslev 2001). 
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Polycythaemia 
Polycythaemia or erythrocytosis is the overproduction of erythrocytes. Polycythaemia can be 
divided in two diseases, polycythaemia vera and erythremia .In polycythaemia vera, not only 
the number of red blood cells is higher, but also that of the granulocytes and platelets. The 
erythroid progenitors grow without the need for Epo or are responsive to a very low amount 
of this hormone (Erslev 200 l ). In erythremia only the number of red cells is elevated. This 
can be caused by an inherited mutations, for example mutants of the Epo receptor leading to a 
abnormal response of the erythroid precursors (Kralovics et al. 1997). 
Anemia 
Anaemia is defined as a reduced concentration of hemoglobin or erythrocytes in the blood. 
Anaemia can be the result oflack of production or excessive breakdown of red blood cells, or 
lack of a functional protein, usually hemoglobin. Anaemia is often secondary to renal failure, 
liver disease, poor diet or uptake of nutrients, chronic inflammatory and malignant diseases 
like leukaemias and other cancers. It can also be caused by an inherited mutation (Lee 1998). 
Aplastic anaemia is a lack ofblood cell production caused by aplasia of the bone 
marrow. Examples are the hereditary Fanconi anaemias and the Josephs-Diamond-Blackfan 
syndrome. Fanconi anaemia is a recessive inheritable disease, that shows a reduction of all 
blood cells. For Faconi anemia, eight gene complementation groups have been described 
( d'Apolito et al. 1998). An aplastic anaemia only affecting the erythrocytes (red cell aplasia) is 
the Josephs-Diamond-Blackfan syndrome in which there is a great reduction or almost 
complete absence of nucleated erythroid precursors but plentiful granulocytes and 
megakaryocytes (Wang et al. 1978). The defect underlying tllls disease, a reduced response to 
Epo, is thought to be a defect intrinsic to the progenitor (Tsai et al. l989a). 
Chronic red cell aplasia is often associated with autoimmune disorders. The red cells 
are selectively destroyed via T -cell mediated destruction or via antibodies produced by the B-
cells (Krantz and Kao 1967). Aplastic anaemia can also be caused by direct damage to the 
bone marrow by radiation or cytotoxic drugs (Lee 1998). 
Another cause of anaemia is the production of non-functional erythrocytes. This can 
be due to shortage of a component or substance that is needed for proper red blood cell 
production. 
Iron deficiency is the most common cause of anaemia, as iron is an important part of 
the hemoglobin proteins. Vitamin Bl2 or folate deficiency disturbs the maturation of 
erythroblasts. The maturation of the nucleus is delayed compared to the cytoplasm. The cause 
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of this is defective DNA synthesis. The origin of this deficiency can be lack offolate in the 
diet, poor absorption, transport and/or storage and loss of the nutrients. 
Sideroblastic anaentia is characterised by abnonnal erythroblasts with a ring of iron 
granules around the nucleus. It is caused by a defect in haem synthesis. It can be hereditary 
(mutations in genes encoding enzymes of the haem synthesis pathway) but also acquired 
(drugs. alcohol, lead poisoning or other marrow disorders) (Lee 1998) 
Haemolytic anaemias are the anaemias that result from an increase in the rate of red 
cell destruction. The nonnallifespan of a red cell in humans is 120 day but in this anaemia the 
cells sometimes survive only a few days. The cause can be hereditary. In these cases the 
synthesis of membranes, membrane proteins, enzymes of red cell metabolism or hemoglobin 
is defective in some way. Acquired causes can be an autoimmune response, direct damage to 
the erythrocytes or infection. An example is Paroxymal Nocturnal Hemoglobinuria (PNH) in 
which the erytlrrocytes have acquired an abnormal sensitivity for complement mediated lysis 
because ofmutation(s) in membrane proteins (Parker and G.R. 1998). 
In erythroleukemia the cells have a normal Epo response but have lost the capacity to 
make functional red blood cells. The bone marrow has enonnous numbers of dysplastic 
erythroblasts (Roggli and Saleem 1982; Means Jr 1998). 
Hemoglobinopathies 
These disease conditions, caused by defects in the globin genes. are very common especially 
in the (sub )tropical areas in the world because heterozygosity for these diseases offers some 
protection against malaria (Luzzi 1991). Hemoglobinopathies can be separated in diseases in 
which there is a lack of production of hemoglobin (thalassentias) and diseases in which a 
mutated form ofhemoglobin is produced such as sickle cell anaemia. 
The thalassemias are the result of a deletion of a gene or a regulatory sequence in 
either the a- or the ~-globin cluster. a thalassemia is often caused by deletion of one or more 
copies of the a genes whereas the majority of the !3 thalassemias are point mutations. Lack of 
a-globin is lethal during gestation whereas lack of I)-globin can be tolerated due to the_-
globin expression (Weatherall2001). 
Sickle cell anaemia is caused by a single point mutation in the I)-hemoglobin gene that 
causes an amino acid change in the protein (Glu67Val6). This minimal change has dramatic 
consequences because sickle hemoglobin (HbS) polymerises and becomes insoluble when 
exposed to low oxygen tension. The formed polymers deform the erythrocyte that thereby 
looses its deformability and can now block capillaries, causing infarction of various organs. 
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There are several other milder mutations called hemoglobin C. D an E that become more 
apparent in combination with HbS or ~-thalassaemia (Beutler 2001 ). 
A condition called Hereditary Persistence of Fetal Hemoglobin (HPFH) in which 
elevated levels of fetal_ -globin are expressed during adulthood is often found together with 
~-thalassemia or sickle cell anaemia. HPFH does not have any harmful effects and fetal 
hemoglobin can substitute for adult ~-globin. For ~-thalassaemia and sickle cell anaemia a 
possible therapy against the effects of the mutations could be the renewed use of the fetal 
globin genes that are normally shut down after birth (Forget 1998). Changing the expression 
of the globin genes is one of the goals of current research in the hemoglobin field. Therefore it 
is important to know how gene expression is controlled. 
Control of gene expression 
Classifications of distinct cell types within an organism are most often based upon appearance 
and function while the genetic information in all cells of an organism is, with very few 
exceptions. identical. The specific properties of a cell are generally established by differential 
gene expression. Some genes are expressed in almost every cell; such genes are usually 
involved in general processes and are therefore called housekeeping genes. 
Tissue specific genes are expressed in specific subset of tissues or cell types and their protein 
products often have a very specialized function for that tissues or cell types. 
The control of expression of protein-encoding genes includes the following steps: 
transcription of DNA to primary RNA transcripts. processing of primary RNA transcripts to 
messenger RNAs (mRNAs). transport ofmRNAs from the nucleus to the cytoplasm. 
stabilisation I degradation of mRNAs, control ofmRNA translation to protein and control of 
protein activity through post-translational modifications and the modulation of protein 
stability. Regulation of transcription is the first important step in the control of gene 
expression. 
General transcription machinerv 
Transcription is defined as the process of synthesis of a single-stranded RNA copy of a gene. 
The enzymes responsible for RNA synthesis are the RNA polytnerases I. II and III. large 
protein complexes formed by multiple polypeptides. RNApol I and III synthesise RNAs with 
structural or catalytic roles such as ribosomal RNAs. The mRNAs for proteins are synthesized 
by RNApolll. It is esrimated that about 1/3 of the genome is transcribed into primary 
transcripts, but only 1.5% consists of coding exons. Because only a small portion of the 
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chromosomal DNA is transcribed to mRNA the RNA polymerases must work very 
selectively. 
In vivo, RNApolii only transcribes DNA after it has been tethered to a start region of a 
gene called the promotor. This is done by the general transcription factors that bind to specific 
sequences in the promotor including the TATA box. the TFIIB recognition element (BRE), 
the initiator (lnr) and the downstream promoter element (DPE). These general transcription 
factors are TF 11-A, -B, -D, -E, -F and -H. The first step consists of the binding ofTFII-D to a 
DNA element called the TATA box or to the down stream promoter element. DPE (Burke and 
Kadonaga 1997). TFII-D is a protein complex composed ofTBP (TATA Binding Protein) 
and the TAFIIs (TBP-associated factors). Binding to the TATA box is mediated by TBP, 
while the TAFI!s are required for binding to the DPE. After TFII-D has bound, TFII-B can 
bind to the TFII-B recognition element BRE, thus further enhancing protein-protein and 
protein-DNA interactions at the core promoter (Lagnmge eta!. 1998). Next, RNApolll binds 
together with TFII-F. Finally, TFII-E and TFII-H are bound. The RNApolll and the general 
transcription factors together form the pre-initiation complex (PIC). TFIIH must 
phosphorylate the carboxy-terminal domain of the large subunit ofRNApolll in order to 
releases RNApolii from the promoter, thus initiating transcription. For more detailed reviews 
the reader is referred to (Buratowski 1994; Green 2000). 
Transcription factors 
Transcription is further regulated by the presence of transcription factors. This is achieved by 
binding to specific regulatory sequences in the DNA and via protein-protein interactions. 
These regulatory sequences are located in promoters, enhancers and locus control regions of 
genes. Transcription factors are classified by the structural motifs that they use to bind DNA 
and/or proteins. These motifs include the homeodomain, the zinc-fmger, the v.ringed-heli."C or 
forkhead, the leucine-zipper, the helix-loop-helix domain, the runt homology domain, the ETS 
domain, the HMG-box. Transcription factors are able to interact with cofactors and proteins 
from the general transcription factor machinery and thereby stimulate or inhibit transcription 
initiation. 
The first step in transcription is unwinding of the chromatin, the compact structure of 
the DNA v.rith histone proteins. Folding of the DNA is essential for these long molecules to fit 
into the relatively small nucleus. The basic units of chromatin are the nucleosomes, 
approximately 200 bp od DNA wrapped around an octamer of two set of histone proteins 
H2A, H2B. H3 an H4. The nucleosomes can be organized in higher order structures that make 
the DNA less accessible for the general transcription machinery. 
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Transcription factors can also assist in opening up chromatin. This can be achieved by 
covalent modifications of the histone proteins, for instance phosphorylation, methylation and 
acetylation, and by an ill-defined ATP-dependent mechanism termed chtomatin remodelling 
that does not involve covalent modifications of proteins and DNA. 
Methylation of cytosine residues in promoters of genes correlates in general with 
transcriptional inactivity. This modification has a permanent character and is therefore 
thought to have an important role in irreversible silencing of genes. As a rule, transcription 
factors lack catalytic domains required for these biochemical reactions. Transcription factors 
usually act by recruiting complexes of co-factors that do contain these catalytic activities. 
These mechanisms have recently been reviewed in detail by Rice, Marmorstein and Wade 
(Marmorstein and Roth 2001; Rice and Allis 2001; Wade 2001). 
Hematopoietic transcription factors 
A class of transcription factors has been identified that can bind to regulatory sequences like 
promoters, enhancers and locus control regions (LCR) important for hematopoietic cell 
development and gene expression. Upon binding they enhance or inhibit transcription of their 
target genes. Binding to other proteins is an essential propert)r because they can form either 
bridging complexes or docking sites. 
The frrst tissue-specific transcription factor described was the zinc-finger protein 
GATA-1 (Wallet al. 1988). A single transcription factor however is not responsible for a 
differentiation program of a lineage. It is the combination of transcription factors present and 
their interactions that is more crucial. For this reason blood cell differentiation has been called 
'"a party for transcription factors'', as interaction partners might change as a party evolves 
(Sieweke and Graf 1998). For example the cofactor and acetyltransferases CBP can interact 
with a wide variety of transcription factors such as GATA-1 and c-myb, but only bipartite 
complexes with GATA-1 and CBP or c-myb and CBP can be shown. This suggest that mutual 
inhibition the transcriptional activity of GATA-1 and c-myb, is caused by the exclusive 
binding ofGATA-1 or c-myb to CBP (Takahashi et al. 2000b). 
Null mutant and transgenic mice have been instrumental in functional studies on the 
role of transcription factors in hematopoiesis (see Table I) (Shivdasani and Orkin 1996). 
Some of the most important factors are mentioned below. The basic helix-loop-helix 
transcription factor Tal-l (SCL, TCL5), overexpressed in T-cell acute lymphoblastic 
leukaemia (ALL), is essential for yolk sac and adult hematopoiesis (Porcher et al. 1996). The 
null mutant mice die in utero (9.5 dpc) (Robb et al. 1995; Shivdasani et al. 1995a). The zinc-
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fmger protein GATA-2 is another transcription factor that is important for all hematopoietic 
cells. The null mutant dies around I 0-11 dpc . GATA-2 is thought to be required for the 
expansion of early hematopoietic cells (Tsai eta!. 1994). The leucine-zipper protein c-myb 
and the runt homology domain transcription factor AML-1, that is the most frequent target of 
chromosomal rearrangements in human leukemia, are essential for definitive but not primitive 
hematopoiesis (Mucenski eta!. 1991) (Okuda eta!. 1996). Transcription factors that are 
important for specific hematopoietic lineage include Pu.l (monocytes, granulocytes and B and 
T lymphocytes) (Scott eta!. 1994), GATA-3 (T-lymphocytes) (Hendriks eta!. 1999), NF-E2 
(platelets) (Shivdasani eta!. 1995b), c-fos (osteoclasts) (Johnson eta!. 1992), lkaros (B-andT 
lymphocytes, NK cells) (Boggs eta!. 1998) and GATA-1 (erythrocytes)(Pevny eta!. 1995). 
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Hematopoietic transcription factors 
DNA binding 
motif 
zinc~finger: 
GATA-1 
GATA-2 
GATA-3 
EKLF 
1995) 
FOG-I 
Ik::rros 
bomeodomain: 
Lh.x2 
HoxA3 
HoxA9 
HoxB6 
HoxCS 
leucine-zipper 
ATF4 
E2F-l 
E2F-2 
E2F-4 
C/EBP-a 
C/EBPI) 
C/EBP_ 
1999) 
C/EBP_ 
c-myb 
c-fos 
jMB 
MAD! 
NF-E2 (p45) 
Stat5a 
Stat5b 
the helb.::-loop-beli.x domain 
tal-l 
E2A 
runt homology domain 
Runxl 
CBFI) 
hematopoietic phenotype 
of the null mutant mice 
block in erythropoiesis and mcgak::uyopoicsis 
yolk sac and adult hematopoiesis defect 
expansion ofT -cell progenitors 
lack of j3-globin expression 
and erythroid differentiation defect 
block in erythropoiesis and megob.ryopoicsis 
B&T lymphocytes an N'K cells 
defimtive erythropoiesis 
thymocyte defect 
defects in myeloid, erythroid, and lymphoid 
hematopoiesis 
increased number of erythroid progenitors 
less BFU-E. CFU-GM 
transient fetal anemia 
T-cell defect 
T-cell defect 
various mature hematopoietic cell types defects. 
block in neutrophilic differentiation 
lymphoprolifcrative disorder 
impaired granulopoiesis, myelodysplasia 
NK-cell maturation defect 
definitive but not primitive hematopoiesis defect 
osteoclast and macrophage defect 
myeloproliferative defect 
granulocyte differentiation defect 
platelet formation 
granulocyte-macrophage defect 
proliferative defect natural killer cells 
yolk sac and adult hematopoiesis defect 
B-ecll defect 
definitive but not primitive hematopoiesis 
definitive but not primitive hematopoiesis 
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reference 
(Pcvnyctal. 1991) 
(Ts:ll et a.l. 1994) 
(Pandolfi ct al. 1995) 
(NuC'L ct a!. 1995; Perkins ct al. 
(Tsang eta!. 1998) 
(Boggs ct al. 1998) 
(Porter et al. 1997) 
(Su and Manley 2000) 
(lzon eta!. 1998) 
(Kappcn 2000) 
(personal communication E. van den 
Akker) 
(Masuoka and Townes 2002) 
(Field ct a!. 1996) 
(Murga eta!. 2001) 
(Rempel ct ol. 2000) 
(Zhangctal.1997) 
(Scrcpanti ct a!. 1995) 
(Lckstrom-Himcs and Xanthopoulos 
(Kaisbo ct ol. 1999) 
(Allen eta!. 1999) 
(Johnson ct al. 1992) 
(Passegue ct ol. 2001) 
(Foley ct al. 1998) 
(Sbivdasani eta!. 1995b) 
(Fcldmanetol. 1997) 
(Imadn et al. 1998) 
(Shivdasani et ol. 1995a) 
(ZhuangctaL 1994) 
(01-..--udn ct a!. 1996) 
(Sa..<:aki et ol. 1996) 
ETS domain 
Pu.l 
Ets·l 
Lim domain 
Lmo21Rbtn·2 
HtvfG.hox 
TCF-1 
Steroid reccntor 
Glucocorticoid receptor 1 
Rcl domain 
c-Rel 
<dB 
nfkbl 
nfkb2 
multiple hematopoietic lineages affected 
Natur:ll killer cells 
yolk sac and adult hematopoiesis defect 
T-ccll defect 
stress erythropoiesis 
(Scott ct aL 1994) 
(Barton ct al. 1998) 
(Yamadaetal.1998b). 
(W[IITcn et al. 1994) 
(Castropetal.1995) 
(Bauer ct al. 1999) 
Multiple hemopoietic defects ::md lymphoid hyperplasia (Kontgcn et al. 1995) 
(Gcrondakis ct al. 1996) 
incrca..-.cde TNFet sensitivity macrophages 
dendritic cell defect 
non-activated B-cell survival defect 
proliferative humoral response defect 
(Beg and Baltimore 1996) 
(Burldy et al. 1995) 
(Grumont et al. 1998) 
(Franzoso ct al. 1998) 
Table 1: Transcription factors with hematopoietic phenotypes of the null mutant. 
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GATA transcription factor family 
GATA-1 is a Zn-finger transcription factor. The Zn-finger motif is a protein domain that was 
first recognised as a DNA binding domain (Miller eta!. 1985). Later it was found that Zn-
finger motif can also mediate protein-protein interactions. In the Zn-fmger motif the 
polypeptide chain is wrapped around a Zn2+ ion that is bound by either cysteine and/or 
histidine thus stabilizing the 3D structure of the protein. When depicted in two-dimensions 
this domain looks like a finger. Proteins can contain multiple Zn-finger domains or different 
types of Zn-finger proteins resulting in several classes of Zn-finger proteins (Klug and 
Schwabe 1995). 
GATA-1 is the founding member of the GATA transcription factor family 
characterized by their two typical Zn-fingers (Tsai eta!. 1989b ). The family consists of six 
members, GATA-1 to GATA-6. These proteins can all bind to a consensus sequence 
(A!T)GATA(NG) with highly conserved Cys-X2-Cys-X17-Cys-Xz-Cys Zn-finger domains 
(Merika and Orkin 1993; Whyatt eta!. 1993). Outside the Zn-finger domains, conservation 
between the different GATA factors is poor. The family is divided into two subgroups; the 
hematopoietic and the non-hematopoeitic group. GATA-1, 2 and 3 are usually defined as the 
hematopoietic members as all three are expressed in hematopoietic cells. However all three 
are also expressed in a number of other tissues; in particular GATA-2 and -3 play essential 
roles in tissues outside the hematopoietic system such as placenta and developing central 
nervous system (Ito eta!. 1993: Pandolfi eta!. 1995; Ma eta!. 1997; Nardelli eta!. 1999). 
GATA-4~ -5 and -6 are expressed in overlapping patterns in tissues such as the intestine, lung 
and heart but not in hematopoietic cells (Molkentin 2000). 
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GATA-6 
GATA-5 
GATA-4 
GATA-3 
GATA-2 
GATA-1 
T = Phosphorylation site 
~ = Lysine-rich acetylation site 
~=Conserved Lysine-rich possible acetylation site 
II= Zn-finger 
Figure 7: the GATA transcription factor family (mouse). 
GATA-1 
470 aa 
404aa 
440aa 
443 aa 
480 aa 
41300 
GAT A-I, also known as NF-El, NF-I, Ery-1 and GF-1, was first discovered as a protein with 
binding activity for the 3' region of the B-globin locus (Wallet a!. 1988). After the gene was 
cloned (Tsai eta!. !989b) it was found that the gene is located on the X-chromosome in both 
mouse and human (Zon eta!. 1990). The protein is expressed in primitive and definitive 
erythroid cells (Fujiwara eta!. 1996) and it is thought to influence transcription of all 
erythroid genes since putative GAT A binding sites are found in the promoters of all erythroid-
specific genes studied. Besides erythroid cells the GATA-1 protein is also expressed in 
megakaryocytes, mast cells, eosinophils and in the Sertoli cells of the testis (Ito eta!. 1993) 
(Yomogida eta!. 1994). 
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The GAT A-I deficient mouse showed that GAT A-I is essential for red blood cell 
development (Pevny eta!. 1991; Fujiwara eta!. !996).In vitro ES cells differentiation studies 
with GAT A-I deficient ES cells pointed out that the erythroid cells did not progress beyond 
the proerythroblast stage (Weiss eta!. 1994; Pevny eta!. 1995). This arrest was also 
confirmed for primitive erythroid cells in GATA-1 deficient mice in vivo (Fujiwara et al. 
1996). Surprisingly. typical erythroid genes like the 0-globin genes were activated to some 
extent in the GAT A-I deficient mice (Fujiwara eta!. 1996).With knockdown mutation in the 
GA TA-l regulatory DNA sequences selective loss of megakaryocytic-specific expression 
could be achieved which caused a defect in the maturation of megakaryocytes (Shivdasani et 
a!. 1997). 
As all GATA factors. GAT A-I has two Zn-fingers of which the C-terminal finger is 
essential for DNA binding and theN-terminal contributes to the stability of the binding but is 
not able to bind DNA on its own. TheN-terminal finger is however essential for interaction 
with FOG-I (see below). A domain claimed to be necessary for transcriptional activity was 
shown to be unimportant for rescuing the knockout phenotype in transgenic mice (Shimizu et 
a!. 2001). 
Diseases related to GAT A-1 malfunction 
The known human diseases related to GATA-1 malfunctioning are single amino acid 
substitutions in theN-terminal Zn-finger causing an inhibition of the interaction of the 
GAT A-I protein with the cofactor FOG-I. These mutations cause thrombocytic defects and 
milder erythroid defects (Nichols eta!. 2000; Freson eta!. 2001; Mehaffey eta!. 2001). 
Target genes ofGATA-1 
All erythroid specific genes studied have GATA sites in their transcription regulatory 
sequences. This group of genes includes erythroid transcription factors, anti-apoptotic genes, 
erythroid membrane protein genes and genes important for hemoglobin synthesis such as 
enzymes of the haem synthesis-pathway and the globins. 
While the role ofGATA-1 in erythropoiesis may be due to transcriptional activation of 
such target genes. a number of putative target genes like the Epo receptor are normally 
expressed in GAT A-I deficient proerythroblasts (Weiss eta!. 1994). The globin genes are 
also expressed in erythroid cells deficient in GATA-1. although at a reduced level (Fujiwara 
eta!. 1996). One possible explanation is that GATA-2 takes over some of the activity of 
GAT A-I. as GATA-2 expression is up regulated in GAT A-I deficient cells (Weiss eta!. 
1994). This idea is supported by experiments in which a lethal GAT A-I mutant, expressing 
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~5% of the normal level ofGATA-1, is rescued by a GATA-2 overexpressing transgene 
driven by a GATA-1 promotor (Takabashi eta!. 2000a). Thus, there appears to be redundancy 
in GATA transcription factor function. 
GAT A-1 as stimulator of differentiation 
In the absence ofGATA-1, el)'throid progenitors in vivo and in vitro do not progress beyond 
the proerythroblast stage (Pevny eta!. 1995). Experiments with a GATA-1 deficient erythroid 
cell line G1E have shown that an inducible GATA-1 protein can rescue the differentiation 
program of these cells (Weiss eta!. 1997). 
GAT A~ 1 as survival factor 
GATA-1 deficient erythroid progenitor cells undergo apoptosis (Pevny et a!. 1995). This 
suggests a role for GATA-1 as survival factor. GATA-1 is able to activate the EpoR promotor 
and Epo signalling is important for erythroid progenitor survival (Zon et al. 1991; Silva et al. 
1996). However, EpoR is expressed normally in GATA-1 deficient mice (Fujiwara eta!. 
1996). One of the target genes ofGATA-1 is Bc!-xL(Gregory eta!. 1999). This is a long 
splice variant of the Bcl-x gene that codes for an anti-apoptotic protein essential for erythroid 
differentiation. Since Bcl-xL expression is low in GATA-1 deficient cells, it is a good 
candidate for the survival factor activated by GATA-1. 
GAT A-1 as regulator of the ceil cycle 
Differentiation of erythroid cell is associated with cell cycle arrest. When assuming that 
GAT A-I is a transcription factor stimulating differentiation factors it might be expected that 
GATA-1 expression would stimulate cell cycle arrest. However when GATA-1 is 
overexpressed in murine erythroleukemia (MEL) cells, an erythroid cell line, the opposite 
occurs. GATA-1 stimulates the cell cycle of MEL cells apparently by activating the crucial 
G liS transition. In addition the overexpressing MEL cells fail to activate differentiation 
markers in response to the chemical inducer DMSO (Whyatt eta!. 1997). In non-erythroid 
cell GATA-1 has also been found to affects the cell cycle as it elongates S-phase in NIH3T3 
fibroblasts, possibly by introducing premature G 1/S transition (Duhart eta!. 1996). Mice that 
overexpress GATA-1 during the late phase of erythroid differentiation die around 12.5 dpc 
due to anaemia caused by inhibition of terminal erythroid differentiation (Chapter 2). 
Collectively. these findings indicate that the control of GAT A-1 activity is crucial for 
erythroid differentiation pathway. 
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Regulation ofGATA-1 activity 
GATA-1 activity in vivo may be modulated by several different mechanisms including: 
transcriptional control, translational control, interactions with co-factors, post translational 
modifications and protein degradation. These will be reviewed here. 
GATA-1 transcriptional control 
The GAT A-I transcription unit contains two alternative first exons that are non-coding (IT 
and IE) and five coding exons (II to VI). The GAT A-I gene is thought to have two distinct 
promoters which are alternatively spliced to the coding exons (Ito et al. 1993). Exon IT is 
primarily used in Sertoli cells of the testis and exon IE in erythroid cells. Since the second 
exon harbours the start of translation, the proteins expressed in erythroid cells and the testis 
are identical. The testis-specific promotor and first exon ( exon ID are located 8 kb upstream 
of the erythroid specific first exon ( exon IE). Both promoters harbour GAIA sites that are 
required for proper promotor function and hence a positive feedback loop was suggested but a 
promoter study in GAIA-I null cells and overexpression ofGAIA-1 in MEL cells do not 
support a regulatory loop (Isai eta!. 1991; McDevitt eta!. 1997; Onodera et al. i997b; 
Whyatt et al. 2000).lnterestingly the GAIA-I promoters lack a IAIA motif (Hannon et al. 
1991). 
The first intron, between the erythroid first erythroid exon IE and exon II, has 
regulatory sequences important for proper expression of the gene in the hematopoietic system 
(Onodera et al. 1997a). A palindromic sequence in the first intron of the chicken gene 
resembles a binding site for the steroid hormone super family. This motif is protected by 
fingerprinting in brain but not in erythroid cells and might represent a negative regulatory 
motif(Hannon et al. 1991). Furthermore, seven BGPI sites and a c-myb site are found the 
chicken GAIA-I promoter (Hannon et al. 1991).1n the mouse, a duplicated CACC motif was 
found (Simonet al. 1992). Despite these detailed analyses of the GAIA-I promoter, many 
questions regarding the complex transcriptional regulation of the GATA-1 gene remain 
unanswered. 
IIIII IV VVI 
~~~~~~~~~~~~~~~._~~~~~~~armm-m--m-ma---
IT IE 
Figure 8: schematic representation of the gene intron-exon organisation 
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Translational control 
In K562 and MEL cells two isoforms ofGATA-1 protein are detected, GATA-1 and GATA-
ls. The difference these two proteins is the lack of a 83 aa N-terminal region in GATA-ls. 
This smaller form ofGATA-1 can arise from alternative usage of the translation initiation 
sites in the GATA-1 mRNA (Calligaris eta!. 1995). Alternative translation starts have been 
described for other transcription factors as a mechanism to regulate the activity by changes in 
the ratio of two isoforms (Calkhoven and Ab 1996). However the levels of expression ofthis 
alternative form in vivo is much lower than that of the full length protein suggesting that this 
is not a relevant mechanism for the regulation of activity. 
GATA-1 expression is been thought to be affected by RNA stability that has been 
shown to change in in vitro differentiation of human erythroid cell lines (Marceau et al. 
1996). It is known however that the first intron of GATA-1 is important for proper expression 
of the protein and RNA stability may play a role in this (Onodera eta!. 1997a). 
Interactions with cofactors 
It has been shown that GATA-1 can interact with several other transcription factors that are 
either ubiquitously or erythroid specifically expressed. The most important factors are 
discussed here. 
The first indications of collaboration between GATA-1 and other factors came from 
the observation that in many erythroid-specific regulatory regions like promoters and the B-
globin Locus Control Region (LCR), GATA binding sites are found in close association with 
AP-l/NF-E2 and Sp-llike binding sites. The Sp-llike binding sites. GC and GT/CACC 
motifs, were proven to be important for proper function of core segments of the LCR. In 
artificial constructs no single motif suffices for the function of these LCR segments (Philipsen 
eta!. 1993; Gillemans eta!. 1998). Furthermore, since the LCR can control B-globin gene 
transcription over large distances, it is thought that protein-protein interactions between 
factors bound to these motifs and the promoters of the globin genes can loop out the 
intervening DNA and bring the LCR in contact with the promoters of the globin genes. This 
would imply that the LCR is a docking site for transcription factors forming a holocomplex 
that interacts with one of the B-globin genes (Hanscombe eta!. 1991; Wijgerde eta!. 1995; 
Dillon eta!. 1997). 
Sp 1 is a ubiquitously expressed Zn-finger protein thought to be important for the 
expression of many genes. Sp 1 and EKLF can bind to the same sites. EKLF is a transcription 
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factor with Zn-fmgers homologous to the Spl Zn fingers. but it is an erythroid-specific 
transcription factor. The GAT A-I, Sp I and EKLF proteins can function synergistically on 
erythroid specific promoters non-erythroid drosophila S2 cells. EKLF and Spl can physically 
interact with GATA-1 via their Zn-finger regions in vitro. Via this interaction EKLF and Spl 
can recruit GAT A-I to a synthetic promotor and vice versa in an transient transfection assay 
(Merika and Orkin 1995; Gregory eta!. 1996). 
The knockout ofSpl showed that Spl is essential for early embryonic development. 
Embryos die around day 9.5 of gestation due to a broad range of abnormalities. The globin 
genes in the null mutants are activated although transcription might be reduced (Marin et al. 
!997). The knockout ofEKLF dies around day 12.5 due to anaemia (Nuez eta!. 1995). EKLF 
is required for the activation of !)-globin expression in vivo (Gillemans et al. 1998). 
Friend of GAT A-I (FOG-I) is a nine Zn-finger protein, that binds to the N-tenninal 
Zn-finger ofGATA-1, -2 and -3 mainly via its 6"' Zn-finger (Tsang eta!. 1997) (Fox eta!. 
1998). FOG-I fmgers 1.5 and 9 also contribute to binding (Fox eta!. 1999). FOG-I is co-
expressed with GAT A-I and although no FOG-I DNA-binding activity is known, GAT A-I 
and FOG-1 can synergistically activate hematopoietic-specific promotor constructs and 
cooperate during megakaryocytic and erythroid development (Tsang eta!. 1997). The 
importance of the interaction is underscored by the report of a dyserythropoietic anemia and 
trombocytopenia caused by a mutation in the GAT A-I gene that abolishes the binding of 
FOG-I to GAT A-I (Nichols eta!. 2000). Experiments with GA TA-l mutants that can not 
bind FOG-! but do bind DNA have shown that FOG-! interaction with GAT A-I is essential 
for GATA-1 function (Crispino eta!. 1999). 
The FOG-I null mutant mouse has a similar phenotype to the GA TA-l null mutant 
mouse with regard to erythroid development but differs considerably in megakaryocytic 
development as these cells fail to develop (Tsang eta!. 1998). Surprisingly, a mutant GATA-1 
trans gene lacking theN-terminal fmger is able to rescue the primitive erythropoiesis of the 
GAT A-I knockdown mouse, suggesting that the interaction between GAT A-I and FOG-I is 
not essential for primitive erythropoiesis and that FOG-I functions independently at this stage 
(Shimizu eta!. 2001). 
The existence of another FOG protein, FOG-2, has brought up the idea that 
interactions with FOG proteins are a common theme in the regulation ofGATA factors. FOG-
2 is expressed at low levels in the majority of tissues and at higher levels in heart and skeletal 
muscle. It can also interact with GATA-1 (Hohnes eta!. 1999). FOG-2 can interact with 
GATA-4 thereby repressing its transcriptional activity (Tevosian et a!. 1999) (Lu et a!. !999; 
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Svensson et al. 1999). Furthermore it has been shown that FOG in Xenopus can act as a 
repressor of GAT A-I and erythropoiesis (Deconinck et al. 2000). The general idea is that 
FOGs can be activators but also repressors of GATA factors depending on the promotor and 
the cofactor environment. The repression of GAT As via FOGs is at least partially mediated 
via CtBP2 (C-teminal Binding Protein) that is able to bind to a PLDLS domain present in 
several Zn-fmger proteins (BKLF,EVI-1, AREB6, ZEB and FOG) and repress their 
transactivation potential (Fox et al. 1999; Hohnes et al. 1999; Svensson et al. 2000; Fossett et 
al. 2001) (Turner and Crossley 1998). This interaction between FOG-I and CtBP is however 
not essential for normal erythropoiesis yet a FOG-2 mutant lacking the CtBP2 binding 
domain is no longer functional (Katz et al. 2002) (Fossett et al. 2001). 
In Drosophila the FOG homologue U-Shaped, Ush, functions primarily as a repressor 
and not as a activator or synergistic partner (Fossett et al. 2001). Many questions about how 
FOG and GAT A cooperate remain unanswered. 
GATA-1 can also bind the Rb protein and overexpression ofGATA-1 results in 
inactivation ofRb by hyperphosphorylation through an unknown mechanism (Whyatt et al. 
1997). This observation was surprising as it was believed that high levels of GAT A-I 
expression induce differentiation by arresting the cell cycle in G I. Rb phosphorylation 
however inactivates Rb and releases the E2F transcription factors and this is essential for 
G liS progression (Harbour and Dean 2000). 
The Rb null matant has a neuronal and erythroid phenorype and the mice die around 
day 14.5 of gestation (Jacks et al. 1992; Lee et al. 1992). These defects are 
cell nonautonomous as Rb -/- ES cells can contribute to all tissues in chimaeric mice and only 
show certain histological defects including cataracts, hyperplasia of the adrenal medulla. and 
enlarged cells in the cerebellum and the liver but no defects in the erythrocytes (Williams et 
al. 1994). This is remarkably similar to phenorype of the GAT A-I overexpressing mice 
(Whyatt et al. 2000). GATA-1 overexpressing mice also show a cell nonautonomous 
inhibition of erythropoiesis. This is further described below and in chapter 2 of this thesis. 
The Lim domain protein Rbtn2 is also thought to cooperate with GATA-1 based on 
similarities of the lmockout phenotypes and the expression of the two proteins (Warren et al. 
1994; Silver and Palis 1997). Rbtn2 may function as a scaffold protein since no DNA binding 
activity has been found. Formation of complexes involving Rbtn2, GATA-1, Tal-l and E47 
has been shown (Osada et al. 1995; Osada et al. 1997). Also a complex involving GAT A-I, 
Tal-l and E2A, and Ldbl!NLI has been discovered (Wadman et al. 1997). It is suggested that 
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variation in the amounts of these complexes can be important in the regulation of 
erythropoiesis. 
The Ets-domain transcription factor Pu.1 (or Spi-1) is important for myeloid and B-cells 
commitment. It is thought to promote myeloid differentiation by suppression of non-myeloid 
genes like GATA-1 and by activation of its own promoter and turning on the three myeloid 
CSF receptors (M, GM, and G) (Nerlov and Graf 1998). Furthermore, overexpression ofPu.1 
blocks erythroid differentiation. It has been suggested that overexpression ofPu.l results in 
reduced DNA binding by GATA-1 (Yamada et al. 1998a; Zhang et al. 2000). Similarly 
GATA-1 is thought to inhibit the activation of targets ofPu.l (Zhang et al. 1999; Nerlov et al. 
2000). In addition it has also been shown that Pu.1 and GATA-1 can physically interact and 
thus, the balance between GATA-1 and Pu.l might be an important regulatory step in the 
differentiation of myeloid and erythroid cells (Rekhtman et al. 1999). 
Post translational modifications 
The activity of may proteins is controlled by covalent post-translational modifications. A 
wide variety of post translational modifications is known such as acetylation~ 
phosphorylation, methylation and glycosylation. These modifications can control activity, 
specificity, stability and the localisation of a modified protein (Han and Martinage 1992). 
Two cofactors ofGATA-1. P300 and CBP, are almost identical acetyltransferases that 
are connected with transcription and cell transformation. These proteins interact with a many 
different proteins including general transcription factors and tissue-specific transcription 
factors. This suggests a pivotal role in transcription. cell growth, transformation and 
development (Goodman and Smolik 2000). These proteins can bind to GATA-1 and acetylate 
the GATA-1 protein, thereby stimulating transcriptional activity (Blobel et al. 1998; Boyes et 
al. 1998). It has also been suggested that acetylation is required for differentiation of a 
GATA-1 null erythroid cell line G 1E when transfected with a GATA-1-expressing retrovirus 
(Hung et al. 1999). The acetylation of chicken GATA-1 by p300 increases DNA binding 
activity in vitro and in transfected MEL cells. This increase in binding capacity might be 
caused by a conformational change which could also influence the interaction ofGATA-1 
with other proteins (Boyes et al. 1998). This effect bas not been seen with mammalian 
GATA-1 (Hung et al. 1999). 
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Phosphorylation is a common mechanism for regulation of protein activity for many 
cellular processes including cell cycle control, transcriptional activity, specificity and signal 
transduction (Whitmarsh and Davis 2000). GATA-1 can be phosphorylated on seven serines 
(Crossley and Orkin 1994). Of these seven serine residues, six (aa 26, 49, 72, 142, 178, 187) 
are phosphorylated in uninduced MEL cells and the seventh (aa 310) is increasingly 
phosphorylated upon DMSO induction. Mutations in GATA-1 that replace the serines for 
alanines did not change DNA binding affinity, DNA bending, or the transcriptional activity of 
GATA-1 on a reporter construct transfected in NIH3T3 cells. Another report shows that in 
K652 cells phosphorylation ofGATA-1 does influence DNA binding and confmns the 
absence of such an effect in MEL cells (Partington and Patient 1999). Though Ser 310 is 
located in a classical nuclear localisation signal, it does not influence nuclear transport. This is 
unlike what is seen in chicken cells, where upon differentiation, cGATA-1 was increasingly 
phosphorylated and transported into the nucleus (Briegel eta!. 1996). The discrepancy 
between these two results may be explained by the difference between avian and mammalian 
erythropoiesis. In avian erythropoiesis, the erythrocytes remain nucleated. The conservation 
bernreen the avian and mammalian GATA-1 proteins is much lower than among the 
mammalian GATA-1 proteins. i\nother reason could be that the cells used are not comparable 
in their developmental stage and as a consequence, GATA-1 is mainly nuclear in MEL cells, 
whereas in the chicken cells it is mostly cytoplasmic. 
,,, r rr ? r 
T = Phosphorylation site 
? = acetylation site 
I]= Zn-finger 
Phosphorylation sites: aa 26, 49, 72, 142, 178, 187 and 310 
Lysine rich acetylation sites: aa 245-252, 308-316 
Zn fingers: 204- 228, 258 - 282 
Figure 9: Schematic representation ofGATA-1 with the Zn-fingers. phosphorylation and acetylation 
sites. 
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In conclusion, the few reports on GAT A-I phosphorylation have been contradicting 
and thus its role in the regulation of GAT A-I function is still unclear. It might be that 
phosphorylation does play a role in mammalian cells, for instance in regulating the interaction 
between GAT A-I and other proteins like the cofactor CBP. It is known that phosphorylation 
of p53 is of great importance for the interaction of CBP and p53 (Lambert et al. 1998). 
Phosphorylation of the GATA-1 protein might be required very early in erythroid 
differentiation, a question which could not be addressed with the methods used so far. 
Knockin mutant mice with substitution of serine 310 might elucidate whether or not 
phosphorylation of this amino acid is important. 
GAT A-1 protein degradation 
The level of transcription factors can be regulated by the rate of synthesis and degradation. 
Protein degradation can, like protein synthesis, be a very controlled mechanism of regulation 
as in the case of the addition ofubiquitin and subsequent degradation (Desterro eta!. 2000). 
Protein degradation is important feature of apoptosis and in mediated by Caspase proteins that 
can be activated by stimulated death ligand receptors (Budihardjo et al. 1999). 
Erythroblasts express several death receptors: Fas (CD95), tumour necrosis factor 
(TNF) receptor, TRAIL receptor-! (DR4) and TRAIL receptor-2 (DR5), especially at the 
basophilic erythroblast stage (Rusten and Jacobsen 1995; De Maria et al. !999a; De Maria et 
aL 1999b). Erythroid progenitors acquire a transient sensitivity to death ligands until the 
orthochromatic erythroblast stage. It has been shown that these more mature erythroblasts 
express the ligand for Fas, Fas-Jigand (FasL). The death ligands TNF-a, Trail and Fas have 
been shown to negatively regulate erythropoiesis through Caspase-3-mediated cleavage of 
GAT A-I (De Maria et al. 1999b). These data have led to the proposal of a model with a 
negative feedback mechanism in the erythroblastic islands. Upon accumulation of mature 
erythroblasts, FasL levels increase leading to GATA-1 cleavage in the erythroid progenitors. 
This reduction ofGATA-1 activity results in differentiation arrest of these immature 
erythroblasts (Orkin and Weiss 1999) (De Maria et al. !999a). 
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and others 
.j, 
Many targets 
(known and unknown) 
.!. 
Reversible arrest 
.!. 
Death 
Maturation 
Figure 10: The negative feedback model of immature by mature erythroid progenitor cells via death 
ligand signalling, caspase activation and GATA-1 degradation. 
(Adapted from (Orkin and Weiss 1999)) 
There are however a few questions that remain unanswered. Why is the caspase 
cleavage site not conserved in an evolutionary close organism like the mouse? Is this a 
common way to regulate the activity ofGATA factors? 'What is the in vivo relevance of the 
breakdown of GATA-1 ? It is for instance known that in death ligands besides inducing 
apoptosis, can also have effects on proliferation and differentiation (Baud and Karin 2001 ), 
Furthermore it has been shown that caspase activation is required for terminal erythroid 
differentiation in vitro, inhibition of caspases leads to a block at the basophilic erythroblast 
stage (Zermati et aL 2001), 
We suggest that GATA-1 activity is dynamically regulated during differentiation, 
because in mice overexpressing GATA-1 erythroblasts are blocked in terminal maturation. 
This block is alleviated in mice that overexpress GATA-1 heterocellularly, We propose a 
model in which a signal, REDS for ~d cell Qifferentiation ~ignal, expressed by the mature 
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erythroblast, reduces the GATA-1 activity in the immature erythroblast thereby allowing 
these cells to complete differentiation (Fig.ll) (Chapter 2). 
proerythroblast 
1)1\j basophilic erythroblast 
~, polychromatic erythroblast 
(I orthochromatic erythroblast 
8 erythrocyte 
• pyknotic nucleus 
-::}i.~ macrophage 
Figure 11: A simplified model of the erythroblastic island. The position of the central macrophage and 
the arrangement of the erythroid progenitors within the macrophage· s extensions are shoVIll. The 
process of pyknosis, enucleation and phagocytosis of the expelled nuclei arc represented. 
The other GATA transcription factor proteins 
GATA-2 
GATA-2 is expressed in the early hematopoietic progenitors, early erythroid cells, mast cells 
and megakaryocytes . Other sites of expression are the placenta and the developing central 
nervous system where it overlaps with GATA-3 expression (Ma et al. 1997). A suggested 
mechanism how GATA-2 influences transcription is via regulation of chromatin accessibility 
by associating with histone deacetylases HDAC3 and HDAC5 (Ozawa et al. 2001). 
The mouse null mutant showed that GATA-2 is essential for all hematopoiesis (Tsai et 
al. 1994). The GATA-2 -/-mice die between 10 and ll dpc due to severe anaemia, but 
already look pale at day 9.5. Although the primitive erythrocytes look normal they are 
reduced in number two to seven-fold. In chimaeras GATA-2 -1- ES cells did contribute to all 
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tissues except the definitive haematopoietic lineages. In vitro differentiation ofGATA-2 -/-
ES cells revealed a profound deficit in definitive hematopoietic stem cells or progenitor cells 
largely related to poor expansion of the cellular pool in response to hematopoietic growth 
factors. It has been proposed that GATA-2 regulates genes controlling growth factor 
responsiveness or the proliferative capacity of early hematopoietic cells. (Tsai et al. 1994). It 
is known that in pluripotent stem cells the GATA-2level is higher than in more differentiated 
cells and this supports the idea that GATA-2 is down regulated during differentiation (Orlic et 
al. 1995). GATA-1 may play a role in this process in the erythroid lineage because GATA-2 
is upregulated -50-fold in GATA-1 -/-erythroid cells (Weiss et al. 1994). Overexpression 
studies have shown that high GATA-2levels inhibit differentiation and also block 
proliferation (Heyworth et al. 1999; Persons et al. 1999) (Briegel eta!. l993)(R. Rattier 
unpublished data). 
In the placenta GATA-2, together with GATA-3, regulates the synthesis of placental 
hormones (Ma et al. 1997). In the central nervous system GATA-2 and GATA-3 also have 
overlapping expression patterns in some areas. GATA-2 is expressed from 9 dpc onwards and 
analysis of the GATA-2 -1- mice showed that the expression ofGATA-2 in the developing 
CNS of the mouse embryo is essential for GATA-3 expression. Loss ofGATA-2leads to 
defects in neurogenesis with a notable lack of ventral neuronal progenitors(Nardelli et al. 
1999; Para et al. 1999). 
Finally, partial rescue experiments showed that GATA-2 is also important for proper 
urogenital development (Zhou eta!. 1998). 
GATA-3 
GATA-3 was first identified as a transcription factor binding to the enhancer of the TCRa 
enhancer (Ho et al. 1991). The expression pattern ofGATA-3 very complex as it is frrst 
expressed in the ectoplacental cone and the trophoblast cells, after day 10.5 dpc in T-
lymphocytes, the central and peripheral nervous system, otic and optic vesicles, cochlear 
endothelial cells, kidney, liver, adrenal gland, mesonephros, Wolfian duct, ureteric bud, 
whisker follicles and the primary palate (Oosterwegel eta!. 1992; George et al. 1994; 
Lakshmanan et al. 1999). In transgenic experiments using YACs as big as 625 kb (450 kb 5' 
and 150 kb 3'ofthe gene), no complete expression pattern could be achieved, showing that 
some of regulatory elements of the GATA-3 gene are not in close proximity of the actual 
coding sequence (Lakshmanan et al. 1999). 
GATA-3 haplo-insufficiency has been associated with the hypoparathyroidism, 
sensorineural deafness, renal anomaly syndrome in humans (HDR) (Van Esch et al. 2000; 
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Van Esch and Devriendt 2001 ). In contrast mice heterozygous for the GATA-3 mutation are 
fertile and appeared to be normal. Homozygous mutant embryos die between day ll and 12 
dpc and display massive internal bleeding, marked gro\Vth retardation, severe defom1ities of 
the brain and spinal cord, and gross aberrations in fetal liver hematopoiesis(Pandolfi et al. 
1995). An indication of the actual cause of death was found by a failed rescue experiment 
with a trans gene that did not express in the thymus and the symphathoadrenal system 
(Lakshmanan et al. 1998). This experiment showed that loss of GATA-3 leads to reduced 
accumulation of tyrosine hydroxylase (Th) and dopamine B-hydroxylase (Dbh) in the 
sympathic nervous system (SNS) which leads to reduced noradrenaline levels. The GATA-3 
mutation-induced lethality could be partially averted by feeding pregnant GATA-3 +/-
intercrossed female mice catechol intermediates (Lim et al. 2000). This temporal rescue 
revealed roles for GATA-3 in some other tissues and organs that could previously not be 
detected. These older embryos had renal hypoplasia and developmental defects in structures 
derived from cephalic neural crest cells such as the tongue, mandible, tooth primordia and 
semicircular canals (Lim et al. 2000). 
In chimearic mice GATA-3 null cells can contribute to the brain, kidney and lungs but not 
to the T-cells (Hendriks et al. 1999). Thus, although it has been suggested that GATA-3 could 
be involved in the process of intra-embryonic stem cell generation, of all the hematopoietic 
cells GATA-3 is only essential forT -cell development (Manaia et al. 2000) (Ting et al. 1996). 
Furthermore, GATA-3 is thought to be important for the expansion ofT-cell progenitors and 
for the control of subsequent proliferation steps, as GATA-3 expression appears to be coupled 
to the cell cycle (Hendriks eta!. 1999). The level of expression during T-cell development is 
influencing the commitment process, as enforced expression ofGATA-3 inhibits CD8 single 
positive cells and induces the formation of the Th2-committed T-cell compartment and Th2-
specific cytokines (Nawijn et al. ZOO! b) (Zheng and Flavelll997; Nawijn et al. 200la). The 
regulation ofGATA-3 expression is therefore a central issue in T-cell development. A 
lymphoid-specific protein ROG. repressor ofGATA, is induced in Thl cells. It interacts with 
GATA-3 and represses its fimction (Miaw et al. 2000). Acetylation ofGATA-3 also regulates 
its function and has impact on the survival and homing capacity of the T-ce11s in secondary 
lymphoid organs (Yamagata eta!. 2000). 
GATA-4 
During embryogenesis GATA-4 is expressed in the visceral yolk sac endoderm, in the 
cardiogenic mesoderm and subsequently in the heart, in proximal and distal gut, testis, ovary 
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and liver (Morrisey et al. 1996). Expression persists in the adult heart. ovary, testis, liver and 
small intestine (Arceci et al. 1993). 
Heterozygous GATA-4 null mice have no phenotype but homozygous GATA-4 null 
mice arrest in development between 7 and 9.5 dpc due to severe developmental abnormalities. 
They lack a primitive heart tube and foregut and develop partially outside the yolk sac 
(Molkentin et al. 1997). It has been suggested that GATA-4 is essential for terminal cardiac 
differentiation, but GATA-4 null ES cells contribute normally to the three heart layers in 
chimeric embryos and the mutant cardiomyocytes in such embryos have a fully differentiated 
phenotype (Narita et al. 1997). It has been suggested that GATA-5 and GATA-6 are partially 
compensating for the absence ofGATA-4. In the absence ofGATA-4. the level ofGATA-6 is 
significantly upregulated in vivo and in vitro in differentiated ES cells (Kuo et al. 1997). 
GATA-4 is thought to be required for the migration or folding morphogenesis of the 
precardiogenic splanchnic mesodermal cells at the level of the anterior intestinal portal 
(Molkentin et al. 1997). 
GATA-5 
GATA-5 is expressed during development in precardiac mesoderm and throughout the heart 
until 16 dpc, the developing lung. urogenital ridge, the bladder and the gut and postnatally 
only in the intestine. stomach, bladder and the lungs (Morrisey et al. 1997). 
GATA-5 is the only GATA transcription factor without a embryonic lethal phenotype 
of the null mutant. The GATA-5 deficient male mice are undistinguishable from wild type 
mice, the females exhibit urogenital abnormalities that included vaginal and uterine defects 
and hypospadias (Molkentin et al. 2000). As GATA-5 overlaps in expression with either 
GATA-4 or GATA-6 or both, its function is probably overlapping for most targets. Despite 
this, it might be influencing the expression of some genes, for example during heart formation 
(Kakita et al. 1999; Morimoto eta!. 1999) or in stomach (Sakamoto eta!. 2000). Also GATA-
5 -1- I GATA-4 +1- or GATA-5 -1- I GATA-6 +I- compound mutant mice showed no extra 
phenotype, thus one copy of the other GAT As is sufficient for proper development 
(Molkentin et al. 2000). On the other hand in zebrafish GATA-5 is required for expression of 
myocardial genes and for the formation of the heart tube, similar to the role ofGATA-4 in 
mice (Reiter et al. 1999). This suggests that during evolution most of the function ofGATA-5 
has been taken over by GATA-4. 
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GATA-6 
GATA-6 is frrst expressed before implantation in the blastocyst, followed by expression in the 
developing heart, gut, lungs, liver, aorta, urogenital ridge, arterial smooth muscle cells, the 
stomach and the testis. In most of these tissues it persists after birth (Morrisey et al. 1996; 
Morrisey et al. 1998) (Kiiveri et al. 1999). 
The knockout showed that GATA-6 is essential for early embryonic development. It is 
embryonic lethal shortly after implantation (5.5 dpc) (Koutsourakis et al. 1999). Furthermore 
experiments with chimeric mice and embryonic lung-explant cultures showed that GATA-6 is 
required for normal branching morphogenesis and late epithelial cell differentiation (Keijzer 
et al. 2001). It has been suggested that GATA-6 should be down regulated during heart 
formation as overexpression leads to an excess of cells, thickening of the myocardial muscle 
and a block in differentiation (Gove et al. 1997). This might be similar to GATA-1 
overexpression in erythroid cells (Chapter 2). 
Summary GATA transcription factor family 
The transcription factors of the GAT A-family are essential for the proper development of 
several tissues in vivo (Pevny eta!. 1991; Tsai et al. 1994; Pandolfi et al. 1995; Molkentin et 
al. 1997) (Koutsourakis et al. 1999) . It has been shown that GATA factors are important 
regulators of development and are suggested to be ·master' regulators of the choice between 
differentiation and proliferation (Tsai et al. 1994; Whyatt et al. 1997; Whyatt et al. 2000) 
(Gove et al. 1997; Hendriks et al. 1999). 
Tissues knovm to express GATA transcription factors often express more than one 
GATA factor. These GATA factors are then often separately expressed at consecutive periods 
but with an intermediate period with overlapping expression. Examples are erythroid 
progenitors (GATA-1 and -2), Sertoli cells (GATA-1, 4 and -6), nervous system (GATA-2 
and -3) and heart and gut (GATA-4,5 and-6). It has been suggested that GATA transcription 
factors~ that overlap in expression pattern, can regulate each others transcription and that the 
switch in the expression of one GATA factor to the other, is essential for the progression of 
differentiation. This is probably an oversimplification and so far it has not been convincingly 
demonstrated that a GATA factor can act as a regulatory switch of differentiation, as several 
overexpression studies never resulted in an enhanced or accelerated differentiation process but 
rather in sustained proliferation and a block in differentiation. 
Other studies suggest that it does not matter which GATA factor is expressed but that 
the level and the timing of expression of a GATA factor is more important for proper 
differentiation. The biochemical properties of the factors may be largely interchangeable. 
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There are a number of reports that support this possibility. In a primitive murine myeloid cell 
line megakaryocyte differentiation can be induced by GAIA-I and -2, and only the C-
te1.11'rinal GAT A-I Zn-finger is essential for differentiation to occur (Visvader et al. 1992; 
Visvader eta!. 1995). The GAIA-I null mutant can be partially rescued by a knock-in 
mutation ofGATA-3 in the GAIA-I locus (Tsai eta!. 1998). Takahashi eta! showed that a 
lethal GATA-1 promotor knockdown mutation can be largely rescued by transgenes 
expressing GATA-2 or -3 under control ofGATA-1 regulatory elements. The 
interchangeability of the different proteins suggests that expression at the right time, place and 
level are the very important parameters for GAIA function (Takahashi eta!. 2000a). 
In addition to this there are many similarities between the mechanisms used by the GAT As as 
they can all interact with CBP/P300 (GAIA- I (Blobel eta!. 1998), GAIA- 2, 3 and 4 
(Blobel eta!. 1998), GATA-5 (Kakita eta!. 1999),GATA-6 (Wada eta!. 2000)) and FOG-I 
or-2 (Tsang et al. 1997). Recently interaction between the peroxisome proliferator activated 
receptor (PP AR) binding protein (PBP) and GAIA-I ,-2,-3,-4 and -6 was described 
(Crawford eta!. 2001). This interaction was suspected after comparison of the PBP -/-mice 
with the GATA factor-/- mice. PBP is an important coactivator ofPPAR_ and several other 
nuclear receptors and transcriptional complexes where it is thought to function as a bridging 
factor (Crawford eta!. 2001). Although a great deal has been learned about the biological 
roles of the GATA factors, many interesting and fundamental questions remain. How are they 
regulated~ how are they linked to cell cycle regulation and differentiation, what are the 
essential target genes and what is the composition and the importance of the complexes in 
which they are present? The search for answers continues and with the help of new 
technology of the emerging genomics, proteomics and bioinformatics fields we may solve 
these questions, and undoubtedly ask new ones. 
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Abstract 
GATA-1 is a tissue-specific transcription factor essential for erythropoiesis [Pevny, 1991 
#!][Weiss, 1994 #2]. We demonstrate that GATA-1 overexpression in erythroid cells inhibits 
their differentiation, leading to a lethal anaemia. Using X-inactivation of a GATA-1 trans gene 
and chimeric animals~ we show that this defect is intrinsic to erythroid cells and yet 
nevertheless cell nonautonomous. Usually, cell nonautonomy is thought to reflect aberrant 
gene function in cells other than those that exhibit the phenotype [Rossant, 1998 #3]. Based 
on our data, we propose an alternative mechanism in which a signal originating from wild-
type erythroid cells restores normal differentiation to GATA-1 overexpressing cells in vivo. 
The existence of such a signalling mechanism indicates that previous interpretations of cell 
nonautonomous defects may be erroneous in some cases and may in fact assign gene function 
to incorrect cell types. 
GATA-1 expression is required at the relatively immature proerythroblast stage [Pevny, 1991 
#!][Weiss, 1994 #2], since GATA-1 null proerythroblasts undergo apoptosis [Weiss, 1995 #4] 
and reduced GATA-1 levels inhibit proerythroblast differentiation [Takahashi, 1998 #5]. 
However, the role ofGATA-llater in erythroid differentiation remains obscure. Murine 
erythroleukemia (MEL) cells overexpressing GATA-1 under the control of the erythroid-
specific human beta-globin locus control region linked to the beta-globin promoter (construct 
PEV3-GATA-l) fail to activate the expression of differentiation markers in response to the 
chemical inducer dimethyl sulphoxide (DMSO) and do not undergo differentiation-associated 
proliferative arrest [Whyatt, 1997 #6]. Embryonic stem (ES) cell clones overexpressing 
GATA-1 also generate erythroid colonies inhibited in terminal differentiation [Whyatt, 1997 
#6]. Furthermore, overexpression of an inducible GAT A-I fusion protein (GATA-1-LBD, 
containing the tamoxifen-inducible ligand-binding domain of the oestrogen receptor) also 
inhibits erythroid differentiation (unpublished observations, R.Ferreira and D.Whyatt). These 
results may explain our failure to produce a transgenic line of mice via conventional 
microinjection ofPEV3-GATA-l, since loss of erythroid differentiation would be lethal in 
vivo. 
To circumvent this, we exploited the process ofX-inactivation [Kuroda, 1997 #7]. An 
X-linked GATA-1 transgene should be transcriptionally active in 50% offemale erythroid 
precursors. In males, X-inactivation does not occur and all erythroid cells should overexpress 
GATA-1. Mice can survive to term when 50% of erythroid precursors fail to differentiate 
normally, for example in females with one disrupted GATA-1 allele (which is X-linked). 
However, approximately 30% ofGATA-1 null heterozygous females die from 15.5 days post 
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coitus ( dpc) with severe anaemia. In survivors, anaemia is transient and recovery is thought to 
be due to in vivo selection of normal progenitors [Fujiwara, 1996 #8][Tsai, 1998 #9], 
DNA fluorecence-in-situ-hybridisation (DNA-FISH) screening of male ES cells stably 
transfected with PEV3-GATA-l demonstrated localisation of the transgene to the X 
chromosome in clone G4, The expected ratio in male to female progeny (38:34) was observed 
from 100% germline transmitting male chimeras generated from this clone, Fl females 
carrying the transgene and F1 males (except one) being non-transgenic. The phenotypically 
male transgenic animal contained two X chromosomes (one carrying the transgene) and one Y 
chromosome (data not shown). Chimeras generated from four other ES cell clones containing 
autosomal transgene integrations failed to give germline transmission. 
Transgenic females were mated and progeny examined. Transgenic females are 
indistinguishable from wild-type littermates. Male transgenics are anaemic from 12.5 dpc and 
dead by 14,5 dpc (Figure Ia and !b), Backcrossing GAT A-I overexpressing females to FVB 
males for eight generations resulted in no viable transgenic males (excluding the XXY male). 
At 13.5 dpc, the number of enucleated erythrocytes relative to nucleated erythrocytes is 
reduced more than three-fold in transgenic males compared to controls, demonstrating that 
definitive erythropoiesis is inhibited (Figure !c), 
The fetal liver of transgenic male embryos, the site of definitive erythropoiesis at 13.5 dpc. is 
normal in size, ce11 number and contains similar numbers of apoptotic cells (TUNEL assay, 
data not shown) compared to controls. However, transgenic male fetal livers contain 
significantly more early basopllllic erythroid precursors and fewer late benzidine positive cells 
(Figure lc), confirming that fetal liver erythropoiesis is defective. Surprisingly, female 
transgenics display no alteration in the morphology of cells in the fetal liver and have normal 
numbers of enucleated erythrocytes at this stage (Figure 1c). Expression of putative GATA-1 
target genes such as a-globin is unchanged in female transgenics, since RNA-FISH detection 
of a-globin nascent transcripts on 13.5 dpc fetal liver cells shows a normal number of cells 
transcribing a-globin (72% compared to 73% in controls). Furthermore, co-staining shows 
that half of these cells are positive for trans gene-derived GAT A-I transcripts (data not 
shovro), suggesting the transgene is sensitive to X-inactivation. 
69 
a 
b 
c 
Liver 
12.5 
Blood 
13.5 
11.5 
wt male 2 
wtfemale 2 
GATA·1 tg. male 2 
GATA-1 tg. female 3 
wt 
d' 
tg 
d' 
tg 
~ 
day post coitus 
14_5 l adult 12.5 13.5 
14 18 2 56 
21 13 1 52 
24 13 4 0 
23 ana-emic 9 anaemic 4 dead 
1 dead 
22 
4dead 
12 3 47 
II{ proerythroblast 
1!J basophilic erythr~;~blast 
[!I polychromatic erythroblast 
EJ orthochromatic erythroblast 
liJ prlmi!M:! erythrocyte 
[!] definitive erythrocyW 
68 ±$ (n=Tl 37 !7 rn=Ol 68 :4 rn=5l %enucleated ceUs 
2.1 0.6 2.1 enucleated.: nucleated cells 
Figure 1: GATA-1 overexpression in vivo. a, Representative v.rild-type (v.rt) males and transgenics (tg) 
of either sex. 11.5 dpc to 14.5 dpc, yolk sacs intact. b, Genotype and phenotype of embryos and adults, 
excluding Fl. Death was scored by lack of heartbeat. pallor as anaemia. c, Disaggrcgated 12.5 dpc 
fetal liver and 13.5 dpc blood. Indicated by key is morphology of differentiating erythroid precusors 
and erythrocytes. Arrowheads indicate erythroid precusors in male transgenic blood (<3% of all cells). 
Beneath is percentage enucleated erythrocytes (>300 events/embryo). number of independent embryos 
and standard deviations. Ratio of enucleated to nucleated erythroid cells is shovm. 
Consistent with this interpretation, Western blot analysis demonstrates a higher level of 
transgene-derived GATA-1 protein in male versus female transgenic embryos (Figure 2a). 
RNA-FISH using a GATA-1 probe demonstrates that at 12.5 dpc, 66% of transgenic male 
fetal liver cells are positive for trans gene-derived GATA-1 nascent transcripts (appearing as a 
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bright nuclear dot), while 32% of transgenic female cells are GATA-1 positive (Figure 2b). 
This method did not detect endogenous GATA-1 transcripts. Co-staining for Xist RNA shows 
a single punctate signal in male fetal liver cells, corresponding to transcription from the Xist 
allele on the active X chromosome. Female cells also contain a larger area of accumulated 
Xist RNA on the inactive X chromosome (or Barr body) [Parming, 1997 #lO][Sheardown, 
1997 #11]. Apparent co-localisation of Barr body and GATA-1 signals occurs in less than 5% 
of double positive cells (Figure 2b and data not sho'Wll), confirming that male transgenics 
express the transgene pancellularly and females heterocellularly in response to X-inactivation. 
tg!j! tgd' 
1 
.. --- --···•aML--"'"·GATA-1 
. ' --- "- ~endo. GATA-.1 
1-,_.,... •- ..,_......,.._~~cyclinA2 
b 
wtd' tgd' 
32±2 66:t:3 %trans.GATA~1"" 
(r~=3) (n"'3) 
Figure 2: GATA-1 transgene is subject to X-inactivation. a, Western blot of nuclear extracts from 13.5 
dpc fetal livers, with anti-GATA-1 antibody N6. DMSO-induccd control (PEV3) and GATA-l 
overexpressing (PEV3-GATA-1) MEL cell samples are included. Position ofmyc-tagged transgene-
dcrived GATA-1 (trans.GATA-1) and endogenous GATA-1 (endo.GATA-1) indicated. Cyclin A2 
used as loading control. b, RNA-FISH on 12.5 dpc disaggregated fetal liver cells. Cells stained for 
GATA-1 (green) and Xist (red). Representative cells shown. Percentage of transgenc-derived GATA-1 
positive cells, number of embryos and standard deviations indicated. 
Survival of transgenic mice is not dependent on being female per se, since a transgenic XXY 
male (where X-inactivation occurs [Kuroda, 1997 #7]) is viable. One could argue that the 
observed phenotype is due to the X chromosomal integration event itself. However, 
overexpression of the tarnoxifen-inducible GATA-1-LBD in mice inhibits erythroid 
differentiation independent of the integration site. GATA-1-LBD accumulates to lower levels 
than PEV3-GATA-1 derived protein and consequently induces a milder phenotype (15% 
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reduction as compared to a 60% reduction in the proportion of differentiated erythroid cells in 
a CFU-E assay, data not shown). 
To examine the relative contribution ofGATA-1 overexpressing cells to the erythroid 
lineage, transgenic females were bred with males containing a lacZ gene insertion in the X-
inactivation sensitive Bruton's tyrosine kinase (Btk1'"') locus [Hendriks, 1996 #12]. We find 
the same number oflacZ positive erythroid cells in the fetal livers of 13.5 dpc BtkiuoZI+ and 
compound Btk~uoz+/GATA-1 transgenic females (Fignre 3a). Adult Btk~ua males or females 
express lacZ in 50% or 25% of large erythroid precursors in the bone marrow respectively. 
Compound BtklucZ·•"/GATA-1 transgenic females also express lacZ in 25% of large erythroid 
precursors (Fignre 3b ). 
a %erythroid % lacz· (of erythroid) 
wlldtype male 
85±2 0.5 ±0.2 (n=5) 
Bti(:>O• female 
(n=7) 84 ±3 9.0 ±3.3 
GATA-1 tg. male 
79 ±3 1.3 ±0.3 (n=7) 
GATA-1 tg. 
85±2 9.9 ±2.1 Btl<'.::~· female 
(n=9) 
b o/olacZ Erythrold B-eef! Granulocytic Monocyf1c 
staining targe medium lineage lineage lineage 
wild-type 3 3 6 
Btk1.><:: male 
#1 55 19 81 63 92 
tf2 53 16 90 61 91 
Btk1><=~· female 
#1 20 7 31 33 45 
tf2 23 7 39 27 46 
#G 24 9 37 25 44 
GATA-1 tg. 
Btk'"'""' female 
#1 35 12 46 34 56 
tf2 26 9 37 30 46 
#G 24 7 35 22 39 
Figure 3: GATA-1 transgene is subject to X-inactivation. a.. Percentage of erythroid cells and 
percentage of lacz+ erythroid cells in 13.5 dpc fetal livers from female GATA-1 transgenic mice mated 
to Btkw.cz males. Number of embryos and standard deviations indicated. b, Percentage oflacz+ staining 
cells in haematopoietic lineages of six week old mice. Erythroid cells are arbritrarily divided into large 
and medium-sized based on forward scatter (FSC) value. Note the GATA-1 transgenic Btkln.C7J+ female 
(#1) expressing lacZ in a high number of erythroid precursors also expresses lacZ in a higher than 
expected number of cells in the B-cell and monocytic lineages. This reflects the normal variance of the 
binomial distribution ofX-inactivation balance in early pluripotent precursors. 
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Thus, there is a normal representation of cells with an active lacZ gene in the erythroid 
compartment ofGATA-1 overexpressing females throughout development. We conclude 
there is no selection for or against GATA-1 overexpressing cells in females. Since these 
females generate normal numbers of defmitive erythrocytes, the GATA-1 overexpressing 
cells must be differentiating normally in vivo. 
To confirm that GATA-1 overexpressing cells contribute to the adult erythrocyte pooL 
chimeric animals were generated with clone G4 cells (which are male and express the GATA-
1 transgene pancellularly). These cells contribute up to 50% of the erythrocytes. as assayed by 
globin chain isoform analysis (Figure 4a) and confirmed by glucose phosphate isomerase 
analysis (data not shown). These cells are morphologically normal (Figure 4b ). Furthermore, 
analysis of the blood of female transgenic mice demonstrates no effect on other blood cell 
parameters. including red cell number, cell volume and haemoglobin content (data not 
shown). 
b C57bl6 G4ch#8 
- ---] 
-- -- ~ 
- • '*" '? 
Figure 4: GATA-1 ovcrexpressing CFU-Es fail to differentiate and undergo apoptosis in vitro. a. 
Representative histogram plots of FSC (indicating relative cell size) of viable erythroid cells from 
CFU-E assays performed on disaggregated fetal liver cells of 13.5 dpc embryos. Cells harvested 
before culture (day 0). after 24 hours (day 1) and 48 hours (day 2) of culture. Shown is the curve 
obtained by mixing transgenic male and wild-type samples in a 1:1 ratio after different periods of 
culture. b. Percentage of dead erythroid cells in same samples as a. Due to a background of dead cells 
with a FSC <327 (using our instrument settings). present in all CFU-E samples. cells with a FSC<327 
were excluded from this analysis. 
To determine the differentiation stage which is affected in the transgenic males, burst-
forming unit-erythroid (BFU-E, reflecting early committed erythroid progenitors) and colony-
forming unit-erythroid (CFU-E, reflecting a later stage in erythroid differentiation) assays 
were performed. The same number of colonies in BFU-E and CFU-E assays are formed from 
both wild-type and transgenic 12.5 dpc and 13.5 dpc fetal livers (data not shown). CFU-E 
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colonies develop from single cells [Cormack, 1976 #13] and do not require accessory cells to 
form [Sawada, 1989 #14], so the effect ofGATA-1 overexpression on female transgenic 
precursors when no longer in close contact with non-overexpressing cells could be addressed. 
In male transgenic CFU-E colonies, the production of small late differentiated erythroid cells 
is inhibited (Figure 5a) and after 24 hours approximately 40% of erythroid cells are dead, 
compared to 20% in wild-type cultures (Figure 5b). Female transgenic CFU-E cultures have 
an intermediate phenotype (Figure 5a and 5b ), identical to that found when wild-type and 
male transgenic cells are mixed before or after culture at a 1:1 ratio. This demonstrates that 
female GATA-1 overexpressing erythroid precursors are intrinsically defective and behave 
identically to transgenic male erythroid precursors when removed from the fetal liver. 
Gene function is ''"cell autonomous'· when a cell displays a phenotype that corresponds to its 
genotype, regardless of the genotype of surrounding cells. Gene function is defined as "'cell 
nonautonomous" when a cell exhibits a phenotype that does not correspond to its genotype 
[Apfeld, 1998 #15]. In mosaics (ie. female transgenics and male chimeras), the phenotype of 
GATA-1 transgenic cells is wild-type. Therefore, the function of the GATA-1 transgene is 
cell nonautonomous. The conventional interpretation would be that GATA-1 overexpressing 
erythroid cells are normal and that the GAT A-I trans gene causes a defect in a non-erythroid 
cell normally supporting erythropoiesis. If so, then all erythroid precursors in female 
transgenics would behave identically in vivo and in vitro. However, this is not the case (Figure 
5). Thus, the conventional interpretation of cell nonautonomy is incorrect. 
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a 
b 
tg~ 
r-1 1:1 
~wt+tgo" 
----Forward scatter----
% dead erythroid cells 
day 0 day 1 day2 
wildtype 9>2 18 >2 15 :!:6 (n=9) 
GATA-1 tg. male 11 ±3 37 ±4 42 ±7 (c=5) 
GATA-1 tg. female 13 :t7 27 ±3 29 ±3 (c=4) 
Figure 5: GATA-1 overexpressing CFU-Es fail to differentiate and undergo apoptosis in vitro. a, 
Representative histogram plots of FSC (indicating relative cell size) of viable erythroid cells from 
CFU-E assays performed on disaggregated fetal liver cells of 13.5 dpc embryos. Cells harvested 
before culture (day 0), after 24 hours (day 1) and 48 hours (day 2) of culture. Shown is the curve 
obtained by mixing transgenic male and wild-type samples in a 1:1 ratio after different periods of 
culture. b. Percentage of dead erythroid cells in same samples as a. Due to a background of dead cells 
with a FSC <327 (using our instrument settings). present in all CFU-E samples. cells with a FSC<327 
were excluded from this analysis. 
Possibly the mutant erythroid cells produce a negative factor inhibiting differentiation and this 
is diluted in mosaics. However, to be cell nonautonomous, expression of such a negative 
signalling factor would have to be the only defect in the GATA-1 overexpressing cells. 
Considering the biochemical effects ofGATA-1 overexpression in erythroid cells [Whyatt, 
1997 #6][Dubart, 1996 #16][Briegel, 1996 #17], this is unlikely. Since GATA-1 
overexpressing erythroid cells are intrinsically defective, they must be responding to a signal 
reversing these defects in mosaics. Therefore, we propose wildwtype cells produce a positive 
factor activating the differentiation ofGATA-1 overexpressing cells. We tentatively name this 
activity red c~ll Qifferentiation §igna! or REDS. The cells producing REDS must be absent or 
reduced in transgenic males. Definitive erythropoiesis occurs in erythroblastic islands [Bessis, 
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1983 #18]. These contain a central macrophage surrounded by erythroid cells at all stages of 
maturation, with immature cells close to the macrophage and mature cells near the edge of the 
island [Bessis. 1983 #18][Bemard; 1991 #19] (Figure 6). The obvious candidate source of 
REDS is mature erythroid cells. since this is the only cell population clearly reduced in the 
transgenic males. Merely allowing wild-type fetal liver cells to contact GATA-1 
overexpressing cells by mixing them in liquid culture does not restore differentiation to the 
latter (data not shown). indicating that disruption of the structure of the erythroblastic island 
also disrupts REDS activity. We suggest mature erythroid cells on the periphery of the island 
are the source of REDS. In mosaics, late erythroid cells overexpressing GATA-1 are 
juxtaposed with REDS-producing wild-type mature cells in the same erythroblastic island 
and/or the neighbouring island. This overcomes the defects induced by high GATA-1 levels 
and allows the final stages of erythroid maturation to proceed. In male transgenic mice there 
is no such juxtaposition. Death ligands expressed by mature erythroid cells can induce the 
degradation ofGATA-1 [De Maria. 1999 #20]. It is therefore possible that death ligands are a 
component of REDS. Supporting this. death ligands partially reverse the effect of GAT A-1 
overexpression in vitro (data not shown). 
There is one precedent for a signalling mechanism similar to that we propose. C. 
elegans larvae null for the IGF receptor homologue DAF-2 enter a state of diapause rather 
than develop into adulthood. However, DAF-2 null mosaic animals can become adult with all 
cells differentiating into adult tissues. Significantly~ an adult phenotype was not associated 
with an obligato:ry requirement for DAF-2 activity in a particular cell. Consequently. this 
study suggested that secondary signals operate to ensure that all cells adopt the same 
developmental fate [Apfeld. 1998 #15]. Furthermore. our observations have important 
implications in interpreting other cell nonautonomous defects. For example~ loss of the 
retinoblastoma protein (pRb) results in a cell nonautonomous inhibition of erythropoiesis. In 
accordance with the conventional interpretation of cell nonautonomy. it was concluded that 
pRb null erythroid cells are normal and that pRb function is required in stromal cells 
supporting erythropoiesis [Williams. 1994 #2l][Maandag. 1994 #22]. This conclusion may be 
incorrect, since transplantation studies suggest that pRb is required in erythroid cells [Hu, 
1997 #23]. This discrepancy remains unexplained. However~ one could resolve these 
conflicting data by suggesting that the effect of pRb loss in erythroid cells is reversed by a 
signal supplied by wild-type cells. similar to that which restores the normal differentiation of 
GAT A-I overexpressing erythroid cells. 
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proerythroblast 
basophilic erythroblast 
~ polychromatic erythroblast 
8 orthochromatic erythroblast 
fA\ erythrocyte 
o pyknotic nucleus 
macrophage 
Figure 6 A simplified model of the erytbroblastic island. The position of the central macrophage and 
the arrangement of the crytbroid precursors (as indicated by the key) within the macrophage's 
cytoplasmic extensions are shown. The process of pyknosis, enucleation and phagocytosis of expelled 
pyknotic nuclei arc represented. Arrows indicate the putative signal REDS. being produced by late 
differentiated erythroid cells. Graph indicates the proposed process ofGATA-1 regulation late in the 
differentiation process. 
Methods 
Plasmids, probes and primers. 
Plasmids PEV3-GATA-l and PEV3 have been previously described [Elefanty, 1996 #24]. 
Details of the cloning steps to produce the puromycin resistant version ofPEV3-GATA-1 are 
available on request. Integration ofPEV3-GATA-l in ES cells and mice was screened by 
Southern blot using a lkb internal probe corresponding to the 5' end of the GATA-1 
minigene. DNA-FISH and RNA-FISH was performed using a FITC-labelled 4.3 kb fragment 
spanning exon 2 to exon 6 of the GATA-1 gene, a Texas-Red labelled 21 kb human beta-
globin LCR probe and a Texeas-Red labelled 6.5 kb fragment corresponding to the Xis! RNA 
(gift ofN. Brockdorff, London). Embryos were sexed by PCR using primers specific for the 
Zfy gene [Nagarnine, 1989 #25]. 
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Western blotting 
Nuclear extracts were prepared as previously described [Andrews, 1991 #26]. 5!-lg of each 
sample was subject to electrophoresis through a I 0% SDS/polyacrylamide gel, transferred 
onto nitrocellulose and probed with anti-GAT A-I antibody N6 (Santa Cruz, CA, cat# sc-625) 
or anti-cyclin A2 antibody C-19 (Santa Cruz, cat# sc-596) and an appropriate secondary 
antibody before detection using chemiluminesence. 
ES cells 
The puromycin resistant version ofPEV3-GATA-l was linearized with Pvu! and 
electroporated into !29°LA-derived ES cells as previously described [Pandolfi, 1995 #27] and 
individual clones selected in l)..lg/ml puromycin. 
Mice 
Chimeric mice were generated by injecting ES cell clones generated as above into C57bl6 
blastocysts. Chimeras were then bred with wild-type FVB males and screened by coat colour 
for germ-line transmission. Transgenic females were then mated to FVB males or Btkmcz 
males and sacrificed during gestation or allowed to go to term. 
Blood and fetal liver cell analvsis 
Blood and/or disaggregated fetal livers were collected from embryos or adults and prepared 
on slides by cytocentrifugation. Slides were stained with neutral benzidine and a modified 
Giemsa-like stain. 
Hemoglobin analysis 
Globin chain representation in chimeric animals was analysed as described previously 
[Maandag, 1994 #22]. 
DNA- and RNA-FISH 
DNA-FISH was performed as previously described [Mulder, 1995 #28]. RNA-FISH was 
performed on disaggregated fetal liver cells as previously described [Wijgerde, 1995 #29]. 
CFU-Eassay 
CFU-E assays were performed as previously described [Wong, 1986 #30]. Fetal livers were 
disaggregated into single cells by passage through a I 00!-lffi mesh and plated at a density of 
3xl 05 cells per ml in methylcellulose containing I U/ml Epo. Colonies were grown for times 
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indicated and then collected and washed with PBS to remove residual methylcellulose before 
staining. 
FACS analysis 
Single cell suspensions of bone marrow, fetal livers and cultured cells were prepared as 
above, stained and FACS analysed as described previously [Sawada, 1989 #14]. 5xl 04 events 
taken per sample. Antibodies and stains used: R-PE-conjugated TER119 antibody 
(Pharmingen), 7-aminoactinomycin-D (7AAD, Molecular Probes BV), fluoroscein-di-b-D-
ga!actopynmoside (FDG, Molecular Probes BV), biotin-conjugated ER-MP20 antibody, 
cychrome-conjugated CD45RJB220 (Pharmingen) and Tricolor-streptavidin secondary 
antibody (Ca!atag Laboratories, CA). Cell populations were divided as follows: non-viable 
(7 AADl, erythroid (TER119l, large erythroid (TER119+ /FSChigh), medium-sized erythroid 
(TER119+ /FSCmcdi=), B-celllineage (B220+ /ER-MP20'/TEK), granulocytic (ER-
MP20+/TERI19-) and monocytic (ER-MP20high/TER119.). 
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A conditional knockout allele ofthe GA TA-l gene 
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Abstract 
To elucidate the function of the transcription factor GAT A-I beyond 10.5 dpc, a conditional 
knockout allele was generated, using the Cre-loxP system. The GAT A-I coding exons were 
bracketed by two loxP sites yielding the .. floxed .. GATA-Ilocus. We fused Cre with the 
ligand-binding domain (LBD) of the estrogen receptor containing a mutation that renders it 
sensitive to activation by 4-hydroxy Tamoxifen. A ~LCRIB-globin promoter construct was 
used to express the Cre protein or the inducible Cre-LBD protein in erythroid cells. We found 
that Tamoxifen induction resulted in a ve:ry low frequency of recombination, suggesting that 
Cre-LBD is an inefficient recombinase, or that it was not high enough expressed. We obtained 
germline transmission of the GATA-1 null allele through breeding of the floxed GAT A-I 
mice to a transgenic mouse line expressing Cre under the zona pellucida 3 promoter. 
Introduction 
The GATA transcription factor family consists of six members (GATA-1 to 6). The family 
can be divided in two groups, the hematopoietic (GATA-1, -2 and -3) and the heart and gnt 
group (GATA-4, -5 and -6) (Weiss and Orkin 1995; Molkentin 2000). The members share 
highly homologous Zn-finger DNA binding domains, and they all bind to the consensus 
binding site (T/ A)GATA(NG). There is little sequence conservation outside the DNA 
binding domain. Most members are important for differentiation and proliferation of specific 
cell types (Pevny et al. 1991; Tsai et al. 1994; Pandolfi et al. 1995; Molkentin et al. 1997; 
Koutsourakis et al. 1999; Molkentin et al. 2000). 
GATA-1 is a tissue-specific transcription factor expressed in erythrocytes, megakaryocytes, 
eosinophils, mast cells and in the Sertoli cells of the testis (Ito et al. 1993). GATA-1 is 
essential for the progression of erythroid precursor cells beyond the proerythroblast stage 
(Pevny et al. 1991; Fujiwara et al. 1996). The GAT A-I null mutant mouse is embryonic lethal 
around day 10-11 of gestation. To further investigate the role of GAT A-I later in 
development and in the different tissues in which GATA-1 is expressed we generated a 
conditionallmockout allele of the GATA-1 gene using the Cre-lm~P recombination system. 
This approach is based on the observation that the bacteriophage PI Cre recombinase protein 
excises the DNA between two directly repeated 34 bp recognition sequences called loxP 
sites.(Sauer 1998). We inserted two loxP sites followed by a splice acceptor site and GFP 
reporter gene in the GATA-llocus by homologous recombination in mouse ES cells. Upon 
the action ofCre, the coding exons of the GATA-1 gene are deleted and transcripts from the 
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first, non-coding, exon of the GATA-1 gene are spliced onto a splice acceptor site provided 
by the GFP reporter. 
To gain control over the activity ofCre, we constructed aCre protein fused to the ligand-
binding domain of the estrogen receptor (Cre-LBD). Fusion to the ligand binding domain 
confers hormonal control because of binding to heat shock protein hsp90 thereby inhibiting 
nuclear transport and/or activity of the Cre protein (Scherrer et al. 1993). We used a mutant 
LBD that is sensitive only to fhe exogenous-ligand 4-hydroxy-Tamoxifen ( 40H-T) 
(Littlewood eta!. 1995), fhus rendering the activity of Cre dependent on the presence of 40H-
T (Chambraud et al. 1990). Transgenic mice were generated that express the Cre-LBD under 
the transcriptional control offhe ~-globin r<LCR and promoter. Compound transgenic mice 
were made containing the CreLBD transgene and the floxed GATA-1 allele. In vivo 
administration ofTamoxifen, even for a prolonged period of over three months, did not result 
in any detectable recombination of the GATA-llocus. However, when we differentiated fetal 
livers cells in hanging drop cultures (Chapter 5) in the presence of 40H-T, we observed 40H-
T dependent Cre-mediated recombination of the flexed GATA-1 locus. The frequency was 
very low thus precluding the analysis of the GATA-1 knockout phenotype in fetal liver cells. 
We conclude that the Cre-LBD protein is an inefficient recombinase or that the CreLBD was 
not high enough expressed; this is supported by our observation that the expression of Cre 
with the same B-globin ~LCR!promoter construct results in quantitative recombination of the 
flexed GATA-llocus in the fetal liver. To generate GATA-1 null mutant mice we bred the 
floxed GATA-1 mice though the female germline of a transgenic line expressing Cre under 
the promoter of the Zona Pelucida 3 promoter (zp3 Cre) (Lewandoski eta!. 1997). The zp3 
trans gene, the Cre protein is expressed in the oocyte, this resulted in the establishment of a 
mouse line carrying a true null mutation for the GATA-1 gene. 
Results 
Construction of the floxed GATA-11ocus 
Two loxP sites were inserted in the GATA-llocus. The targeting construct (Fig. IA) was 
designed with the first loxP site inserted in the first intron between exon la and Ib, and the 
second was placed after exon VI. At the 3' site of this loxP site, a splice acceptor sequence 
and a GFP gene were placed, with the aim to render GFP expression, after recombination, 
dependent on transcription of the GATA-1 gene from the endogenous non-coding first exons. 
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Figure 1: (A) GATA-llocus, targeting vector. floxed locus. recombined locus and the GFP transcript 
of the recombined locus, (B) ES cell clone screened for the loss of the GAT A-I gene. Genomic DNA 
was cut with BarnHL blotted and hybridiscd with an externalS' probe and an internal probe (Fig. 1) 
86 
Analysis of the ES cells 
ES cells, of male origin, were electroporated with the linearised (digestion with Spel) 
knockout construct and grown in medium containing 0418. After 10 days, 300 clones were 
picked and screened for the presence of the desired homologous recombination event with a 
external 3 • probe flanking the right homologous arm (Figure lA). Approximately I 0% had 
recombined correctly at the 3' end of the construct. Positive clones were karyotyped and two 
clones. with the correct number of chromosomes, were electroporated with a plasmid 
expressing Cre, under the transcriptional control of the PGK promoter and with a hygromycin 
resistance gene. These ES cells were selected for hygromycin resistance and clones were 
picked screened for the recombination at the GAT A-I locus (Figure !B). 
To assess whether the floxed GAT A-I locus is still fully ftmctional, an ES cell line 
containing the flexed GATA-1 locus, a recombined clone derived from this line, and wild 
type ES cells were subjected to in vitro differentiation to the erythroid lineage (VV eiss et al. 
1994). The differentiated wild type and floxed GATA-1 ES cells formed colonies of 
hemoglobin producing cells which looked identical. while the differentiated knockout cells 
hardly showed formation of any colonies ofhemoglobinised cells (Fig. 2). This leads to the 
conclusion that in the GATA-llox ES cells the GATA-llocus is still ftmctional and that we 
successfully deleted it in the GAT A-I KO ES cells. 
wild type GATA-1 lox knockout 
Figure 2: In vitro differentiated wild type, GATA-1 floxed and GATA-1 KO ( GATA-1 floxedl PGK 
Cre compound) ES cells. 
Chimaeric mice 
The floxed GAT A-I ES cells were injected into C57/bl6 blastocysts and chimaeric mice were 
born. These mice transmitted the floxed GATA-1 allele to their offspring. Male F2 mice 
carrying the floxed GAT A-I allele survived. showing that GAT A-I is expressed at 
physiological levels from the floxed allele. 
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Null mutant mice 
Transgenic mice with the Cre protein expressed under the control of the zona pellucida 3 gene 
promoter were bred with the flexed GATA-1 mice to generate GATA-1 null mutant mice. 
Female offspring with both the Cre transgene and the flexed GATA-llocus transmitted the 
recombined GATA-llocus to their offspring, but below the frequency expected according to 
Mendelian distribution. Out of94 pups born, 8 were heterozygous females (8,5%). The 
expected ratio is lout of 7 (14,3%). That less GATA-1 heterozygous females would be born 
could be predicted, as it has been reported that one third of the heterozygous females die in 
utero due to anaemia caused by random inactivation of the X chromosome bearing the normal 
allele (Fujiwara eta!. 1996; Tsai eta!. 1998). 
To recombine the floxed GATA-1 allele in an erythroid-specific manner, mice were 
generated by breeding the flexed mice with mice expressing the Cre protein under the control 
of the ~-globin !!LCR and promoter (pEV -Cre mice). These erythroid knockouts (GATA-1 
lox+ I pEV-Cre males) were indistinguishable form the null mutant embryos and died by 11.5 
dpc due to anemia (Fig. 3). Furthermore, GATA-llox +/-/ pEV-Cre females were often 
anaemic and sometimes also dead due to variable X-inactivation (Fig 3.) 
wild type GATA-1+/- knockout 
Figure 3: Wild type, GATA-1 +/-female and knockout male 12.5 dpc embcyos. 
Tamoxifen induced recombination 
Transgenic mice were generated that express the Cre-LBD fusion-protein under the 
transcriptional control of the f3-g1obin r..tLCR and promoter. Compound transgenic mice were 
made containing the CreLBD transgene and the floxed GATA-1 allele. To activate the Cre-
LBD protein in vivo, GATA-llox +I CreLBD males mice were given drinking water with 
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100 1-'g/ml Tamoxifen and I% ethanol (v/v). Hematological values the compound transgenic 
and wild type mice were measured after two and nine weeks. After nine weeks, the animals 
were sacrificed and spleen and bone marrow were isolated for DNA and RNA analysis. 
Spleens were weighed and no significant difference was measured (Table !). Standard 
hematological values were also identical (Table I). 
GATA-11ox+/ 
pEV CreLBD wild type 
(n=5) (n=4) 
Spleen (mg) 96 ( ±7) 83 (±20) 
WBC(x10') 7.7 ( ±2.6) 7.2 ( ±2.2) 
RBC(x10") 9.0 ( ±0.6) 9.8 ( ±0.6) 
HBG (mmol/1) 9.0 ( ±0.8) 9.6 ( ±0.5) 
HCT (1/1) 0.50 ( ±0.05) 0.54 ( ±0.03) 
MCT (ft) 56 (±2) 55 ( ±3) 
PLT (x 1 09) 1450 (±348) 1315 ( ±161) 
Table 1: Spleen weight and hematological values after nine weeks ofTamoxifen administration. 
(WBC: white blood cell count. RBC: red blood cell count. HBG: Hemoglobin. HCT: hematocrit, 
MCV: mean cell volume. PLT: platelets) 
No recombination of the floxed GAT A-I allele was detected by Southern blotting or with 
PCR. There were no differences in the FACS analysis of bone marrow cells after two days of 
differentiation in the hanging drop cultures (data not shown). This means that this 
recombination system is not sensitive enough for GATA-1 in erythroid cells in vivo. If any 
recombination was achieved it was too minimal to detect. It is furthermore very probable that 
erythroid precursors that might have recombined the GAT A-I locus underwent apoptosis and 
could not be detected. If this were happening at all, it did not influence the standard 
hematological values. 
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40H-T induced recombination ex vivo 
To determine whether recombination of the flexed GATA-1 allele could be achieved ex vivo, 
fetal liver cells were isolated from 12.5 dpc compound GAT A-I floxed +/PEV Cre-LBD 
embryos. The cells were used for hanging drop cultures (Chapter 5) with or without the 
addition of 40H-T. DNA and RNA were isolated after 0,1, 2 and 3 days of culture and the 
cells were analysed by FACS for differentiation. Three different genotypes were used in this 
experiment: GAT A-I lox+/ Cre-LBD-/male, GA TA-l +/-/Cre-LBD +/-/female and GAT A-I 
lox +/Cre-LBD +/-/male. The results show that only the embryos heterozygous for the pEV 
Cre-LBD trans gene are able to recombine the floxed GAT A-I allele, and that recombination 
is dependent on the presence 40H-T (Fig. 4, lanes 9, II, 12, 14, 15). After two days of culture 
a very minimal amount of recombination could be shown by PCR (Fig.4lane 9). This 
increased after 3 days of culture (Fig. 4, lanes II. 12). The recombined GAT A-I knockout 
PCR product is however preferentially amplified over the flexed GAT A-I PCR product as 
seen by using genomic DNA ofGATA-1 +/-females (data not shown). 
Thus Cre-LBD is functional and inducible by 40H-T, recombination is at too low a 
level to be complete, estimated to be lower than <5% after two days of hanging drop culture. 
sex 
GATA~11ox 
recombined 
2.8 kb 
GATA~1 lox 
1.4 kb 
0 
2 
+/-
f 
+I-
day 1 
3 4 5 
+ + +/-
m m f 
+!- - +/-
day2 day3 day3 + 
6 7 8 9 1011 1213 1415 16 
+ + +I- + + +/- + + +/- + 
m m f m m f m m f m 
+!- - +!- +!- - +!- +!- - +/- +/-
Figure 4: Ethidium bromide stained agarose gel of the products of a PCR on genomic DNA of 
erythroid precursor cells. cultured in hanging drops for 0. 1. 2. or 3 days. with or vvithout the presence 
of 40H-T. Three compound transgenic genotypes arc present: GATA-1lox +/ PEV Cre-LBD-/malc 
(lanes 1. 4. 7. 10 and 13). GATA-1 +1-/Cre-LBD +/-/female (lanes 2. 5. 8, 11 and 14) and GATA-llox 
+/Cre-LBD +/-/male (lanes 3. 6. 9. 12 and 15). Lane 16 is a positive control PCR for the recombined 
locus. This is a representative of three experiments experiment, a total of32 embryos were analysed. 
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After two days of hanging drop culture, RNA from 4xl04 cells was isolated and RT 
PCR performed and showed that GATA-1 mRNA levels are not affected by the addition of 
40H-T to the cultures (Figure 5). This can be explained by the minimal recombination shown 
by the genontic PCR (Figure 4). 
To assess differentiation, the cells were harvested from the hanging drop cultures and 
subjected to FACS analysis. Viable erythroid cells were analysed for size by forward scatter 
as a measurement for differentiation. This did not reveal changes in the differentiation profiles 
between the genotypically different progenitors after addition of 40H-T to the media (data not 
shown). Finally, BFU-E assays with and without 40H-T also showed no difference between 
the genotypically different progenitors (data not shown). 
I 
- +40HT 
GATA-11ox + +I- + + +!- + 
sex (m/f) m f m m f m 
Cre-LBD - +/- +!- - +I- +/-
GA~-1-.. I I I I I I J HPRT -+-
Figure 5 RT PCR for GATA-1 (product 297 bp) and HPRT (product 247 bp) on total RNA from 
erythroid cells after being cultured in hanging drops for two days. Male GATA-llox mice, with or 
without one inducible Cre allele. PEV CrcLBD. Female mice were heterozygous for the GATA-1 lox 
allele and heterozygous for the inducible Cre allele. PEV CreLBD. 
Discussion 
To learn more about the function of the transcription factor GATA-1, an inducible knockout 
was designed using the Cre-loxP system. To get complete recombination from the oocyte 
onward the GATA-1 lox mice were transmitted trough a transgenic mouse line expressing Cre 
under the ZP3 promoter. An erythroid specific knockout was generated by breeding the flexed 
GATA-1 mice with transgenic mice expressing Cre under the control of the J.!LCR and the f)-
globin promoter. The activity of the Cre protein was made inducible by the fusion to the 
ligand-binding domain of the estrogen receptor rendering it sensitive to the exogenous 
hormone 4-hyd.roxy Tamoxifen. Transgenic mice were generated in which the expression of 
the inducible Cre protein was under the control of the J.!LCR and the f)-globin promoter. 
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Unfortunately the activity of the inducible Cre protein was insufficient to generate a 
phenotype in mice or isolated cells. 
There can be several reasons why the inducible Cre-LBD functioned so poorly. The 
sensitivity to 40H-T could have been too low. After we started doing our experiments an 
improved version of the LBD was published that has a 3 to 4 times higher sensitivity for 
40H-T in cell lines (Feil eta!. 1997) and up to 10 times higher in mice (Indra eta!. 1999). 
Possibly, delivery of the 40H-T to the bone marrow is ineffective. This could also have been 
a problem in a comparable system driven by the CMV promoter (Brocard eta!. 1997). The 
issue of drug delivery does not apply when the cells are cultured in a dish and we were indeed 
able to show recombination in this experimental set-up. However, the majority of the cells 
still contained the floxed GATA-1 locus. A formal possibility is that the progenitors are 
rapidly removed through apoptosis after recombination. However, if this were the case we 
should have seen recombination occurring in female cells in which the inactive 
X chromosome carried the floxed locus. A more likely explanation is that addition of the LBD 
interferes with the activity of the Cre protein also in the presence of a ligand. During the 
recombination process, a complex of four Cre molecules bound to two loxP sites must be 
formed. Proper spatial alignment of this complex is important to catalyze the recombination 
reaction. Since the LBD is ve:ry bulky, it may impair the efficiency of the reaction through 
steric hindrance. Nevertheless, there are examples in the literature describing systems where 
Cre-LBD is active in vivo and in cultured cells (Feil eta!. 1997; Li eta!. 2000; Vooijs eta!. 
2001). Other important parameters are suggested to be the distance between the two lox sites, 
the locus used.. the expression of the Cre-LBD, the tissue and the expression of the target gene 
(Vooijs eta!. 2001). In our case the distance between the lox sites is unfavourably large (!0 
kb ). The Cre-LBD protein is expressed but the level of expression might have been too low 
and mosaic. 
The concept of an inducible deletion of a gene is an excellent idea but the methods 
have to improve. Other ways to get inducebility have been tried, making use of the 
glucocorticoid receptor ligand binding domain (Brocard et al. 1998), ecdyson receptor 
(Sawicki eta!. 1998), the Tet-system (St-Onge eta!. 1996) or even a combination of the ER-
LBD with the Tet-systern (Chiba eta!. 2000). Finally, an alternative way of delivering the Cre 
protein has been described. A fusion of Cre to a short membrane translocation sequence 
(MTS) can be offered to cells immediately by intraperitoneal injection (Chen and Behringer 
2001; Jo eta!. 2001) or simply by adding it to cells (Le eta!. 1999). 
Despite our disappointing results with the inducible Cre-LBD system, the floxed 
GATA-1 mouse is still an important tool. In Chapter 4, we describe the Sertoli cell-specific 
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knockout of GAT A-I through the specific deletion of the gene by aCre transgene expressed 
under the control of the Desert Hedgehog promoter. In addition, the role ofGATA-1 in 
megakaryocytes, mast cells and eosinophil cells can be investigated by breeding flexed 
GATA-1 mice with mice that express the Cre protein under the control of the appropriate 
regulatory sequences. 
Materials and Methods 
Construction floxed GAT A-1 locus 
The 3'homologous region is an EcoRI fragment 3' from the last exon isolated from the 
GATA-llocus containing cosmid pTCF 3'mGATA-l. A larger BaroHI/Sall fragment that 
contained all the coding exons was cloned into a low copy number plasmid to yield pSC3Z m 
GAT A-I genomic. In this construct, the 5'loxP site was inserted in an EcoRI site in the intron 
betv.reen the first erythroid non-coding exon IE and the second exon. 
In plasmid pGT1.8 IRES ~geo the IRES and the lacZ gene were replaced (Sacl-Xho/blunt) 
with a GFP gene from the plasmid phGFP-S65T (Sacl-BaroHI/blunt). The cassette with the 
splice acceptor. GFP and the Neomycin selectable marker was excised with Sal!. 
The 3'loxP site (Xhol fragment), the GFP cassette (Sail fragment) and the 3'homologous 
region (EcoRI fragment) were put together in pBluescript and taken out with Spel and Pvul. 
This fragment was insetted in the Sail site (3'ofthe 6"' and last exon) of the pSC3Z mGATA-
1 genomic clone vector containing the S'loxP site. The construct was Iinearised with Spel. 
ES cells 
El4 ES cells were electroporated with the targeting construct and grown in medium 
containing G418 (Neomycin resistance selection).± 300 clones were picked and screened by 
Southern blotting for homologous recombination in the GATA-1 locus. The genomic DNA 
was digested with Xbal and the blot was hybridised with probe 3' GATA-1 EcoRI-Xhal, 
which is adjacent to the 3" homologous region. The targeting efficiency was -10%. Genomic 
integrity ofES cell clones was checked by karyotyping. Recombinant and wild type ES cells 
were transiently transfected with aCre expression plasmid (pGK Hyg Cre, a kind gift from 
G.Weeda) and put on hygromycine selection. Screening for recombination was done by 
Southern blotting using a 5'GATA-l probe (5' part of the construct BaroHI-Ncoljust before 
the 5'lox site, figure lA). 
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Construction of the inducible Cre-LBD fusion protein. 
Cre was recovered with PCR and cloned in pGEM-T (Promega). A BamHI site was created at 
the 3'end of the Cre coding region by PCR. A BamHI-EcoRI fragment of the estrogen 
receptor that comprised the ligand binding domain (LBD) with the mutation (Gly 525 -'7 Arg) 
(a kind gift from M. Parker) was ligated in frame to the 3 end· of the Cre coding sequence. 
The fusion construct was taken out with Sal and Sacll and pEV3 vector that uses the !'LCR 
and the (3-globin gene promoter to drive erythroid expression of inserted cDNAs (Needham et 
a!. 1992). 
Mice 
Chimaeric mice were generated by injecting an ES cell clone with the floxed GATA-llocus 
in C571bl6 blastocysts. Chimeras were then bred with wild type C571bl6 females and the 
offspring was screened by coat colour for germline transmission. Transgenic mice were 
generated by oocyte injection. 
In vitro differentiation ofES cells 
ES cell were grovm in llvfDM medium (+Glutamine) containing FCS (10%), non-essential 
amino acids(Gibco BRL), penicillin (100 U/ml final), streptomycin (100 ~g/ml), ~­
mercaptoethanol (100 )'M), monothioglycerol (150 ~M) and leukemia inhibitory factor (LIF) 
(I 000 U/ml) for 2 days and collected. They were then taken up in a differentiation medium 
which is the medium described above without LIF but with Epo (I U/ml) and IL-3 (IOng/ml). 
The cell concentration was adjusted to 5xl04cells/ml. 20 ~l droplets were pipetted on the 
inside of the lid of a bacterial dish and put back on the dish filled with PBS. After 2 days the 
cells have formed aggregates. They were collected and grovm in the same medium for 4 
additional days after which most of the cells have attached to the surface. The cells were 
ttypsinised, taken up in differentiation medium with 3% methylcellulose, insulin ( 40 ng/ml) 
and stem cell factor (SCF) followed by incubation for 4-6 days. 
Tamoxifen 
Tamoxifen (Sigma) was dissolved in absolute ethanol at a concentration of 10 mg/ml. For in 
vivo treatment, this stock solution was added to the drinking water to obtain a final Tamoxifen 
concentration of 100 J..lg/ml. 
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Hematological analvsis 
Mice were bled by orbital bleeding and blood samples were analysed on a F800 microcell 
counter. 
Hanging drops 
Hanging drop cultures were performed as described in Chapter 5. Cells were cultured with or 
without the addition of 40H-T to a final concentration of 5 JlM). 15 drops were used for 
FACS analysis. 15 for DNA isolation and 30 for RNA isolation. 
Detection of the k-nockout allele by PCR 
For the detection of the knockout allele three PCR primers were used: 
A (5'-CGCCGAGCTGTGTGTAGTAA-3'), 
B (5'-TTCCTCTTTCTCCTCCTCCG-3') and 
C (5'-GGTGCTCAGGTAGTGGTTG-3). 
Primers A &Bare in the GATA-llocus. 5' and 3' of the first loxP site. Primer Cis in the 
GFP sequence. These primers can generate three products: 
A-B: 1.4 kb. floxed GATA-1 locus 
A-C: +/- 10 kb. floxed GATA-1locus 
A-C: 2.8 kb, recombined GATA-1 locus (lmockout) 
We observed that the 2.8 kb product is preferentially amplified over the 1.4 kb product. A 
robust quantitative analysis of recombination efficiency is therefore not possible with these 
primers. Expand polymerase (Boehringer Mannheim) was used for 30 cycles (30 sec 94C, 1 
min 60C and 3 min. 68 C). 
RTPCR 
Total RNA was isolated with the tri reagent (Sigma) from cells grown in hanging drop 
cultures . After oligo-dT primed eDNA synthesis, PCR was performed with the following 
primers: 
GATA-1 sense: 5'-TCCTCTGCATCAACAAGCCCA-3', 
GATA-1 anti: 5'-GTTGAGCAGTGGATACACCTG-3', product size 297 bp. 
HPRT sense:5'-CACAGGACTAGAACACCTGC-3', 
HPRT anti: 5'-GCTGGTGAAAAGGACCTCTC-3', product size 247 bp. 
SuperTaq polymerase was used for 28 cycles (30 sec. 94C, 30 sec. 60C and 3 min. 72). 
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Chapter4 
A tissue-specific deletion reveals that GATA-1 is 
not essential for Sertoli cell function. 
Fokke Lindeboom, Nynke Gillemans, Alar Karis, Martine Jaegle, Dies Meijer, 
Frank Grosveld and Sjaak Philipsen 
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Abstract 
GATA-1 is a transcription factor that is essential for the development of erythroid cells: 
GATA-1 null mutants die in utero due to the consequences of severe anemia. Outside the 
hematopoietic system, GATA -1 is expressed in the Sertoli cells of the testis. To elucidate the 
function ofGATA-1 in the mouse testis, we made a Sertoli cell-specific knockout of the 
GATA-1 gene using the Cre-lm~P system. In these experiments a normally functioning 
'"flexed" GATA-1 gene was deleted in Sertoli cells in vivo by means of aCre trans gene driven 
by the Desert Hedgehog gene promoter. Surprisingly, morphology of the testis and 
spermatogenesis were not affected by deletion of GATA -1 in Sertoli cells, demonstrating that 
GA TA-l is not essential for testis development or spermatogenesis in the mouse. 
Introduction 
The GATA transcription factor family consists of six members (GATA-1 to -6). The family is 
divided in two groups, the hematopoietic (GATA-1,-2 and -3)(Weiss and Orkin 1995) and the 
heart and gut group (GATA-4.-5 and -6) (Molkentin 2000). The members share their highest 
homology in the Zn-fmger DNA binding domain and they all bind to the consensus binding 
site (T/A)GATA(NG). Outside the DNA binding domain they are quite different. Most 
members are important for the proliferation and differentiation of specific cell types 
(Introduction, this thesis). 
GATA factors are thought to be important transcriptional regulators of several Sertoli 
cell-specific (Hales 2001; Tremblay and Viger 2001). These target genes have GATA sites in 
their promoters that are essential for optimal expression of reporter genes in transient 
transfection assays (Tremblay and Viger 2001). In Sertoli cells GATA-1, -4 and -6 are 
expressed (Ito et al. 1993; Yomogida et al. 1994). 
Besides Sertoli cells GATA-1 is expressed in erythrocytes, eosinophils and mast cells 
(Evans and Felsenfeld 1989; Tsai et al. 1989; Martinet al. 1990; Romeo et al. 1990; Zon et al. 
1993). GATA-1 is essential for erythroid precursor cells to progress beyond the 
proerythroblast stage (Pevny et al. 1991). The GATA-1 transcription unit contains two 
alternative first exons that are non-coding (IT and IE) and five coding exons (II to VI). The 
GATA-1 gene is thought to have two distinct promoters which are alternatively spliced to the 
coding exons (Ito et al. 1993). Exon IT is primarily used in Sertoli cells of the testis and exon 
IE in erythroid cells. Since the second exon harbours the start of translation, the proteins 
expressed in erythroid cells and the testis are identical. The testis-specific promoter and first 
exon ( exon IT) are located 8 kb upstream ofthe erythroid specific first exon (ex on IE). Both 
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promoters harbour GAT A sites that are required for proper promoter function and hence a 
positive feedback loop was suggested but a promoter study in GATA-1 null cells and 
overexpression ofGATA-1 in MEL cells do not support a regulatory loop (Tsai et al. 1991; 
McDevitt eta!. 1997; Onodera et al. 1997b; Whyatt et al. 2000). In the mouse and the rat 
gene, erythroid and a testis specific promoter elements have been described (Onodera et al. 
1997b). It has been suggested that GAT A-I is a developmental-stage and spennatogenic-
cycle specific regulator of gene expression in Sertoli cells ['! omogida et al. 1994). 
Although no GAT A-I target genes in the Sertoli cells have been found it is believed 
that the anti-miillerian Hormone (AMH). also known as miillerian inhibiting substance (MIS). 
is a possible target (Watanabe et al. 2000). A model has been proposed in which GATA-4 is 
involved as a positive regulator of AMH expression in the early fetaVperinatal pre-Sertoli 
cells while GATA-1 acts as a repressor of AMH expression at later stages (Beau et al. 2000; 
Watanabe et al. 2000). The expression patterns of the GATA factors and AMH conform to 
this model and, GATA-1 has also been shown to be able to bind to the AMH promoter in 
vitro (Ketola et al. 1999; Beau et al. 2000). Furthermore. two human males harbouring a 
mutation in the GATA-1 gene displayed cryptorchidism (Nichols et al. 2000); a phenotype 
also observed in mice overexpressing very high levels of AMH under the metallothionein-1 
promoter (Behringer et al. 1990). However. cryptorchidism has not been reported for X-
linked-thrombocytopenic males with different GATA-1 mutations (Freson et al. 2001; 
Mehaffey et al. 2001). Other Sertoli cell-specific candidate target genes ofGATA-1 are the 
follicle-stimulating hormone receptor (FSHR). inhibin a subunit and inhibin/activin ~-B­
subunit. For FSHR, this is based on a conserved GAT A site in the core promoter and the 
observations that this site is occupied in Sertoli cells as shown by in vivo footprinting and can 
bind GATA-1 in in vitro electro-mobility-shift assays (EMSA) (Kim and Griswold 2001). For 
inhibin a subunit and inhibin/activin f)-B-subunit,. the notion is based on transient transfection 
assays with a bacterial reporter gene driven by the corresponding promoters in a rat testicular 
Leydig ttunor cell line MA-10 and mouse Sertoli cell line MSC-1 (Feng and Chen 1994) 
(Feng et al. 2000). In these studies, the GATA sites were essential for expression. In addition 
to this, the expression of the inhibin a subunit and the inhibinlactivin f)-B subunit occurs in a 
pattern similar to GATA-1 (Feng et al. 1989; Keinan et al. 1989; Krmnmen et al. 1989). The 
caveat of these experiments is that they were all perfonned in cell lines, and the results may 
therefore not reflect the in vivo role of GAT A-I appropriately. 
The GATA-1 null mutant is embryonic lethal due to a block in erythropoiesis at the 
proerythroblast stage (Pevny et al. 1991; Fujiwara et al. 1996). To overcome this early 
embryonic lethality we made a conditional knockout allele ( cKO) of the GATA-1 gene using 
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Cre-loxP (Sauer 1996). To delete the GATA-1 gene in Sertoli cells, we made use of a 
transgenic mouse line in which Cre expression is driven by the promoter of the Desert 
Hedgehog gene(Dhh). Dhh is expressed in Schann cells in the nervous system, vascular 
endothelium, endocardium and in Sertoli cells but not in hematopoietic cells (Bitgood et al. 
1996). The expression ofDhh in Sertoli cells becomes apparent at 11.5 dpc, approximately 
one day after the formation ofSertoli cell precursors (Bitgood et al. 1996). This approach has 
enabled us to study the role of GATA-1 in the testis during development and in adult mice. 
Results 
Targetino- of the lox sites in the GATA-1locus 
A targeting construct (Fig. la) was designed with the frrst loxP site inserted in an EcoRI site 
in the first intron, in between erythroid exon IE and exon II, and the second loxP after exon 
VI in the 3 'flanking region of the gene. A splice acceptor sequence, GFP eDNA and 
neomycin selectable marker gene were placed 3 · to the second loxP site, with the aim to 
activate GFP expression after Crewmediated excision of the GATA-1 coding sequences. ES 
cells were electroporated with the targeting construct and grown in medium containing G418. 
Southern blot analysis of300 clones showed that approximately 10% had recombined 
correctly at the 3 · end of the construct. Several clones were transiently transfected with a Cre 
expression vector and screened for recombination. In one of these. we could demonstrate 
appropriate recombination (Fig. 1 b). This clone was karyotyped, checked for correct number 
of chromosomes and used for blastocyst injections. Chimeric mice were born and mated with 
C57 /Bl6. Offspring was checked for the conditional knockout ( cKO) GATA-1 locus and 
backcrossed to FVB mice. In further generations, hemizygous and homozygous GATA-1 
cKO mice were born according to Mendelian distribution. These mice were healthy and fertile 
with no apparent phenotype, indicating that expression of GATA-1 was not disturbed by the 
presence oftv.ro loxP sites and the GFP~neo cassette in the locus. 
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Figure 1: (A) GATA-llocus, with the testis specific frrst exon (IT) used by the testis promoter 
approximately 8 kb upstream of the erythroid specific first ex on (IE) used by the erythroid promoter. 
The coding exons (II -VI) are used in both mRNAs. After recombination with the targeting vector, the 
GATA-1 locus has two loxP sites and the splice-acceptor-GFP cassette inserted and is now called 
floxed. After recombination of the floxed GATA-1locus the GATA-1 coding exons are deleted and 
the GFP transcript should be expressed. (B) Southern blot of genomic ES cell DNA after transient Cre 
transfection, digested v..rith BamHI hybridiscd with an internal eDNA probe and the s· GATA-1 probe. 
shov..ring recombination of the floxed GATA-1 allele. 
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A Sertoli cell-specific null mutant for the GAT A-1 gene. 
To obtain mice that are Sertoli cell-specific null mutants for the GATA-1 gene, conditional 
knockout GATA-1 mice (cKO) were crossed with Dhh-Cre transgenic mice. In male 
offspring, ere-mediated recombination at the GATA-1 locus occurred only in mice 
harbouring the Dhh-Cre transgene. However, we were unable to detect GFP expression with 
RT PCR or in cryosections (data not shown). 
The absence ofGATA-1 expression in the testis was checked by RT-PCR. No GAT A-
I transcript could be detected in the GATA-1 cKO males with the Dhh-Cre transgene (Fig. 2). 
GATA-1 + 
HPRT + 
Figure 2: RT PCR for GATA-1 (297 bp) and HPRT (247 bp) on total testis eDNA from GATA-1 cKO 
and GATA-1 cKO/Dhh Cremale mice. 
Fertility 
No difference was found in breeding the 4 Sertoli cell-specific null mutants mice and their 
cKO littermates with wt FVB females. The Sertoli cell-specific null mutants gave rise to 8 
litters had an average size(± 8 pups) and the distribution between males and females was 
equal (32-30: 52-48%). Since the mice develop to maturity it can be concluded that the Dhh-
Cre transgene does not express the Cre protein in erythroid precursor cells. The Sertoli cell-
specific null mutants were willing to mate and the distribution of the several possible 
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genotypes was according to Mendelian law. Their fertility did not decrease as the mice aged 
(>!year). 
Gonadal tissue and sperm counts 
Testes, epididymides and seminal vesicles ofGATA-1 cKO and Sertoli cell-specific GATA-1 
knockout littermates of different ages were isolated and weighed and the gross morphology 
was compared. Sperm was isolated from the epididymides and cell numbers counted. Within 
the same age groups, no significant differences were found betv.reen any of the mice analysed 
(Table!). 
seminal 
sperm 
count 
age ko/wt n testis epididymis vesicles (x 106per 
(days) (mg) (sd) (mg) (sd) (mg) (sd) epididymus) {sd) 
24 wt 1 35.5 1.6 10.0 - 5.7 - -
ko 3 42.1 3.9 10.5 2.1 6.4 1.3 -
52 wt 1 67.5 21.9 23.2 - 52.3 - 18.0 
ko 1 90.5 2.1 29.3 - 60.5 - 19.0 
74 wt 3 101.0 15.9 40.4 9.8 65.5 5.6 31.7 6.6 
ko 4 102.0 11.5 38.0 1.8 61.6 9.6 28.5 26.6 
Table 1: A comparison of testes, epididymides. seminal vesicles and sperm counts of GA TA-1 cKO 
and Sertoli cell-specific GATA-1 knockout littermates of different ages. 
Expression of potential Sertoli cell-specific GAT A-1 target genes 
Real-time RT-PCR on RNA of testis from two-week-old KO and cKO mice was performed to 
compare the expression of suggested GATA-1 target genes AMH, FSHR, inhibin a-subunit 
and activin/inbibin ~A and ~B subunit. Also the expression of Star (steroidogenic acute 
regulatory protein) and Cypl9 (PIT Aromatase) since these genes have essential GATA sites 
in their regulatory elements (Silverman eta!. 1999) (Jin eta!. 2000). As controls HPRT and 
cyclophiline primers were used (table 2). No significant differences could be detected leading 
to the conclusion that GATA-1 can be omitted for the proper expression of these genes. 
Expression of other GA TA family members 
In erythroid GATA-1 null cells the transcription of GATA-2 is highly upregu!ated and this 
can imply some interchangeability between GATA factors (Weiss eta!. 1994). Furthermore a 
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negative regulation ofGATA-2 transcription by GATA-1 was suggested (Weiss eta!. 1994). 
A transgene !bat expresses tbe GATA-2 eDNA under GATA-1 regulatory sequences can 
rescue tbe embryonic letbal phenotype oftbe GATA-1 knockdown ntice (Takahashi eta!. 
2000). To see iftbere is such a relation between GATA factors in tbe testis, real-time RT-
PCR on RNA of testis from two weeks old cKO and GATA-1 testis KO ntice was performed 
to detect transcript levels of different GAT A fantily members that are expressed. No 
difference in tbe levels ofGATA-2, GATA-4 or GATA-6 between different genotypes were 
detected. 
cKO 
cKO Dhh Cre 
cycle threshold (sd) cycle threshold (sd) 
AMH 26.6 1.2 25.5 0.7 
FSHR 25.3 0.3 24.7 0.6 
inhibin a. 23.5 0.4 24.1 0.6 
inhibin J3A 27.5 0.4 27.5 0.6 
inhibin J3B 22.8 0.1 23.1 0.1 
STAR 23.7 0.2 24.3 0.2 
Cyp19 28.1 0.1 26.8 0.4 
GATA-2 27.6 0.4 26.4 0.6 
GATA-4 24.2 0.4 23.8 0.3 
GATA-6 24.7 0.2 24.6 0.3 
HPRT 24.4 0.3 24.7 0.1 
Cyclophiline 20.2 0.1 19.7 0.0 
Table 2: Expression of possible target genes and GATA transcription factors measured with 
real-time PCR. 
106 
Discussion 
Here, we describe the generation of a mouse line in which the GATA-1 gene has been flanked 
by lox.P sites. After Cre-mediated recombination, the coding sequences of the GATA~l gene 
are deleted and a GFP reporter gene is brought under the control of the GATA-1 erythroid-
and testis-specific promoters. However, we have been unable to detect expression of the GFP 
reporter from the recombined locus, both in Sertoli- and erythroid cells (data not shown). 
Since expression ofGFP was also negative by RT-PCR analysis, a likely explanation is that 
the part of the gene which is deleted by the recombination event contains important regulatory 
regions for the expression of the GATA-1 gene. The GATA-llocus appears to contain 
multiple regulatory elements (Schwartzbauer et al. 1992; Trainor et al. 1995; Onodera et al. 
1997a; Onodera et al. 1997b; Vyas et al. 1999). It is now lmown that at least one of these 
elements resides in the area deleted in the recombined locus (Onodera et al. 1997a); our data 
support the notion that this element is important for erythroid expression of the GATA-1 gene 
in the context of the endogenous locus. Apart from the testis-specific promoter, testis-specific 
enhancer elements of GATA-1 expression are not known; we suggest that such elements 
reside in the area deleted by Cre in the GATA-1 cKO locus described here. Most importantly, 
insertion of the lox.P sites and the GFP-neo cassette gene did not appear to affect the 
expression ofGATA-1 and the GATA-1 cKO mice developed normally. 
Our data demonstrate that a Sertoli cell-specific lmockout ofGATA-1 does not result 
in an apparent phenotype based on the analysis of the expression of putative testis-specific 
GATA-1 target genes, testis development, spermatogenesis and male fertility. This is 
surprising since specific modulation ofGATA-1 expression during testis development has 
been reported. and a number of potential target genes has been identified (F eng and Chen 
1994; Yomogida et al. 1994; Feng et al. 1998; Beau et al. 2000; Feng et al. 2000; Watanabe et 
al. 2000; Kim and Griswold 2001). These target genes have been identified through in vitro 
promoter srudies that utilize proximal promoter that stimulate the expression of reporter 
genes. These assays can only mimic the in vivo situation to a very limited extent for several 
reasons such as the possibility that important regulatory elements are omitted, the promoter 
not being in its normal chromatin environment and the cells used being transformed cells. 
A testis promoter knockdown mutation in a mouse did not show a phenotype 
(Shivdasani et al. 1997). However, in these experiments it can not be excluded that residual 
GATA-1 expression from the erythroid promoter, masks the phenotype in Sertoli cells. 
In the present study, we have used the Dhb-Cre transgene used to delete the GATA-1 
gene in Sertoli cells. This promoter becomes active around 12.5 dpc in pre-Sertoli cells, long 
before GATA-1 expression is normally activated, 7 days postpartum ( dpp ), in this cell 
107 
lineage (Bitgood et al. 1996; Beau et al. 2000). Thus, this is the first description of the 
consequences of a true GATA-1 null mutation in Sertoli cells. The absence of a notable 
phenotype could be explained by functional overlap with other GATA factors, most likely 
GATA-4 and GATA-6 because these are also expressed in Sertoli cells (Viger et al. 1998; 
Ketola et al. 1999). GATA-4 promotes the expression of several Sertoli cell-specific promoter 
constructs in tissue culture (Tremblay and Viger 2001). The model implicating GAT A-I in 
the downregulation of AMH expression predicts that the absence of GATA-1 in Sertoli cells 
would result in sustained high-level AMH expression directed by GATA-4. Aberrantly very 
high AMH levels may result in a phenotype, since overexpression of A11H in male mice can 
affect sexual development adversely (Behringer et al. 1990). However. we do not fmd any 
changes in AMH expression at 17 dpp in the GA TA -I mutants, and therefore conclude that if 
GATA-1 is involved in the physiological downregulation of AMH expression, it is not an 
essential regulator of this process at this timepoint. 
Finally, it remains possible that the expression ofGATA-1 in Sertoli cells is an 
unimportant whim of Nature with no functional consequences. This is unlikely since the 
expression is very specifically regulated and it is conserved between man and mouse 
(Yomogida et al. 1994). Furthermore, two human males bearing a GAT A-I mutation 
(V205M) displayed cryptorchidism (Nichols et al. 2000). Although our data suggest that loss 
of GATA-1 function may not be responsible for the observed cryptorchidism, an alternative 
explanation is that the V205M mutation has a dominant-negative effect. resulting in a more 
drastic phenotype than complete loss ofGATA-1 activity in Sertoli cells. This suggests 
functional redundancy ofGATA factors in Sertoli cell development. The work reported here 
sets the stage to address this issue through the analysis of compound Sertoli cell-specific 
knockout mutants ofGATA factors, using the Dhh-Cre mice described in this paper. 
Methods 
Construction of the floxed GATA-Ilocus 
The 3 'homologous region is an EcoRl fragment 3' from the last exon isolated from the 
GAT A-I locus-containing cosmid (pTCF 3'mGATA-I) A larger BamHI/Sall fragment 
containing all the coding exons was cloned into a low copy-number plasmid (pSC3Z m 
GATA-1 genomic). In this construct the 5'lox site was inserted in an EcoRl site in the intron 
between the first erythroid non-coding exon IE and the second exon. 
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In plasmid pGTI.8 Ires Bgeo the IRES and the lacZ gene were replaced (Sacl-Xho/blunt) for 
a GFP gene from the plasmid phGFP-S65T (Sacl-BamHI!blunt). The cassette with the splice 
acceptor. GFP and the Neo selectable marker was excised with Sail. 
The 3 'lox site (in Xhol). the GFP cassette (in Sall) and the 3 'homologous region (in EcoRI) 
were put together in pBluescript and taken out with Spel and Pvul. This fragment was 
inserted in the Sall site (3'ofthe 6th and last exon) of the pSC3Z mGATA-1 gene with the 
5'lox site. The construct was linearised with Spel and used to electroporate El4 ES cells. 
ES cells 
E 14 ES cells were electroporated with the targeting construct and gro"WD in medium 
containing G418 to select for integration of the neomycin gene.± 300 clones were picked and 
screened by Southern blotting for homologous recombination in the GATA-1 locus. The 
genomic DNA was digested with Xhal and the blot was hybridised with probe 3 • GAT A-I 
EcoRI-Xbai. that is adjacent to the 3' homologous region. Positive ES cell clones were 
transfected with a vector expressing Cre under the PGK promoter and a hygromycin 
resistance marker. Clones were screened for recombination by Southern blot analysis, using a 
5'GATA-l probe (5' part of the construct BarnHI-Ncol fragment just before the 5'lox site). 
Mice 
Chimaeric mice were generated by injecting ES cell clones generated as above into C57/bl6 
blastocysts. Chimearas were then bred with wild type C57/bl6 mice and screened for germline 
transmission. Transgenic mice were mated to FVB males. 
RT-PCR 
RNA was isolate with TRl REAGENTTM (Sigma prod.nr. T9424). 
5~ g of RNA were used for the reverse transcription reaction with oligo dT (18-mer) and 
random hexarners. The following oligonucleotides were used for RT-PCR and real time RT-
PCR. Real-time PCR was preformed in niplo. 
gene sense and anti sense :Qrimer 12roduct size Qm) 
AMH 5'- AGCTGGACACCATGCCTTTC-3' 
5'-AGGGTCTCTAGGAAGGGGTC-3' 88 
Cyclophilin 5'-TCACCA TTTCCGACTGTGGAC-3' 
5'-ACAGGACATTGCGAGCAGATG-3' 120 
Cyp 19 5'- TCGAGTACTTCCCTAAGCCC -3' 
5'-GCCAAAAGGCTGAAAGTACC -3' 83 
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FSHR 5'- GCAAACTGGAGGCGGCAAAC -3' 
5'- TCTGATCCCCAGGCTGAGTC -3' 97 
GATA-1 5'-TCCTCTGCATCAACAAGCCCA-3' 
5'GTTGAGCAGTGGATACACCTG-3' 297 
GATA-2 5' -AGAACCGGCCGCTCATCAAG-3' 
5'-GGTGGTGGTTGTCGTCTGAC-3' 92 
GATA-4 5'-TCTCACTATGGGCACAGCAG-3' 
5' -ACAGCACTGGATGGATGGAG-3' 82 
GATA-6 5' -ATCCCAGAACCCATTCATCC-3' 
5' -AGACCAAA TGGCTCCCAGTG-3' 82 
HPRT 5'-CACAGGACTAGAACACCTGC-3' 
5' -GCTGGTGAAAAGGACCTCTC-3' 247 
Inhibin-a mouse 5' -CTCCCAGGCTATCCTTTTCC-3' 
5' -AGTGAAGAGGCCTTCCTCAG-3' 97 
Inhibin-B-A 5' -AGCAGACCTCGGAGATCATC-3' 
5'-CTGCCTTCCTTGGAAA TCTC-3' 82 
Inhibin-J3-B 5' -AAACAA TCCTTCGAGTGGCC-3' 
5'-GGGTGTGTACGGACAGAAAAG-3' 98 
StAR 5-GGAAGTCCCTCCAAGACTAAAC-3 
5'-TGGTTGATGATTGTCTTCGG-3' 80 
SQerm counts 
Seminal vesicles were flushed with PBS and a fraction was counted under the microscope. 
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Chapter 5 
A hanging drop culturing method 
to differentiate erythroid precursor cells 
Fokke Lindeboom, Laura Gutierez, Rita Ferreira, Roy Drissen, Frank Grosveld, 
Sjaak Philipsen and David Whyatt 
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Abstract 
We describe a suspension culnue method to study the differentiation of primary erythroid 
precursor cells from fetal liver. With this system, differentiation of erythroid precursors 
occurs in very small volumes of culture media. The method is very useful when the number of 
cells is a limiting factor., and when many different media or conditions have to be tested., e.g. 
in screens for novel pharmaceutical compounds. We show that this method enables the 
analysis of cells during erythroid differentiation with a variety of techniques including F ACS, 
cytospin and Western blotting. 
Introduction 
The maturation of erythroid progenitors is a complex process of which many aspect, such as 
gene expression, cell signalling and enucleation, are still unclear. Erythroid precursors 
differentiate in vivo in a structure called the erythroblastic island, a sponge-like structure 
composed of one or two central macrophages in close contact with erythroid progenitors in 
different stages of differentiation lying in the invaginations of the macrophage (Bessis et al. 
1983). The adhesion between erythroid cells and the macrophage is thought to occur at the 
CFU-E stage ofmanuation (Breton-Gorius et al. 1991). 
Erythroid precursors such as CFU-E, BFU-E and CFU-mix that are present fetal liver, 
are studied mainly in methyl cellulose-based (MeC) assays, that allow these precursors to 
form colonies (Wong et al. 1986; Metcalf 1989). Because these MeC assays are clonal assays, 
they can be used to determine the number ofCFU-Es, BFU-Es or CFU-mixes by counting the 
number of colonies derived from these precursor cells. Disadvantages of these MeC assays 
are that they are labour-intensive~ use only small numbers of cells because of the low cell 
densities that are required in these assays. Growing progenitors in suspension bags is an 
alternative method that allows the generation oflarge numbers of cells (Dolznig et al. 2001 ). 
Here, we describe a method to culture primary erythroid precursor cells in hanging 
drops. Culturing cells in hanging drops has been described previously for a variety of different 
cell types. It is most commonly used in studies ofT -cell development (Brenner et al. 1983; 
Sagara et al. 1997; Tokoro et al. 1998). Hanging drops are also used to study oocyte and 
embryo development (Sanders et al. 1978; Potter and Morris 1985; Spindler et al. 2000), ES 
cell differentiation (Prelle et al. 2000). mesenchymal cell aggregates and macrophages 
(Crowle and May 1978). So far, this culnue system has not been applied to analyse terminal 
differentiation of erythroid precursor cells. 
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In this assay, ~2.5xl04 fetal liver cells are placed in 20~1 droplets of medium hanging 
from the lid of a Petri dish filled with PBS. Within two days, erythroid progenitors derived 
from the fetal liver differentiate quantitatively to mature erythrocytes. Major advantages of 
this method are that only small amounts of media and growth factors are needed, and that it 
requires limited numbers of cells. We describe a method for this purpose that uses a simple 
medium containing growth factors (erythropoietin (Epo) and insulin), fetal calf serum (FCS) 
and hemin. Erythroid cells derived form the fetal liver are grown for two days in a drop of 
medium suspended from the lid of a culture dish. By FACS analysis and cytospins, we show 
that the cells undergo terminal erythroid differentiation, including enucleation, during these 
two days. To validate the usefulness of this assay, we have used fetal liver cells of mice with 
perturbed expression of the transcription factor GAT A-I, that have well-characterized defects 
in erythropoiesis. 
Results 
In order to have an assay in which we can mimic the erythroblastic island structure and 
differentiate erythroid progenitors in close proximity of each other we designed the erythroid 
hanging drop cultures. With this method the cells sink towards each other at the bottom of the 
droplet. 
Maturation of erythroid precursors in hanging drop cultures 
As erythrocytes mature they go through several morphological changes, including a 
pronounced decrease in size as they develop from proerythroblasts (14-19 ~min diameter) to 
basophilic erythroblasts (12-17 ~m), polychromatic erythroblasts (12-15 ~m), orthochromatic 
erythroblasts (8-12 ~m), reticulocytes and finally mature erythrocytes (7.8 ~m maximum) 
(Dessypris EN 1998). We used this property to follow maturation of the primary murine fetal 
liver cells cultured in hanging drops. 
After gating the late erythroid cells based on the TER 119 marker, we used forward 
scatter (FSC) as a measurement for cell size and 7 AAD staining as a measurement for cell 
death. At the start of the hanging drop culture (day 0), most cells are immature. and hence 
relatively large_ During the rnro days of culture most alive cells had matured and decreased in 
cell size (Fig. I). 
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Figure 1 :Live erythroid cells (TER119+ and 7 AADJ analysed on size (forward scatter) : hanging 
drops day 0, day 1. day 2. Mouse erythroid cells were identified with the R-PE conjugated TER119 
antibody, viability of the cells was measure by negative staining with stain 7-aminoactinomycin-D 
(7 AAD). 105 events were analysed. 
To confirm that the F ACS analysis described above measures differentiation, cultured 
fetal liver cells were sorted in three populations: Ter119'/FSChigh/7 AAD' , 
Ter119+/FSC10w/7AAD' and Terll9'/FSC10w/7AAD+ cells. Cytospins were prepared from 
these sorted populations, and stained using a combination of neutral benzidine histological 
dyes. Hemoglobin has a peroxidase activity by which it can oxidize benzidine, or benzidine 
derivatives such as 0-dianisid.ine, generating a brown chromophore which can be used as an 
estimate of hemoglobin concentration (Liem et aL 1979). This showed that FSChi"'nAAD· 
population contains the immature cells, since they display basophilic (blue) staining of their 
cytoplasm (Fig. 2A). In this population the majority of the cells still have a nucleus and only a 
minority stains weakly brown for hemoglobin. The Fscsmu.tl/7 AAD- cells population contains 
mainly cells staining positive for hemoglobin; most of these cells have enucleated (Fig. 2B). 
The FSC'mrut/7 AAD+ appears to consist predominantly of expelled nuclei, occasionally still 
surrounded by a rim of cytoplasm (Fig. 2C). 
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Figure 2: Cytospins of the sorted populations. (A) TER119+/FSChigh/7AAD- cells, the immature 
crythroblasts. (B) TER119+/FSC10w/7AAD- cells. the mature enucleated cells (C) 
TER119+/FSC10"'/7AAD+. the expelled nuclei. 
Composition of differentiation media 
To examine which factors in the medium influence the differentiation and proliferation we 
compared several media and compared the hanging drop cultures with standard 
methyl-cellulose (MeC) CFU-E cultures. We followed differentiation by compared the 
number of small enucleated cells (Ml ), the intermediated sized cells (M2) and the big 
immature cells (M3) (figure 3). We varied the amount offetal calf serum (FCS), 
Erythropoietin (EPO), insulin and hemin. The FCS is necessary for cell survival. The standard 
medium contains 20% FCS and a reduction to 10% FCS only resulted in a slight decrease in 
cell survival (figure 3, sample l and 2). Without FCS most cells did not survive (figure 3, 
sample 3). Hemin has a small but positive effect on differentiation and the viability of the 
TERll9+ cells during culture (compare sample l, 7 and 8, figure 3) . Hemin is known to 
stimulate the hemoglobinisation of erythrocytes and stimulate erythropoiesis in vitro (Alter et 
al. 1989). The presence of insulin did not affect differentiation or viability (sample land 6, 
figure 3) although it has been reported to be important for the final stages of erythropoiesis 
(Beug et al. 1995). Insulin is present in very low concentration in FCS and this might be 
sufficient for the maturing erythroblast. Surprisingly EPO did not appear to be a crucial 
factor. It is known to be important for the survival of the progenitors as this has been shown 
to be a role in vivo (Lacombe and Mayeux 1998) . This is reflected in the number of big cells 
(M3) in the culture with 0, 2 and 10 units ofEPO (sample 5, land 4 respectively, figure 3). 
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Figure 3: Differentiation of erythroid progenitor cells measured by cell size. Ml are the enucleated, 
small cells, M2 are the intermediate size cells. M3 are the immature, big cells. Percentages are of total 
number of cells in the culture. Cells cultured in 8 different media in hanging drops. 5xl04 events 
analysed. This is a representative of three experiments. 
Genetically modified mice 
GATA-1 
The assay described above is particularly useful for the analysis of the late stages of erythroid 
differentiation. We examined several transgenic mouse lines with genetic modifications that 
influence the expression level of the erythroid-specific transcription factor GATA-1 in 
erythroid progenitor cells. GATA -1 is required for erythroid cells to mature beyond the 
proerythroblast stage (Pevny eta!. 1991; Fujiwara eta!. 1996). However, GATA-1 
overexpression in erythroid progenitors also blocks differentiation (Whyatt et al. 2000). 
Furthermore, GATA binding sites are found in the promoters of almost all erythroid-specific 
genes suggesting a pivotal role for GATA-1 in erythropoiesis. We isolated fetal liver cells 
from embryos at 12.5 dpc, since this is the predominant site of erythropoiesis, and at this time 
point the embryos of the different genotypes used are still alive. 
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GATA -1 overexpression 
A transgenic mouse line was used that overexpressed GATA-1 under the control of the 
~-globin locus control region and the ~ globin promoter. This GATA-1 overexpressing 
transgenic mouse line has the transgene integrated on the X chromosome (Whyatt et al. 2000). 
Therefore, female mice overexpress GAT A-I in -50% of their cells, as a consequence ofX-
inactivation. Males hemizygous for this transgene overexpress GATA-1 in all their erythroid 
cells and die in utero owing to a late defect in erythroid differentiation (Whyatt eta!. 2000). In 
contrast, the females survive and surprisingly, the overexpressing cells contribute normally to 
the erythroid cell population. It is thought that the rescue of GATA-1 overexpressing 
erythroid cells in female transgenic mice is brought about by a signal emanating from the non-
overexpressing. normally differentiating, erythroid cells (i.e the cells that have X-inactivated 
the transgene) (Whyatt eta!. 2000). 
In our differentiation assay, cells derived from 12.5 day transgenic male fetal livers are 
indeed severely impaired in differentiation, with only a few cells undergoing enucleation. The 
female cells with the active transgene (the overexpressing cells) differentiate normally in vivo 
but are defective in culture since they are blocked in differentiation when they are removed 
from the fetal liver and cultured in hanging drops (Whyatt eta!. 2000). This is demonstrated 
in the differentiation histogram plots of the TER119+/7AAD- cells after 2 days of hanging 
drop culture. The GATA -1 tg female cells have an intermediate phenotype between the wt en 
GATA-1 tg male cells (figure 4). 
wild type 
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Figure 4. F ACS analysis of wt and GATA-1 tg male and female overexpressing erythroid progenitors 
(TER119+/7 AAD) after 2 days of hanging drop culture. 
Overexpression of a tamoxifen-inducible GATA-1-LBD fusion protein 
To study the role of GATA-1 further we also generated transgenic mice with an inducible 
GATA-1 -Ligand Binding Domain (GATA-1-LBD) fusion protein. This fusion with a 
121 
mutated LBD from the estrogen receptor confers inducibility upon the presence of 4-hydroxy-
tamoxifen (40H-T) (Metzger et al. 1995). Fetal liver cells. isolated from the GATA-1-LBD 
transgenics, were cultured in hanging drops in medium with and without 40H-T. Cells 
collected from 10 drops were isolated and nuclear proteins were extracted from these cells. 
The extracts were used for the Western blot analysis (Figure 5). This demonstrate that GATA-
1-LBD can be clearly detected in the nuclear fraction after 40H-T addition, possibly 
reflecting the nuclear translocation of the fusion protein that is thought to occur upon ligand 
binding. The cells cultured with 40H-T showed a mild but significant reduction of 
TER119+/7AAD./FCS10wcells (13%) (Whyatt et al. 2000). We conclude that the culture 
method can also be used for the analysis of the biological effects of inducible systems. as 
exemplified by LBD fusion proteins. 
wl 
4 OH-T + 
I 
GATA-1 
LBO 
GATA-1 
LBO 
+/- +I+ 
+ + 
• +- GATA-1 LBO 
I W Mtcf W W lid +- endogenous GATA-1 
Figure 5. Western blot of nuclear extracts of fetal liver cells cultured in hanging drops with or without 
4-hyd.roxy tamoxifen (40H-T) after one day of hanging drop culturing. 
GATA -1 null mutant 
GAT A-I null mutant mice die between I 0.5 and 11.5 dpc.(Pevny et al. 1991; Fujiwara et al. 
1996). Fetal liver cells from heterozygous female mice express TER119 in approximately 
50% of the cells compared to wild type fetal liver cells (Table 1 ). The variation between the 
number ofTER119+ cells is due to variable X-inactivation which is also thought to be the 
cause of prenatal death of one third of the heterozygous females (Tsai et al. 1998) (Fujiwara et 
al. 1996) (Chapter 3). GAT A-I null cells are arrested in the proerythroblast stage and never 
make it to the stage were they start expressing the TER119 antigen. During the cultures, of 
fetal liver cells from the heterozygous null mutant mice, there is a relative increase of 
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TER119+ cells. compared to the wild type cultures.(Table 1). This increase ofTER!l9+ cells 
can not be explained by a more cell death of the TERll9- cells as measure by 7 AAD positive 
staining. 
% 7AAD• 
% TER119• cells ofTER119. cells 
n= day 0 day 1 day2 day 2 
WT 10 70 (±6) 81 (± 2) 76 (±7) 57 (r12) 
GATA-1 +/- 6 36 (±9) 56 (r4) 62 (±4) 57 (±3) 
Table 1: Percentage ofTER119+ fetal liver from wild type and GATA-1 +/-cells after 0, 1 and 2 day 
of hanging drop culture, and the percentage of7AAD+ (dead) cells of the TER119. cells. n is number 
of embryos. 
The TER119+ cells. in which the GATA-1 null allele is inactivated and the wild type allele is 
active. differentiated slightly less well than wild type cells did (Table 2). This could be caused 
by a negative influence of the dead TER119. GATA-1 +/-cells. with the wild type allele 
inactivated, in the culture. 
% differentiated cells 
n= day 0 day 1 day 2 
WT 10 3(±21 12(±21 31 (±21 
GATA-1 +/- 6 3 (± 11 9(±1) 24(±3) 
Table 2: Percentage of differentiated cells (FSC10"') of the TER119+/7AAD"/cells from wild type and 
GATA-1 +/-fetal liver cells after 0, 1 and 2 day of hanging drop culture. n is the number of embryos. 
Discussion 
Here, we describe a method that allows the quantitative analysis of differentiation of primary 
erythroid progenitors. In t\Vo days, freshly isolated fetal liver cells complete differentiation 
into mature erythrocytes. A major advantage of this method is that a small number of cells can 
be cultured and analysed. This is important when, for instance. a 11.5 dpc fetal liver is used as 
the source of cells. It is also useful when many different media have to be used to test 
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different components. We cultured fetal liver cells of several mouse lines defective or 
inducible defective in their erythroid differentiation process and found that this method is 
useful to analyse the defects found in these mice. 
Surprisingly the cells in hanging drop assays do differentiate in the absence of 
exogenous Epo. Normally, Epo is produced in response to hypoxia in the kidneys during adult 
life or in the liver during fetal and neonatal life (Krantz 1991; Eckardt 1995). It is known that 
Epo is needed for survival, proliferation and differentiation of erythroid progenitors (Kelley et 
al. 1993; Kirby et al. 1996; Lacombe and Mayeux 1998). Epo is essential to form CFU-E 
colonies in methyl-cellulose. although Epo is not required for the formation of the progenitor 
from which this colony is formed (Wu eta!. 1995; Wu et al. 1997). Small amounts ofEpo are 
present in FCS but at levels insufficient for erythroid survival and differentiation. The ability 
to differentiate in the absence ofEpo could be explained by the fact that the final steps of the 
erythroid differentiation process are thought to be Epa-independent, and/or the observation 
that erythroid progenitors are capable of producing Epo themselves (Stopka et al. 1998). Since 
the cells grow in close proximity of each other, this might result in a locally effective Epo 
concentration allowing erythroid differentiation. 
This assay however does not mimic the cell-cell interactions that occur in vivo 
completely. GATA-1 overexpressing cells in a mixed cell environment (transgenic females or 
chimaeric mice) differentiate normally in vivo owing to the activity of the proposed REDS 
signal, but in hanging drops these overexpressing cells are blocked in differentiation even 
when they are mixed with wild type cells. It has been suggested that the 3D structure of the 
erythroblastic island is required for REDS signalling to operate (Whyart et al. 2000); this 
structure is not maintained in the assay described here. 
Further analysis of the behaviour of the heterozygous GATA-l null mutant cells has to 
be done to explain the increase in TERll9+ cells and the lower number ofTERll9• cells that 
fully differentiate. 
In conclusion, we have described a differentiation assay for primary erythroid cells 
that is complementary to the classical CFU-E assay. The advantage of the new assay is that 
allows the simultaneous analysis oflarge numbers of samples, and that it is well geared 
towards the screening of growth media, biological and pharmaceutical compounds. It thus is a 
useful new tool to study the terminal differentiation of erythroid progenitors. 
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Methods 
Cells 
Mouse embryos were collected at 12.5 or 13.5 days of gestation. Fetal livers were dissected 
and disrupted in DMEM with 20% FCS amd antibiotics. 
Hanging drop cultures 
The cell concentrations were measured with a Coulter counter or an electronic cell analyser 
(Casyl, Schiirfe Systems, Reutlingen, Germany). The required number of cells was spun 
down and taken up in the medium, consisting ofDMEM supplemented with Epo (1 unit/ml), 
insulin (5f'g/ml), hemin (2mM), penicillin (lOOu/ml), streptomycin (!OO[!g/ml), ~-mercapto­
ethanol (1 OO[!M) and 20 %fetal calf serum (FCS). The cells were taken up in the medium at a 
concentration of 1.25xl06cells/ml, but cell concentrations ranging from 5x105 to 5x106 
cells/ml have been used successfully. 20_1 drops, containing -2.5xl04 cells each, were 
pipetted on the inside of a culture dish lid, after which it was carefully placed back on the dish 
which was filled with PBS to avoid evaporation. Cultures were harvested after 1, 2 or 3 days 
in PBS with 10% FCS and washed once. Since we have found that differentiation did not 
proceed further after day 2 of incubation, so that cultures were collected after 2 days. 
F ACS analysis 
Single cell suspensions were stained and analysed as described (Sawada eta!. 1989). The R-
PE conjugated TER119 antibody (Pharmingen) was used in a 1 in 50 dilution (Kina eta!. 
2000), to identify erythroid cells. 7-arninoactinomycin-D (7AAD, Molecular Probes BV) was 
used for determining cell viability at 1 !J.g/ml. Measurements were done on the FACScan 
(Becton Dickinson). 
Cvtospins 
Cells were prepared on slides by 5 minutes cyto-centrifugation at 500 rpm. The slides were 
dried and stained with 1% 0-dianisidine (Sigma) in methanol and a modified Giemsa like 
stain (Diff.Quick Red and Blue, Dade Diagnostika) (Beug eta!. 1982). 
Western blotting 
Nuclear extracts were prepared as described (Andrews and Faller 1991). Each sample was 
subjected to electrophoreses through a 10% SDS polyacrylamide gel, transferred onto 
nitrocellulose and probed with anti-GATA-1 antibody N6 (SantaCruz) and an appropriate 
secondary antibody before detection by chemilwninesence. 
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General discussion 
The work described in this thesis is aimed at examining the function of the transcription factor 
GATA-1 in the proliferation and differentiation of erythroid progenitors and in the Sertoli 
cells of the testis. Experiments are preformed both in vivo and in vitro, in mice. using 
molecular methods, transgenics. gene targeting and newly developed hanging drops. 
What is the role of GAT A-1 during proliferation and differentiation of erythroid progenitors? 
The necessity ofGATA-1 for erythroid differentiation was shown by the null mutant mice, 
that dies due to fatal anemia around 105-11.5 dpc (Pevny et aL 1991). Erythroid progenitor 
cells without GATA-1 do not progress beyond the proerythroblast stage. The differentiation 
of an erythroid GATA-1 null cell line, G!E, is rescued by transfecting it with GATA-1 
(Weiss eta!. 1997). Furthermore, the null mutant mouse phenotype could be partially 
alleviated by a knockin of the GATA-3 eDNA into the GATA-llocus in vivo (Tsai eta!. 
1998). This partial rescue might be explained by insufficient GATA-3levels. GATA-1 
knockdown mice, that express 5% of the normal level ofGATA-1 protein. die around 
I 0.5 dpc of severe anemia, comparable to the null mutant. These mice can be rescued by 
GATA-1, -2 and -3 transgenes driven by a GATA-1 promoter (Takahashi eta!. 2000). During 
adulthood the mutants rescued by GATA-2 and-3 develop anemia while the mice rescued by 
GATA-1 do not (Takahashi et aL 2000). Two explanations are possible, the fiiSt, and most 
probable, is that GATA-2 and -3 can not completely substitute for GATA-1 due to different 
biochemical properties or posttranslational regulation of GATA-2 and -3, especially during 
adult life. The second is that GATA-2 and -3 do not accumulate not enough protein and 
therefore are not able to completely replace GATA-1 in the GATA-1 knockdown mutant 
mice, but GATA-2 or GATA-3 are expressed at similar or higher levels than GATA-1 is 
expressed in the wt mice (Takahashi et aL 2000). Thus, the knockout and rescue experiments 
show that GATA-1 is essential for erythroid differentiation. The overall protein homology 
between GATA-1 and GATA-2 and -3 is 32 % in both cases. The highest homology. up to 90 
%, is found in the Zn-finger domains. Outside those domains it is~ 15%. Although the 
proteins are very homologous in the Zn-finger domains. it is still surprising that the family 
members 2 and 3 could rescue the lethal phenotype of the GATA-1 knockdown so well. It 
appears that the protein-protein interaction and DNA-binding activities of the Zn-finger 
domains comprise a large part of the biological function of these GATA factors. 
It is suggested that GATA-1 drives cells into differentiation (Shivdasani and Orkin 
1996). To test this hypothesis, we preformed experiments in which we manipulated the 
protein levels ofGATA-1. The overexpression experiments demonstrated that artificially 
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elevated GATA-llevels cause a block in erythroid differentiation at the stage of the 
basophilic proerythroblast (Chapter 2). These results lead us to propose a model in which 
GATA-1 regulates differentiation in two ways. One way is by regulating the expression of 
erythroid-specific genes like a classical transcription factor. All erythroid specific genes 
known to date have GATA binding sites in the regulatory elements. The second way would be 
that GATA-1 regulates differentiation by stimulating cell cycle progression. 
Proliferation during differentiation 
Overexpression experiments in MEL showed that high levels ofGATA-1 block 
differentiation probably through an illegitimate acceleration of the cell cycle by stimulating S-
phase entry (Whyatt et al. 1997). In vivo overexpression also results in a block in 
differentiation (Chapter 2). In our model, we propose that high levels of GATA-1 are needed 
to drive the rapid cell divisions characteristic for immature erythroid progenitors, as it is 
known that CFU-E stage progenitors divide more quickly than BFU-E progenitors and that 
beyond CFU-E stage the cells exhibit a progressive decrease in proliferative capacity (Iscove 
1977; Gregory and Eaves 1978). Terminal differentiation is however associated with cell 
cycle arrest in the G1-phase. We therefore claim that as erythroid progenitors progress to 
terminal differentiation, they have to down-regulate GATA-1 activity in order to stop dividing 
(Figure 1 ). Thus, proliferation and differentiation are intertwined processes. 
In the GAT A -1 null mutant mice, erythroid-specific genes are expressed at lower 
levels and cells do not go through the proliferative phase but instead undergo apoptosis at the 
proerythroblast stage, possibly due to the reduced expression of the survival factor BclxL, a 
GATA-1 target gene. In GATA-1 overexpressing cells, the cells are unable to exit the cell 
cycle. causing a differentiation block at the later developmental stage of the basophilic 
proerythroblast. The cells don't succumb to apoptosis, since they express GATA-1 target 
genes including BclxL at normal levels. 
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Figure 1: Dynamic regulation ofGATA-1 activity during erythroid differentiation. As cells go through 
a proliferative phase the GAT A-I activity should be high. To undergo terminal differentiation and cell 
cycle arrest. GATA-1 activity has to be down-regulated. 
GA TA-1 and the cell cvcle 
How does GAT A-I influence the cell cycle? The first clues to answer this question came from 
an erythroid progenitor MEL cell line overexpressing GAT A-I. When this cell line was 
induced to differentiate, it displayed an accelerated cell cycle and lack of expression of 
differentiation markers (Wbyatt eta!. 1997). 
The expression of known players in cell cycle regulation was measured and it was 
found that the phosphorylation status of a pivotal player, the Retinoblastoma protein (Rb) was 
affected. In cells overexpressing GAT A-I, Rb protein remained hyperphosphorylated after 
induction of differentiation (Wbyatt eta!. 1997).Rb is an important regulator of terminal 
differentiation of several cell types including erythrocytes (Jacks eta!. 1992). The activity of 
Rb is regulated by phosphorylation (Sherr 1996) (Fig.2); hypophosphorylated (active) Rb is a 
repressor of G I to S-phase progression. Hypophosphorylated Rb binds to the E2F 
transcription factors thus inhibiting the transcription ofE2F target genes. Upon 
phosphorylation, Rb is released from the E2Fs, these can now activate their target genes and 
G 1 to S-phase progression can occur. The question arises how GATA-1 influences Rb 
phosphorylation. GATA-1 can bind directly to Rb in vitro (Wbyatt eta!. 1997) and this 
interaction could influence phosphorylation status ofRb. 
Other proteins involved in cell cycle regulation were also measured such as p27, p21 
cyclin D2, cyclin D3, cyclin E, and one of the few proteins that changed before Rb 
phosphorylation was cyclin A (D.Wbyatt, unpublished data). This cyclin can bind to cyclin 
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dependent kinase 2, and is needed at two points in the cell cycle, for S-phase entry S-phase 
entry and mitosis (Pagano et aL 1992). Attempts to overexpress cyclin A in J\.1EL cells were 
unsuccessful, since higher cyclin A mRNA levels did not lead to higher cyclin A protein 
levels (D.Whyatt, unpublished data). Furthermore, although the promoter of the cyclin A gene 
contains a potential GATA binding site, it is probably not a direct GATA-1 target gene since 
the cyclin A levels are mainly regulated post-transcriptionally in MEL cells, and cyclin A 
mRNA levels are unaltered in MEL cells overexpressing GATA-1 (Minshull et al. 1989). 
The observation that the erythroid phenotypes of mice overexpressing GATA-1 and of 
Rb null mutant mice are very similar suggests functional relationships between these factors. 
In both cases, the block in erythropoiesis occurs at a similar stage of differentiation of the 
progenitors. More surprising, both phenotypes appear to be cell nonautonomous defects 
(Williams et al. 1994; Whyatt et al. 2000). This means that in a homogeneous mutant cell 
population (mutant cells only) the mutant cells have a mutant phenotype, but that in a mixed 
cell population (mutant+ wild type cells) mutant cells do not display the mutant phenotype. 
We have proposed that in the case ofGATA-1 overexpressing mice, the mutant cells are 
rescued by a signal supplied by wild type erythroid cells. This postulated signal is called 
REDS for red cell differentiation signal. This signal must come from the wild type red blood 
cells as in the mixed population (e.g. a transgenic GATA-1 female with the transgene on one 
of the X chromosomes, or a chimaeric mouse) the only cell that is different compared to a 
uniform overexpressing cell population (e.g. in a transgenic GATA-1 male with the transgene 
on the X chromosome) is the wild type erythroid cell (Whyatt and Grosveld 2002). It is 
possible that a similar signal operates in the cell nonautonomy of the Rb null mutation. 
Another potentially important observation is that the co-activator p300 can acetylate 
Rb, which inbibits phosphorylation by Cdks (Chan et al. 2001). The lysines that are acetylated 
might be part of the docking site for the Cdks (Adams et al. 1996). This mechanism might be 
the entry point for the regulation ofRb phosphorylation by GATA-1, since GATA-1 can 
interact directly with p300 and the closely related CBP protein (Blobel et al. 1998; Boyes et 
al. 1998). High levels ofGATA-1 will bind more CBP/p300 thus preventing it from binding 
to Rb. This would result in reduced acetylation ofRb thus indirectly promoting Rb 
phosphorylation, allowing the cells to progress to S phase. Conversely, low GATA-1 levels 
would pennit Rb acetylation, resulting in an abundance ofhypophosphorylated Rb as required 
for the G 1 arrest associated with terminal differentiation (see Fig. 2, D.\Vhyatt, personal 
communication). 
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Figure 2: Possible mechanism for the regulation of the cell cycle by GAT A-I via CBP/p300 and Rb. 
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How does this fit with the wild type, GATA-l overexpressing and GATA-l knockout 
phenotype? 
Wild tvoe situation 
In the wild type situation, GATA-l is regulated such that GATA-l peaks (Rb is more easily 
phosphorylated) when the progenitors have to divide rapidly. During terminal differentiation 
GATA-l is downregulated, Rb is acetylated and the cells arrest in G l. GATA-l target genes 
are expressed and the progenitors mature to erythrocytes. 
GAT A-1 overexpression 
CBP/p300 is bound quantitatively by GATA-1, and therefore Rb is less acetylated leading to 
a shift in the balance of phosphorylation ofRb to hyper-phosphorylated Rb. leading to a 
progression from Gl into S-phase because of the release ofE2F transcription factors. In a 
mixed cell population this mechanism is bypassed at some point by the signal REDS (Chapter 
2). Most likely is the possibility that the signal causes a decrease of GATA-l activity. One 
way this can be achieved is via protein degradation. It has been shown that late erythroid 
progenitors (the orthochromatic erythroblast) express the Fas ligand for the receptor protein 
Fas (CD95) that is expressed in the earlier cells (basophilic erythroblasts) (De Maria et al. 
1999a). Signalling via these receptors can trigger a pathway that can activate Caspase 3 that is 
able to cleave the GATA-l protein(De Maria et al. l999b ). It was suggested that this pathway 
regulates the rate of erythropoiesis as a negative feedback mechanism (Orkin and Weiss 
1999). In our model, it is a mechanism to downregulate GATA-l during differentiation and 
therefore a pathway that is always necessary for erythropoiesis. Our experiments have shown 
that GATA-l activity must be downregulated during terminal differentiation (Chapter 2). 
If the signal does not rescue via GATA-l degradation it has to influence the cell cycle 
machinery via one of the other proteins like Rb, CBP/p300, E2Fs, CDK.is etc. Maybe REDS 
functions as a regulator of GATA-1 and one or more of these proteins. That REDS influences 
more than one target is more likely, as cell signalling pathways often do not influence only 
one target at the time. 
GAT A-1 null mutant 
In the GATA-l null mutant, CBP/p300 is not squelched by GATA-l at all. Rb can be 
acetylated more efficiently and is therefore less well phosphorylated. This blocks cell cycle 
progression of the erythroid progenitors prior to a proliferative phase. The cell cycle arrests 
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prematurely at the proerythroblast stage. The cell cycle arrest should occur at the terminal 
differentiation stage and not before. Obviously, GAT A-I target genes are less well transcribed 
in the GAT A-I null mutant. 
In the absence ofGATA-1, GATA-2 is upregulated (Weiss etal.l994). The 
explanation for this effect is suggested to be the downregulation of GATA-2 by GAT A-I. 
GATA-2 can not completely compensate for the loss ofGATA-1. GATA-2 is able to bind to 
CBP/p300 like GATA-1, but maybe its effect is not the same. Also the upregulation of 
GATA-2 in GATA-1 null mice is probably not exactly the same as the normal level of 
GATA-1. The level ofGATA-1 activity is one very important parameter. This can be 
concluded from the experiment in which the transgene with the GATA-2 eDNA does rescue 
the GATA-1 knockdown, as it is (Takahashi et al. 2000). Although the protein is different 
from GATA-1, GATA-2 only causes problems later in life. The rescue by GATA-2 expressed 
under the GAT A-I regulating sequences shows that the level of expression is very important. 
The drawback of this experiment. however, is that it was performed with GAT A-I 
knockdown mice instead of GATA-1 null mutants. This also leaves the possibility that the 
remaining 5% GATA-1 expression is actually supporting a minimal rescue by GATA-2, 
leading to the aberrant conclusion that GATA-2 can fully take over GATA-l"s role in 
terminal erythroid differentiation. 
CBP/p300 the pivotal protein? 
P300 and CBP interact with a growing list of proteins including general transcription factors, 
tissue-specific transcription factors, and cell cycle regulating proteins. This suggests a pivotal 
role in transcription, cell growth, transformation and development (Goodman and Smolik 
2000). 
In the model suggested above, CBP/P300 has to be ratelimiting. This is in agreement 
with the phenotype of the CBP and the P300 heterozygous knockout. Mice heterozygous for 
the CBP gene develop multi-lineage defects in hematopoietic differentiation. Fewer 
heterozygous p300 mice were born than the expected Mendelian ratio (Yao et al. 1998). Mice 
homozygous for the null allele of either CBP or p300 are not viable and die around 10.5 dpc 
(Kung et al. 2000). p300/CBP compound heterozygous mice are also not viable. The embryos 
were severely stunted and exhibited similar defects as the p300 or CBP homozygous 
knockout (Yao et al. 1998). Thus although P300 and CBP are highly homologous and they 
can perform some of the same functions they are not able to compensate for the loss of the 
other gene. This demonstrates that the combined dose of p300 and CBP is critical for mouse 
embryonic development. Furthermore CBP/P300 has tumor suppressing activity. 
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Heterozygous CBP mice developed a high incidence of hematological malignancies. Bone 
marrow of CBP heterozygotes causes leukemia when transplanted in sublethally irradiated 
mice in almost 40% of the cases (Kung et al. 2000). It was shown that in these cancers the 
wild type allele was also lost. This is compatible with the notion that CBP is an important 
regulator ofRb. However. CBP also interacts with a wide variety of other proteins that can 
influence the cell cycle, including p53, mdm2 and c-myb (Goodman and Smolik 2000). 
The regulation of GA TA-1 activity by REDS 
What is REDS? And how does it work? These questions still have to be answered. The first 
candidates are the so-called death ligands. FasL, TRAIL and TNFa are capable of activating 
caspase~3 which can degrade human GATA-1, and are produced by late erythroid progenitors 
(De Maria et al. 1999b). Experiments with caspase inhibitor have shown that caspase activity 
is required for terminal erythroid differentiation (Zermati et al. 2001), although the caspase-3 
knockout does not have an obvious erythroid defect (Woo et al. 1998). Collectively, death 
ligands meet several of the requirements for REDS activity. However, death ligands added to 
in vitro cultures do not rescue the developmental defect of GATA-1 overexpressing 
progenitors (data not shovro). Possibly, REDS signalling requires close contact between the 
mutant cells and the cells providing the REDS signal, and such close contact may not be 
easily reproduced in vitro. Furthermore, other as yet unidentified death ligands could be the 
REDS signal. This is suggested by the discovery of a novel death ligand receptor in zebrafish 
which is thought to stimulate erythropoiesis (Long et al. 2000). We are currently searching for 
the mammalian homologue of this receptor. 
An additional mechanism for the regulation of GATA~ 1 activity would be via protein 
modifications such as phosphorylation and acetylation. Phosphorylation/dephosphorylation 
can regulate distinct aspects of transcription factor function including localization, protein 
stability, protein-protein interactions and DNA binding (Whitmarsh and Davis 2000). It might 
for instance interfere with the interaction with CBP. Acetylation can also regulate localisation, 
protein-DNA interactions and protein-protein interactions (Bannister and Miska 2000). Until 
now the roles of phosphorylation and acetylation ofGATA-1 are not known, although there 
are reports indicating that these modifications influence the binding affinity of GAT A -1 to 
DNA (Crossley and Orkin 1994; Boyes et al. 1998; Hung et al. 1999; Partington and Patient 
1999). 
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What is the role of GAT A-1 in the testis? 
The role ofGATA-1 in the Sertoli cells has not been elucidated by our the testis-specific 
deletion ofGATA-1. The results of our experiments show that GATA-1 is not essential for 
testis structure or function. It can not be excluded that GAT A -1 is a transcriptional regulator 
in this tissue, since this function may be shared with other co-expressed GA TA factors, 
GATA-2, -4 and -6. It is conceivable that functional redundancy serves as a back-up 
mechanism to assure Sertoli cell function. The generation of compound Sertoli cell-specific 
GATA null mutants would be required to address this issue. Humans with a mutation in 
GATA-1 that disrupts the interaction with the cofactor FOG-1, suffer from anemia, 
thrombocytopenia and cryptorchidism (Nichols et al. 2000). The cryptorchidism may be 
related to the GATA-1 mutation this could be tested by introducing the corresponding 
mutation in the mouse germline. In the testis a FOG-I homologous protein, FOG-2 is highly 
expressed and a mutated GAT A-I protein may have a more pronounced defect than the tissue 
specific null mutant (Lu et al. 1999). 
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Future experiments 
In the future, new experiments will shed more light on the role ofGATA-1. 
To investigate the role of acetylation and phosphorylation of GATA-1, knock-in 
alleles ofGATA-1 mutants with alterations in the amino acids that are thought to be essential 
for these processes, have to be generated. Mutations in residues knovm to influence FOG~ 1 
interaction could also be studied this way. A knock-in allele with a GATA-1 mutation that is 
resistant to caspase-degradation could show ifGATA~l regulation via degradation is an 
important pathway for inactivation. Knock-in mutant mice have the advantage over transgenic 
mice that the endogenous locus is used for expression, and that there is no influence of the 
endogenous wild type gene products. 
Null mutant mice or transgenic mice from genes thought to play a role in the 
regulation ofGATA-1, such as caspase-3 and CBP, could be crossed with GAT A-I 
overexpressing mice to see if the interactions between these gene products are important. 
These experiments have been started in our laboratory (D. Whyatt and L. Gutierrez) 
Further progress can be expected from the application of new technologies. 
Microarray target gene detection is becoming a common technique that enables the genome~ 
wide detection of differences in gene expression between wild type, null mutant, knock-in and 
transgenic mice. 
Human GATA-1 has been purified in an active state and this can be used for studying 
interactions with proteins or DNA (Doubeikovskaia eta!. 200l).ln our laboratory, 
biotinylated mouse GATA-1 is currently used to isolated protein complexes containing 
GAT A-I. Small amounts of co-purifying proteins can now be identified with very sensitive 
mass spectrometry techniques; such analyses reveals which biochemical activities are 
associated with GATA~1·containing multi-protein complexes (J. Strouboulis unpublished 
data). The results of these experiments will provide important answers to the question how 
GAT A-I regulates red blood cell differentiation. 
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Summary 
In this thesis experiments are described, that were designed, to understand the process of red 
blood cell fonuation, better. In particular the final stages of the pathway that a stem cell has to 
follow to become a red blood cell. The experimental chapters are introduced by Chapter 1 of 
which a more simplified summary is given here, including some basic biology. The use of 
lab~slang has been tried to be avoided. 
Introduction 
Cells are the basic units of our body. Imagine them as little bags filled with water or better 
broth. These bags are not completely waterproof. The cells contain several smaller working 
units such as the nucleus (headquarters and control room) and the mitochondria (the power 
station). Many cells together form a tissue or an organ such as the skin, the liver, the heart or 
the blood. 
Blood 
The blood contains different type of blood cells that can be divided in; the platelets, the white 
blood cells and the red blood cells. The platelets are responsible for coagulation of the blood. 
The white blood cells are the army of our immune system. They protect us against bacteria, 
viruses and other unwanted intruders and clean up the mess afterwards. The red blood cells 
are responsible for the transport of oxygen and carbon dioxide. They disrtibute the oxygen 
from the lungs tlrrough the body and collect the carbon dioxide to deliver that to the lungs. 
All types of blood cells are being produced continuously depending on the demands of 
the body. Every day, 200 billion (=200.000.000.000) new red blood cells are made, this 
comes down to 2,3 ntillion red blood cells per second. All the different types of blood cells 
are descendants from the hematopoietic stem cell. These are relatively rare cells that are found 
in the blood producing organs~ the AGM (a small structure in the embryo that forms the 
embryonic kidney and develops in aorta and genitals) and the fetal liver in the embryo, and 
bone marrow after birtb. These cells have the ability to become every type of blood cells. This 
process is called differentiation and during this process the cells go through several 
intermediate stages. We then call the cells precursors. During the differentiation process the 
cells divides many time, thus one stem cell can have many descendants. Stem cell can also 
divide without changing into mature blood cells, this way the number of stem cells is 
maintained at the same level. 
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The differentiation is regulated via regulation mechanisms. Failure of a regulation 
mechanism can lead to diseases in which the formation of a certain blood cell type is affected. 
Anemia is the disease in which not enough blood cells or crippled red blood cells are made. In 
leukemia a precursors keep dividing and do not differentiate to a mature blood cell. 
Differentiation 
Differentiation of cells does not only occur in blood cells but in all tissues, and during 
development of the fertilized oocyte to an adult. The fertilized oocyte is the ultimate stem cell. 
Cells from all the tissues are very different. A neuron with its long dendrites has a totally 
different appearance than a muscle cell. And the functions liver and skin cells are very 
different. All these cells are however descendants of the fertilized oocyte. What a cell looks 
like and what it does depends mainly of the proteins in the cell. Protein are the largest group 
of molecules in the cell. The proteins are the building blocks of the components of the cell, 
perform the communication, repair broken parts. generate energy, collect and recycle garbage 
and catalyse many reactions. Proteins are molecules that are build out of a group of20 amino 
acids. Thus. the differences between cells are mainly determined by the proteins they express. 
How does a cell know which proteins to make? 
The genetic material: DNA 
The information for the development of the body and the individual cells is written in the 
genetic material of the cell, the DNA. that found in the nucleus of the cell. The DNA can be 
envisioned as a manual (the genome) that consists of two sets of big books (the chromosomes, 
46 in humans). These books have only one very long line, in which only four letters; A,T, G 
and CBP/p300 (the bases) appear. These letters form three letter words (codon) that form 
sentences (the genes). The total number of bases in the genome (all the books together) is 
about 6.000.000.000. If every letter would represent a base, it would come down to 20.000 
copies of this thesis in which approximately 40.000 genes are written. In a gene the order of 
the codon determines the order ofthe amino acids of the protein. From genes, relatively 
instable copies are made (mRNA) that are read and translated outside the nucleus (in the 
cytoplasm. These two processes are called transcription and translation (Figure l ). 
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Figure 1: Schematic representation of gene expression~ transcription from DNA to RNA. followed by 
transport of the mRNA and translation of the mRNA to protein. 
Different cell types all have the same genome (the manual). The differences between the 
different cell types are determined by which genes of the manual are transcribed to mRNAs. 
There are genes that are used in basically all cells, the so-called house keeping genes. The 
differences are made by the cell type specific genes. Some part of the manual are not 
important for one cell type and very important for another cell type. For example, the genes 
for hemoglobins are transcribed in red blood cells and not in cell of the pancreas. The cells in 
the pancreas do have the hemoglobin gene but do not use it. They do make insulin that is not 
made by red blood cells. Which genes are used depends on the presence of proteins that are 
able to regulate transcription, the transcription factors. 
Transcription factors 
Transcription factors are protein that regulated transcription because they are able to bind to 
the DNA. Therefore, they are found in the nucleus of the cell. They can regulate transcription 
in several ways. The thin thread of DNA is wrapped around little spools (the nucleosornes), 
these spools form a compact structure called the 30run fiber. This is a rather inaccessible 
structure. For DNA to be transcribed it has to be made accessible for proteins that make the 
RNA copies. Transcription factors can bind to DNA and unfold it or attract other proteins that 
can. An other mechanism is that transcription factors bind to the stretch of DNA just in front 
of the transcription start site called the promoter, that is very important for transcription. 
Transcription factors are thought to attract the protein that carry out the actual transcription, 
and thereby increasing the frequency of transcription. Transcription factors can also inhibit 
transcription, for instance by attracting proteins that can block transcription or block the 
unfolding of the DNA. 
147 
This Thesis 
GATA-1 is very important for the differentiation of red blood cells, but what is the precise 
function of the protein is still not clear, as is way it is regulated. In this thesis, experiments 
that investigate the function and regulation ofGATA-1 are described. GATA-1 is a red blood 
cell specific transcription factor that owns its name to the core of the DNA sequence it binds: 
G, A, T, A. These bind sites are found in the promoters and other regulatory sequences of all 
red blood cell specific genes among which the hemoglobin genes. In experiments with mice 
that made no GATA-1 in their red blood cell precursors, the precursors arrested during their 
maturation process, and the mice died due to anemia. GATA-1 's importance for the 
differentiation process was shown. In experiments done in our laboratory red blood cell 
precursors were generated that made more GAT A-I than normal. These cells, that normally 
can be induced to differentiate, refused to differentiate and kept dividing unlike the control 
cells. 
In Chapter 2 experiments are described in which mice are generated that make more 
GATA-1 in their red blood cell precursors. Mice that make to much GATA-1 in all their red 
blood cells die by the time they are halfway of their gestation. The process of red blood cell 
differentiation is blocked and is the cause of the lethal anemia. This was unexpected because 
it was assumed that GATA-1 would stimulate differentiation. The generation of these mice 
was only possible because in mice that produced more in only a part of their red blood cell 
precursors instead of in all cells. This was achieved in only one experiment in which the extra 
copy of the GATA-1 gene integrated in the X chromosome. In cells offemale mice (with 2 X 
chromosomes), one of the X chromosomes is inactivated. This implies that in 50% of the 
cells the extra copy is inactivated. Surprisingly the other 50% of the cells, that over-produced 
GATA-1, were able to fully differentiate. We concluded from our experiments that the normal 
cells with the inactivated extra GATA-1 gene, can rescue the abnormal cells, that 
overproduced GATA-1 from their fatal block in differentiation. The abnormal cells are getting 
a message from the normal cells to proceed differentiation as if nothing happened. The defect 
of the abnormal cells in non-autonomous. This means that they do not behave as their genetic 
material tells them but that they are controlled by other, normal, cells. It is not known what 
this signal is that is responsible for this but we called it REDS, which stands for red blood cell 
differentiation signal. 
In Chapter 3 experiments are described in which mice should have been able to shut 
down their GATA-1 genes at any given time. Since a mouse without GATA-1 dies after 10 
days of embryonic development, the lack of GATA -1 can not be studied at later timepoints. 
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To overcome this problem a mouse was generated with an adapted GATA-1 gene. The gene 
was adapted in such a way that in front and after the gene DNA sequences were placed, so 
called lox sites, that can be recognized by an enzyme (Cre recombinase) that can delete the 
DNA in between the two lox sites. Imagine a long rope (DNA) in with a knot (two lox sites 
combined) that creates a big loop (the DNA in between the two lox sites), after which scissors 
(the Cre recombinase) can cut the loop out of the rope. By breeding the mice with the adapted 
GATA-1 gene with mice that produce the Cre recombinase (the scissors) in their cells, the 
offspring can have both and these mice will have the GATA-1 gene deleted. After we added a 
biological on/off switch to Cre recombinase it should have been possible to delete the GATA-
1 gene at any given time. This was possible but the efficiency was to low to remove the 
GATA~l gene in all the cell we wanted. This system worked perfectly when we used the Cre 
recombinase without the biological on/off switch. The deletion of GATA-1 in a specific cells 
type was achieved by generating mice that produced the Cre recombinase in a specific cell 
type, and this also worked fine. 
An example of the cell type specific deletion is given in Chapter 4 in which 
experiments are described in which we generated mice that do not produce GATA-1 in their 
testes but do make GATA-1 in their red blood cells. Without this technique it would not have 
been possible to study the deficiency ofGATA-1 in the testes because in the mice that do not 
make GATA-1 at all, die as a embryo. Others claimed that GATA-1 probably had an 
important role in the testes. Our experiments have shown that GATA-1 can be omitted with 
out inhibiting the function of the testis, and that ifGATA-1 has any effect on the function or 
structure, it is very subtle and not detected by us (yet). 
In Chapter 5 a method is described that makes it possible to test red blood cell 
precursors on their ability to differentiate. It is a simple and small scale experiment and is 
used in Chapters 2 and 3. 
In Chapter 6 results from us and others are compared and we speculate about models 
that explain these results, a function and the regulation ofGATA-1. First we speculate about 
the link between GATA -1 and the cell cycle. One of the characteristics of the final stage 
differentiation of the differentiation process is a deceleration of the cell cycle. And secondly 
we speculate about the regulation ofGATA-1 by a signal called REDS. We think that the 
signal is produce by normal cell at the final stages of erythropoiesis. This signal has the 
ability to instructs abnormal cells to differentiate when otherwise the wouldn't. We suggest 
that this signal that this signalling system has a also a function under normal circumstances. 
Possible candidates are discussed. Finally new experiment are discussed that might further 
elucidate the role of GATA-1. 
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Samenvatting 
In dit proefschrift zijn experimenten beschreven die tot doel hadden de vorming van rode 
bloedcellen beter te begrijpen. En wel in bet bijzonder een klein maar belangrijk gedeelte van 
het traject dat een stamcel a:flegt om uiteindelijk een rode bloedcel te worden. De feitelijke 
experimentele hoofdstukk:en zijn ingeleid door Hoofdstuk 1 waarvan hier een 
vereenvoudigde samenvatting met wat basisbiologie waarin het gebruik van lab-slang Gargon) 
zoveel mogelijk is vermeden. 
Inleiding 
Cellen zijn de basiseenheden van ons licbaam. Cell en kunnen worden voorgesteld als kleine 
zak:jes met water ofbeter nog bouillon. Deze zakjes zijn niet geheel waterdicht en bevatten 
zelfweer vele kleine onderdeeltjes die bepaalde functies kunnen uitvoeren zeals bijvoorbeeld 
de celkem (het hoofdkwartier en controlecentrum) of de mitochondrien (de energiecentrales). 
Vele cellen samen kunnen een weefsel of een orgaan vonnen zoals de huid. de lever, het hart 
ofhet bloed. 
Bloed 
Het bloed bevat verschillende bloedcellen die in drie soorten zijn in te del en. de bloedplaatjes. 
de witte bloedcellen en de rode bloedcellen. De plaa~es zijn verantwoordelijk voor de stolling 
van bet bloed. Dewitte bloedcellen vormen bet Ieger van ons afureersysteem. Ze bescbennen 
ons tegen bacterien, virussen of andere indringers en ruirnen de rommel op. De rode 
bloedcellen zijn verantwoordelijk voor het transport van zuurstof en koolstofdioxide. Ze 
verspreiden bet zuurstofvanuit de longen door het bele licbaam en verzamelen onderw-eg bet 
koolstofdioxide om bet afte leveren in de longen. Aile soorten bloedcellen worden continu 
bijgemaakt naargelang de behoefte van het lichaam. Per dag maken wij bijvoorbeeld zo "n 200 
miljard (200.000.000.000) nieuwe rode bloedcellen. wat neerkomt op ongeveer 2,3 miljoen 
rode bloedcellen per seconde. Alle verschillende bloedcellen stanunen afvan 
hematopoetische stamcellen (HSC). Dit zijn relatief zeldzarne cell en die zich bevinden zich in 
de bloedvormende organen. de AGM (een onderdeel van een embryo de embryonale nieren 
gaat vormen en zicb later ontwikkeld tot de aorta en de genitalien) en de foetale lever in een 
embryo en vanaf de geboorte in bet beenmerg. Deze cell en bebben bet vennogen te 
veranderen in iedere soort bloedcel. Dit noemen we differentieren en tijdens dit proces 
doorloopt een eel verscbillende tussenstadia die we voorlopercellen noemen. Tijdens dit 
proces deelt de zo 'n eel zicb vele malen zodat van 1 stamcel vele cellen kunnen afstammen. 
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Daarnaast del en de stameellen zieh ook zonder te veranderen zodat hun aantal min of meer 
gelijk blijft. Voor een goed verloop van dit productieproces zijn er verschillende 
regelmechanismen. Als een of meer van deze ""schakelaars" defect zijn kunnen bepaalde 
zieh.'ies zich openbaren doordat bijvoorbeeld een bepaald eel type niet meer gevormd wordt. 
Zo is bloedarmoede het symptoom van te weinig of niet goed functionerende rode 
bloedcellen. Bij leukemic deelt een voorlopereel zieh ongeremd en ontwikkelt zich niet 
volledig tot een volwassen eel. Die eel is daardoor niet in staat de functie te vervullen van een 
volwassen eel. 
Di fferentieren 
Ret differentieren van eellen gebeurt niet aileen in het bloed maar in aile verschillende 
weefsels en gedurende de ontwikkeling van bevruchte eicel tot volgroeide mens. De eicel en 
de stamcel zijn in dat opzicht vergelijkbaar. De bevruchte eicel is eigenlijk de ultieme stamcel 
afgezien van het feit dat hij zich niet direct vemieuvvt maar in zijn geheel differentieert. De 
cellen van de verschillende weefsels lijken over het algemeen totaal niet op elkaar. Een 
zenuwcel met zijn lange uitlopers heeft een ander uiterlijk dan een spiercel. En ook qua 
functionaliteit kunnen eellen van verschillende weefsels totaal verschillen. Zo heeft een 
levercel weer hele andere functies dan een huidcel. Toeh zijn deze cell en allemaal 
afstammelingen van de eerste eel, de bevruehte eicel. Hoe een eel eruit ziet en wat een eel kan 
doen hangt afvan de eiwitten in die eel. Eiwitten zijn de grootste groep functionele moleculen 
in een eel. Ze kunnen de bouwstenen vormen voor de eel en onderdelen van de eel. de interne 
en exteme communicatie verzorgen, de energiecentrales vormen, reparaties uitvoeren. het 
vuilnis ophalen en recyclen en bepaalde celspeeifieke reacties katalyseren. Eiwitten zijn 
moleculen die zijn opgebouwd uit 20 verschillende bouwstenen, de aminozuren. De 
verschillen tussen cell en worden dus bepaald door de verschillende eiwitten die in een eel 
worden gemaakt en gebruikt. Hoe weet een eel nu wat hij moet do en en worden? 
Ret genetische materiaal: DNA 
Ret gehele bouwplan voor het lichaam en de opdrachten voor de cellen zijn gecodeerd in het 
genetische materiaal van de eel dat zieh in de celkem bevindt, het DNA. Ret DNA kan 
worden voorgesteld als een gebruiksaanwijzing (bet genoom) die bestaat uit twee 
verzamelingen dikke boeken (de chromosomen, 46 bij de mens) met in ieder hoek een lange 
regel opgebouwd uit 4 verschillende letters; A, T, G en C (de basen). Deze letters vormen 
drieletten:voorden (eodons) die op hun beurt weer zinnen vormen (de genen). De totale 
hoeveelheid basen in het genoom (al deze boeken bij elkaar) bedraagt ongeveer 
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6.000.000.000. Als iedere letter een base zou vertegenwoordigen zou dit neerkomen op 
ongeveer 20.000 exemplaren van dit proefschrift. En zij beschrijven ongeveer 30 a 40.000 
genen. In een gen bepaalt de volgorde van de codons de volgorde van de aminozuren van een 
eiwit. Van de genen worden namelijk relatiefinstabiele kopieen (mRNA) gemaakt die 
vervolgens buiten de kern (in bet cytoplasma) worden gelezen en vertaald in eiwitten. Dit beet 
respectievelijk transcriptie en translatie (Figure 1). 
eel kern 
cytoplasma 
eel 
DNA gen 
l transcriptie 
mRNA - 1::: ___ ., 
mRNA--1 translatie 
eiwit~ 
Figuur 1: Schematiscbe weergave van genexpressie: de transcriptie van bet gen. bet modificeren en het 
transport van bet mRNA, gevolgd door de translatie van het mRNA naar eiwit. 
Verschillende celtypen hebben echter allemaal hetzelfde genoom (de handleiding). Het 
verschil tussen deze celtypen zit hem dan ook in welke gedeeltes van het genoom wordt 
overgeschreven naarmRNA 's. Er zijn genen die in alle cellen worden gebruikt (=tot 
expressie komen), de zogenaamde huishoudgenen. Maar het verschil wordt gemaakt door het 
gebruik van celspecifieke genen. Het is te vergelijken met een gebruiksaanwijzing voor 
verschillende modellen van een apparaat. Sornmige boofdstukken zijn niet van toepassing op 
bet ene model en sommige niet op bet andere model en andere hoofdstukken zijn weer op alle 
modellen van toepassing. Zo wordt bet gen voor bemoglobine, bet eiwit dat zuurstof en 
koolstofdioxide bindt en vervoert, aileen in rode bloedcellen overgeschreven en niet in cellen 
van de alvleesklier. Deze cell en bebben het gen wei maar gebruiken het niet. Zij maken wei 
weer insuline dat rode bloedcellen weer niet maken.Welke genen worden gebruikt wordt 
bepaald door eiwitten die de transcriptie van genen kunnen beinvloeden, de 
transcriptiefactoren. 
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Transcriptiefactoren 
Transcriptiefactoren zijn eiwitten die hun functie, het reguleren van transcriptie, kunnen 
uitoefenen door aan het DNA van een gen te binden. Zij bevinden zich dus altijd in de 
celkern. Ze kunnen transcriptie reguleren op verscbillende manieren. DNA, dat je je voor kan 
stellen als een hele lange dunne draad, is normaal gesproken strak opgewonden om kleine 
klosjes (nucleosomen) die op hun beurt weer strak opgevouwen zijn (30 nm fiber). Dit is een 
ontoegankelijke structuur. Om DNA geschikt te laten zijn voor transcriptie moet het een 
relatief open structuur hebben. Transcriptiefactoren kunnen binden aan DNA en de compacte 
structuur opvouwen of andere eiwitten binden die dat kunnen. Een andere manier om 
transcriptie te stimuleren is door te binden aan de promoter van een gen. Dit is het stuk DNA 
dat zich vlak voor de transcriptiestartplaats bevindt en belangrijk is voor de transcriptie. Door 
vervolgens de eiwitten die het transcriptieapparaat vormen te binden, wordt de frequentie van 
transcriptie verhoogd. Transcriptiefactoren kunnen ook de transcriptie blokkeren door in de 
weg te gaan zitten of door eiwitten te binden die transcriptie blokkeren. 
In hun functioneren kunnen transcriptiefactoren ook weer afhankelijk zijn van signalen van 
binnen of van buiten de eel. Door middel van deze signalen kan hun eigen expressie worden 
gereguleerd ofh.-unnen er chemische modificatie aan het eiwitmolecuul worden aangebracht of 
weggehaald die de functie kunnen belnvloeden. 
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Dit proefschrift 
Voor de differentiatie van rode bloedcellen is de transctiptiefactor GATA-l erg belangtijk 
maar de vraag wat nude precieze functie van dit eiwit is en hoe het gereguleerd wordt is nog 
verre van opgehelderd. In dit proefschrift worden experimenten beschreven die de functie en 
regulatie van GATA-1 onderzoeken. GATA-1 is een voor de rode bloedcel specifieke 
transcriptiefactor die zijn naam te danken heeft aan het middelste gedeelte van de DNA base 
volgorde waar het kan binden: G. A) T, A. Deze bindingsplaatsen zijn gevonden in de 
promotoren en andere regulerende stukken DNA van aile rode bloedcel-specifieke genen tot 
nu toe, waaronder de hemoglobine genen. In experimenten waarbij muizen in hun rode 
bloedcel voorlopercellen geen GAT A-I aarunaakten en als embryo stierven door 
bloedannoede, bleven de rode bloedcellen steken tijdens hun rijpingsproces. Dat GATA-l 
belangrijk is voor het laatste gedeelte van het differentiatieproces werd hier mee als bewezen 
beschouwd. In eerdere experimenten gedaan in ons laboratorium werd in rode bloedcel 
voorlopercellen extra GATA-l gemaakt. Deze cellen, die normaal gesproken onder bepaalde 
omstandigheden differentieren, bleven onrijp en gingen, in tegenstelling tot de controlecellen. 
door met delen. 
In Hoofdstuk 2 worden experimenten beschreven met muizen die extra GATA-1 
aarunaken in hun rode bloedcel voorlopercellen. Muizen die GATA-1 aarunaken in al hun 
rode bloedcel voorlopercellen sterven als embryo iets over de helft van de zv.rangerschap. De 
differentiatie van de rode bloedcellen is geblokkeerd en dit is de oorzaak van de fatale 
bloedarmoede. Dit was onverv.racht omdat aangenomen werd dat GATA-1 differentiatie 
stimuleert en als gevolg daarvan de celdeling remt. Het genereren van deze muizen was 
slechts mogelijk als muizen in een gedeelte van hun cellen extra GATA-l maal.:ten in plaats 
van in aile cellen. Dit bleek gelukt te zijn doordat in een van de experimenten een extra kopie 
van het GATA-1 gen in het X-chromosoom terecht bleek te zijn gekomen. In een vrouwelijke 
muis (met 2 X-chromosomen) wordt altijd een van de twee X-~hromosomen uitgeschakeld. 
Dit in tegenstelling tot de andere chromosomen. Dat betekent dat in 50% van de cell en de 
extra kopie ook was uitgeschakeld. Verrassend genoeg bleken de andere 50% van de cellen 
(de ··abnormale" cellen) die extra GATA-l maakten nu wel volledig te kunnen differentieren. 
Hieruit blijk."t dat normale cellen de abnormale cell en kunnen redden van hun ondergang. De 
abnormale cellen krijgen een signaal van de normale cellen om toch vooral maar normaal te 
differentieren. De abnormale cell en hebben een niet-autonoom defect. Dat wil zeggen dat ze 
zich niet gedragen zoals hun genetisch materiaal ze eigenlijk vertelt maar dat ze gestuurd 
worden door de cellen in hun omgeving. Het is nog niet bekend wat het signaal is dat hiervoor 
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gebruikt wordt maar wij hebben het alvast een naam gegeven: REDS. Dat staat voor red blood 
cell differentiation signal, rode bloedcel differentiatie signaal. 
In Hoofdstuk 3 worden experimenten beschreven met muizen waarvan het GATA-1 
gen op een willekeurig tijdstip zou moeten kunnen worden uitgeschakeld. Een muis zonder 
GAT A-I gen sterft al ongeveer halverwege de zwangerschap en zo kan het gemis aan 
GATA-1 niet op laterc leeftijd worden bestudeerd. Hiervoor werd het GATA-1 gen zo 
aangepast dater voor en er achter zgn. knipplaatsen (lox sites) werden aangebracht die 
h."UU111en worden herkend door een knipenzym (Cre recombinase) dat deze plaatsen herkent en 
het DNA tussen de knipplaatsen kan verwijderen. Dit is voor te stellen als lang touw waar je 
op een bepaalde plaats een knoop met een Ius in legt en vervolgens de Ius er met een schaar 
afknipt. Door nu muizen met het aangepaste GAT A -1 gen te kruisen met muizen die het 
knipenzym (de schaar) in hun cell en maken kanje muizen krijgen die beide hebben en in hun 
cellen zal het GATA-1 gen (de Ius) worden verwijderd. Door nu het knipenzym te voorzien 
van een biologische aan/uitschakelaar zou het mogelijk moeten zijn om op ieder willekeurig 
tijdstip het GAT A-I te verwijderen. Dit bleek vooral in theorie een mooi idee. Het systeem 
werkt wei maar is niet efficient genoeg om in alle cell en het GATA-1 gen te verwijderen. Het 
systeem met het knipenzym zonder aan!uitschakelaar werkt perfect en is ook bijzonder goed 
bruikbaar voor het verwijderen van het GATA-1 in een bepaalde groep cellen. Dit werd 
bereih.'t door muizen te genereren die het knipenzym alleen in een bepaalde groep cellen 
maakt. Aileen in deze cell en werd het GATA -1 gen uitgeschakeld. 
Een voorbeeld hiervan wordt gegeven in Hoofdstuk 4 waar muizen worden 
bescbreven die geen GATA-1 gen meer in hun testis (testikels) hebben maar wei in hun rode 
bloedcellen. Zonder deze techniek was het niet mogelijk het gemis aan GAT A-I in de testis te 
bestuderen aangezien de muizen zonder GATA-1 in al hun cellen voortijdig sterven. Andere 
onderzoekers hadden door middel van andere experimenten afgeleid dat GATA-1 wellicht een 
belangrijke functie in de testis zou h."UU111en vervullen. Onze experimenten tonen aan dat 
GATA-1 kan worden weggelaten zonder dat dit enig effect heeft op de structuur en de functie 
van de testis. Wellicht heeft GATA-1 een functie, op andere tijdstippen van de ontwikkeling 
dan die nu zijn bestudeerd of in een stress situatie. 
In Hoofdstuk 5 wordt een techniek beschreven die het mogelijk maakt om rode 
bloedcellen in een eenvoudige en kleinschalige proefte testen op hun vermogen volledig te 
differenW!ren tot een volwassen rode bloedcel. Dit is een nieuwe techniek die is gebruikt in 
Hoofdstukken 2 en 3. 
In Hoofdstuk 6 worden resultaten van ons en anderen vergeleken en wordt er 
gespeculeerd over mogelijke modellen voor de functie en de regulatie van GATA-1. Het 
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eerste model behelst een verband tussen celdeling en GAT A-I. Een afnemende celdeling is 
namelijk een kenmerk van de eindfase van het differentiatieproces. In het tweede model wordt 
gespeculeerd over de regulatie van GAT A-I door REDS. Gedacht wordt aan een 
signaalmolecuul dat wordt uitgescheiden door een nonnale eel~ die wel volledig differentieert, 
dat wordt opgevangen en herkend door een abnormale eel die dan vervolgens toch kan 
differentieren. Dit zal een bestaand systeem zijn dat ook onder normale omstandigheden een 
functie heeft. Mogelijke kandidaten passeren het voetlicht. Als laatste worden mogelijke 
nieuwe proeven besproken die verdere opheldering kunnen geven. 
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